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Abstract 
 
The drastic rise in the world’s population coupled to an ever increasing aging population poses a 
considerable challenge to the orthopaedic community to maintain healthy activity levels.  The field 
of Tissue Engineering and Regenerative Medicine aims to tackle these challenges by implementing 
more biomimetic strategies to improve upon current treatments.  The success of new therapeutic 
developments in musculoskeletal tissue engineering relies on our ability to study and understand 
the complex biological interactions between cells, materials, and native tissues so that we may 
subsequently guide neotissue formation.  This thesis is focused on the development of novel, well-
defined, and reproducible in-vitro tissue culture models to explore, characterise, and control 
cellular behaviour and differentiation for osteochondral regeneration.  In particular, these models 
utilised combinations of polymeric biomaterials, differentiated osteoblasts, human periosteal stem 
cells, and physico-chemical cell signalling cues.  In a commercial venture with PolyNovo Ltd 
(Melbourne, Australia), a novel two-component injectable polymer platform was synthesized and 
evaluated for uses as a biomaterial construct in orthopaedic applications.  The second aspect of this 
thesis focuses on the harvest, isolation, expansion, and extensive characterisation of human 
periosteal cells in-vitro.  The periosteum is a bi-layered membrane that covers the outside of 
cortical bone and has been recently identified as a potential stem cell source; with the ability to 
form osteogenic, chondrogenic, adipogenic, and myogenic tissue types. To detail the heterogeneous 
cellular features and behaviours of human periosteal cells in-vitro, cells were isolated from surgical 
explants, expanding in monolayer in the absence of differentiation supplements, and characterised 
for changes in morphology, growth rate, cell-cycle, gene expression, and phenotype.  Additionally, 
enrichment techniques were designed to preferentially isolate distinct progenitor cell types 
identified in periosteal cell cultures.  Most interestingly, a novel cell-sorting platform utilising 
droplet microfluidic approaches, was developed and evaluated for its ability to identify and 
separate periosteal progenitor cells.  In the third part of this thesis, a 3-dimensional agarose culture 
model was created to control and monitor lineage specific human periosteal cell differentiation in 
various biomechanical and biochemical environments. The work presented herein further 
demonstrates the potential of human periosteal cells for osteochondral repair and more importantly 
provides critical information regarding human periosteal cell expansion, phenotype, and 
differentiation. 
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Figure A.1 Detection of ALP (A) and Col Type I (B) expression in adult human osteoblasts by 
immunofluorescent staining.  Primary osteoblasts were grown on chamber slides for 7 days and 
stained with conjugated antibodies specific for bone ALP (Green) and Col Type I (Red).  Cells 
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Chapter 1  
Introduction 
1.1 Background and motivation 
In developed countries, rapidly growing populations are continuously driving the expectations for a 
longer and more comfortable life. A majority of these demands are being shouldered by the 
medical community, with developments in surgical techniques and advancements in technology 
leading to an increased quality of life.  However, this situation has effectively become a “catch 22”. 
Medical technology has contributed to an increase in human longevity, which has in turn, has 
created a greater need for the replacement of tissues.  This is particularly important for the future, 
as we live in an increasingly aging population, where the number of people over the age of 60 is 
expected to rise by 50% (1;2).  This desire to live a more active, healthy life-style will place 
particular pressure on the orthopaedic community to provide new treatments for sustained mobility 
and ambulation throughout one’s life. These challenges faced by the orthopaedic community have 
led The World Health Authority to decree that 2000-2010 will be the Bone and Joint Decade (1).  
A relatively new branch of medicine has emerged with the intent of circumventing issues 
surrounding the deterioration of tissues due to aging, and trauma.  Aptly named Regenerative 
Medicine, it incorporates the fields of tissue engineering, biomaterials, stem cell technologies, and 
the study of associated human diseases to facilitate the repair, regeneration, and replacement of 
injured tissues (3).   
In recent years, skeletal reconstruction due to joint disease and trauma has become an increasingly 
common and important procedure for the orthopaedic community. In the United States and United 
Kingdom, a combined 50 million people suffer from some form of arthritis, accounting for roughly 
half of all chronic conditions in people over 65 (4;5).  These chronic degenerative joint diseases 
cause extreme pain and considerably limit mobility due to the destruction of joint structure and 
functional impairment.  Yet, these problems are not strictly associated with the elderly. Trauma, a 
major cause of mortality and morbidity in industrialised countries, has become the leading cause of 
death in people aged 1-44 years (6).  Of these trauma cases, a vast majority are musculoskeletal 
(bone, cartilage, and surrounding soft tissues) in nature. In the UK alone, there are approximately 
200,000 hospitalisations due to fractures each year, with more than half of these fractures being to 
the lower extremities (7;8).  Combined, these musculoskeletal disorders cost the UK society over 
£6 billion a year (7). These injuries due to joint disease and trauma may not always be severe, but 
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their management can be complex. Treatment often involves choices between non-operative 
management and different types of surgical intervention (9).   
Conventional approaches in musculoskeletal tissue repair include treatments such as autografts, 
allografts, and artificial grafts. Autologous grafts are the current “gold standard” in tissue repair; 
however, they create additional surgical sites, have limited availability, increase operative and 
recovery time, and have a risk of donor site morbidity (10).  Allografts, although more abundant 
than autografts, are hampered by risks of disease transmission, high cost, and variability of results 
(11). Artificial grafts and implants raise concerns regarding toxicity, fatigue, failure and need for 
revision surgery (12).  This is the current challenge that faces the orthopaedic community to date; 
how do you overcome the limitations of the limited lifespan and continued failing of bioinert 
artificial implants, while still improving the quality of life for millions of patients each year?  To 
address this concern, researchers introduce a number of “ideal” biomaterials each year for proposed 
uses in a wide variety of clinical settings.  However, the successful marriage of both 
biocompatibility and optimal mechanical properties has proved to be an extremely difficult task.    
Although there has been major progress in orthopaedic research in the last 20 years, current 
treatments of severe injuries related to bone and cartilage fail to achieve long-term stability and 
often led to secondary degeneration.  Over the past decade, there has been a definite shift in 
research emphasis, from developing bioinert man-made materials to more biological approaches 
concerning the natural regeneration of tissues (13).  This shift in research has led to the emergence 
of a new field, known generally as Tissue Engineering, where more biological regenerative 
therapies are designed to behave like autologous implants (“gold standard”).  “Tissue engineering 
is an interdisciplinary field that applies the principles of engineering and the life sciences toward 
the development of biological substitutes that restore, maintain, or improve tissue function” (13).  
Tissue engineering effectively seeks to bridge the gap between widely used engineering-based 
solutions (e.g. implantable metals (14;15), calcium phosphate bioceramics (16)) and limited 
biological treatments (e.g. autologous chondrocyte transplantation (17), osteochondral plugs (18)).   
Through the combination of knowledge from numerous fields, biologists, chemists, and engineers 
endeavour to produce “bioinspired” materials that not only serve as a structural tissue replacement, 
but also functionally integrate with the surrounding tissue.  Tissue engineering relies on the 
execution of three distinct strategies: 
? Isolated cells:  This approach avoids complicated surgical intervention, and permits 
expansion and manipulation of the cells towards specialised phenotypes prior to infusion.   
Potential problems include loss of cell function and immune rejection. 
Chapter 1: Introduction 
 
26 
? Cell-seeded matrices: This approach is broken down into two different systems.  In a 
closed system, the cell seeded matrix is encapsulated in a semi-permeable membrane, 
therefore isolated from the outside biological environment, which allows for the transport 
of nutrients and wastes but prevents penetration and destruction by immune cells.  These 
closed-system therapies can be used in pharmacological treatments to target tissue specific 
sites. In an open system, the cell seeded matrix is implanted directly into the patient, and is 
allowed to integrate with the surrounding tissue. 
? Tissue inducing cues:  The approach relies on the induction of appropriate physio-
chemical signalling cues, such as growth factors, into the cellular environment and the 
mechanisms used to deliver these cues to the selected cells. 
The tissue engineering approach to tissue repair and regeneration, shown schematically in Figure 
1.1, relies on a unique combination of the above said strategies.  In utilising these tissue 
engineering strategies in parallel, this thesis aims to design and characterise novel in-vitro 
therapeutic models with the ultimate goal of developing clinically relevant treatments for 
musculoskeletal disorders affecting bone and cartilage.  
 
Figure 1.1 Schematic representation of the methodology behind tissue engineering. (1) Cell isolation usually 
from a biopsy. (2) In-vitro cell expansion in tissue specific culture conditions. (3) The seeding of cells and 
exogenous growth factors into a three-dimensional porous structure called a scaffold. (4) Further culture of 
cell-scaffold construct to allow for infiltration and inhabitation, and finally (5) re-implantation of the cell-
construct tailored for the specific physical environment found at the site of repair and the tissue type it is 
repairing. (picture by Julian George) 
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1.2 Literature Review 
In this thesis, separate research projects were undertaken, each devoted towards a particular aspect 
of the tissue engineering triad; namely biomaterials, stem cells, and environmental stimuli.  In this 
context, a multidisciplinary framework is applied, utilising specific techniques from cell and 
molecular biology, chemistry, materials science, and engineering.  To design rational, “bio-
inspired”, therapies for musculoskeletal tissues, a heightened understanding of the interactions 
between cells, materials, and surrounding biological environment is necessary.  Thus, the following 
background section details the structural and biological properties of bone and cartilage and 
explores the recent developments and current challenges associated with bone and cartilage tissue 
engineering.   
1.2.1 Cartilage and Bone Biology 
Bone is a highly-ordered, hard, yet dynamic composite material (19); cartilage is a structured gel-
like matrix of proteins, proteoglycans and glycosaminoglycans (20). Both are highly organised 
tissues that assemble from the nano- to macro-scales to produce complex structural networks 
(Figure 1.2). Understanding of the subtle interplay that underpins these complex and sophisticated 
molecular dynamics is both challenging and crucial in the design of model systems for the repair 
and regeneration of orthopaedic tissues 
1.2.1.1 Cartilage 
Cartilage has three forms: hyaline, elastic, and fibrocartilage.  The type of cartilage with particular 
importance to the normal functioning of the skeletal system is hyaline cartilage.  The role of 
hyaline cartilage is then to provide a low-friction surface, participate in lubrication of synovial 
joints, and to distribute applied forces to the underlying bones.  For this purpose, hyaline cartilage 
consists of relatively low amounts of cells, chondrocytes, and an extensive extracellular matrix.  
The macromolecules that make up hyaline cartilage include collagen, mainly type II, 
proteoglycans, non-collagenous proteins, such as fibronectin, and glycoproteins (21).  This highly 
networked ECM combined with the fact that cartilage contains 77.7% water gives hyaline cartilage 
its strong mechanical and frictionless biological properties (22). However, when damaged, cartilage 
exhibits a unique inability to heal.  This is due to cartilage’s avascularity, low cell numbers, 
chondrocyte immobility, and limited capacity to proliferate (23).  This inability to regenerate itself 
makes cartilage a prime candidate for developing alternative tissue engineered therapies to heal 
damaged tissue. 
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Figure 1.2 Hierarchical structure of bone and cartilage. Bone and cartilage are highly organised over 
different length scales (adapted from (24)). Bone biomineralizes to form a calcified outer layer filled with 
osteons, or Haversian systems – each supplied by their own vasculature. The osteocytes within these systems 
are surrounded by a dense network of aligned collagen I fibres, which provide templates for the self-
assembly of hydroxyapatite crystals. Cartilage, in contrast, is a non-vascular, turgid network, which supports 
chondrocytes spaced between 10-200μm apart. Hydrophilic proteoglycans, such as aggrecan, interwoven 
between a network of collagen II fibres, provide a shock-absorbing matrix.  
 
1.2.1.2 Bone 
The major functions of bone are to provide mechanical support of soft tissues and provide a site of 
attachment for muscles used in locomotion.  Bones also serve as a major reservoir of calcium and 
phosphorus minerals, protect the central nervous system and organs from trauma, and house bone 
marrow, a primary source of adult stem cells in the body.  Furthermore, bone is capable of 
maintaining optimal shape and structure by a process of continuous self-renewal, such that it can 
respond to changes in its mechanical environment by remodelling (known as Wolff’s law)(25). 
Bone is a dynamic and adaptable organ that plays an integral part in the total functioning of our 
skeletal system.  Bone tissue consists of both cortical (compact) and trabecular (spongy) bone 
(Figure 1.2 and 1.3) containing 4 major cell types embedded in both organic and inorganic matrix 
components.  The cell types include: 
? Mesenchymal precursor cells- located in the periosteum and endosteum, connective tissue 
lining bones.  These cells have the potential to differentiate into osteoblasts, fat cells, 
chondrocytes, or muscle cells (26). 
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? Osteoblasts- bone-forming cells that synthesize and secrete unmineralised matrix 
components. 
? Osteocytes- mature bone cells that have effectively trapped themselves in the bone tissue 
they have secreted.  Maintain bone health by influencing mineral content and regulating 
calcium release into the blood.  Account for about 90% of the cells in the adult skeleton 
(27). 
? Osteoclasts- multinuclear cells that enzymatically break down bone tissue. 
The organic, osteoid, portion of the extracellular matrix consists of proteoglycans, glycoproteins, 
and collagen fibres, mainly type I, all secreted by the osteoblasts.  The inorganic component 
consists of mineral salts known as hydroxyapatites, which are largely composed of calcium 
phosphates.  The hydroxyapatite crystals attach to and surround the collagen fibres.  These ECM 
components give bone its properties of being strong and durable without being brittle.    
Cortical (compact) bone comprises the outer tubular shell of long bones, as well as the outer 
surface of the small and flat bones.  It contains densely packed cylindrical units called osteons (see 
Figure 1.2 and 1.3), which are arranged for optimal resistance to mechanical stresses. Trabecular 
(spongy) bone is less dense than cortical bone, and is found in the interior of flat bones and the 
epiphyses of long bones.  It is composed of an array of interconnected lamellae arranged in an 
irregular latticework of struts and rods, called trabeculae, with the spaces in between containing the 
bone marrow (28). This arrangement of the trabeculae is focused on resisting compressive stresses. 
Within these two types of bone there are thin networks of capillaries, known as Haversian and 
Volkmann’s Canals, where blood flow and nutrient and gas exchange occur.   
1.2.1.3 Periosteum 
The outer surface of long bone shafts is covered by a connective tissue, called the periosteum, 
which is composed of two distinct layers.  A highly cellular thin inner, “cambium”, layer which 
abuts the cortical bone and consists of osteoblasts, fibroblasts, and  mesenchymal progenitor cells,  
that have the capacity to differentiate into both osteoblasts and chondrocytes (29-32).  The thicker 
outer, “fibrous”, layer consists of fibroblastic cells immersed in large amounts of collagen and 
elastin fibres.  In addition to this, both layers are shown to have distinctive nerve and microvascular 
networks (Fig. 2)(33). 
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Figure 1.3 Cross-section of compact bone, trabecular bone, and periosteum (http://training.seer.cancer.gov), 
and corresponding histological images of compact bone and periosteum. 
 
The periosteum is known to cover the surfaces of long bones, however this coverage is not 
contiguous.  Periosteum is absent from articular surfaces, tendon insertions, and sesamoid bone 
surfaces and is present in locations of high-risk for fractures, such as femoral necks, distal radius, 
and vertebrae (34).  Also, site specific differences in periosteum anatomy, mechanical properties, 
and bone formation rates are known to exist throughout the skeleton (35). In support of these 
findings, it is suspected that changes in local mechanical environment in different areas of the 
periosteum may be a contributing factor to the increase or decrease in growth during the bone 
development and remodelling (36;37).   
The periosteum as a whole is anchored to the underlying bone by coarse bundles of collagen and 
elastic fibres, termed Sharpey’s fibres, penetrating from the outer fibrous layer (38).  With maturity 
these fibres thicken and bundles enlarge, effectively strengthening the connection between bone 
and the periosteum. As this process occurs, the effective level of mechanical stress needed to 
stimulate the cambial layer is raised (39).  Most importantly, the periosteum provides the interface 
between bone and muscle, and plays a vital role in remodelling of bone and cartilage tissue during 
developmental growth and fracture healing.    
1.2.1.4 Development and healing 
The developing long bone consists of three regions; diaphysis, epiphyses, and metaphyses.  These 
regions, established in the embryonic stage, continuously change size and shape until skeletal 
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maturity.  These developmental changes are due to an intricate sequential process of mesenchymal 
stem cell differentiation into chondrocytes (cartilage cells), which then undergo well-ordered and 
controlled phases of proliferation, hypertrophic differentiation, apoptosis, vascularisation, and 
finally cartilage ossification (40).  This process, known as endochondral ossification, leads to 
longitudinal growth and bone formation at the region between the epiphyses-metaphyses growth 
plates, directly below the cartilaginous articulating surfaces of the bone.  At the same time, there is 
radial growth of the diaphyseal and metaphyseal growth plates caused by new cortical bone being 
laid down by osteoblasts of the inner cambium of the periosteum.  This process is known as 
intramembranous bone formation. These two processes rely on the delicate functional balance of 
osteoblasts, osteoclasts, and chondrocytes.  This cell coordination is regulated by a plethora of 
factors, including intrinsic and extrinsic growth factors and hormones, and mechanical forces.  For 
an extensive list and discussion of regulatory molecules see Forriol and Shapiro’s review of this 
topic (41).   
During fracture repair in long bones, the periosteum is known to play a vital role in fracture callus 
formation, which promotes subsequent osteogenesis, and eventual ossification (42;43).  Initially, 
the periosteum contributes to increased cell production, resulting in periosteal thickening.  In this 
role the periosteum serves as a source of osteoprogenitor cells and extracellular fluids to nurture 
cells filling the fracture callus (44). In addition, the periosteum provides signalling cues to the 
repair cells to modulate and coordinate cellular processes.  Bone formation in the callus includes 
initial intramembranous bone formation mediated, in part, by periosteal cells undergoing primary 
osteoblastic differentiation and secondary endochondral ossification  by preceding chondrocytic 
differentiation of progenitor cells (45).  The recruitment and differentiation of these progenitor cells 
seems to be regulated by numerous cytokines and the local mechanical environment, however, the 
specific effects and interactions in normal fracture healing are yet to be fully elucidated (46).   This 
topic of cell differentiation control will be covered more completely in future sections. 
Similarly, the periosteum is also known to modulate bone size throughout an individual’s lifespan, 
which is recognised as a critical determinant of bone strength and possibly of fracture resistance 
(47).  This capacity to adapt can be seen during endocortical bone loss, which leads to higher 
stresses on the remaining bone, especially the periosteal surface where stresses are the highest in 
bending.  This change in mechanical environment results in compensatory periosteal bone 
formation to normalise the stress (48).   
The replication of these natural regeneration processes to recreate osteochondral tissues is the 
ultimate hope of musculoskeletal tissue engineering. This complex goal will require a deep 
understanding of the mechanisms behind these regeneration processes combined with an 
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appropriate tissue engineered construct.  Osteochondral constructs should consist of osteogenic 
and/or chondrogenic cell sources combined with an optimal biomaterial cell scaffold.   
1.2.2 Biomaterials 
Important to the success of regenerative strategies, is the ability to develop materials that can 
interface with tissues structurally, mechanically and biofunctionally (49).  Many acute and chronic 
musculoskeletal conditions, such as full-thickness and arthritic defects, require osteochondral 
substitutes to repair the damaged or diseased tissue.  The chemical and biological properties of the 
substitutes can vary greatly depending on the types of materials used.  For both cartilage and bone, 
it is advantageous to find versatile, implantable, biocompatible materials that direct tissue 
regeneration, whilst providing adequate structural support.  Current research is focused on a wide 
variety of bioresponsive materials which can simultaneously provide support and guide tissue 
repair, including bioactive glasses, biodegradable polymers, and extracellular matrix proteins. 
Scaffolds can broadly be termed as a temporary or permanent three-dimensional structure to 
support cells and provide them with a tissue specific environment and architecture (50).  An ideal 
scaffold for bone and cartilage tissue should possess these essential properties(13;19;51-54): 
? Biocompatible:  The scaffold should naturally integrate with the host tissue and should not 
illicit an immune response  
? Biodegradable: Scaffold degradation rate should be in tune with the growth of neo-tissue, 
so that by the time the injury site is totally regenerated the scaffold has been completely 
remodelled and degraded (55). 
? Mechanical Support: Scaffolds should have sufficient mechanical strength to support 
tissue ingrowth and provide a stable architecture for cell attachment.  For in vivo 
implantation, the mechanical properties of the construct should ideally match those of the 
bone and/or cartilage tissue it is repairing to reduce the recovery time (55;56).  
? Optimal Porosity: Scaffolds must have an open, interconnected porous structure with large 
surface area to volume ratios that will allow for nutrient and gas influx and the removal of 
waste. The microporosity (pores <10 µm) contributes to cell-scaffold interactions and the 
resorption and mechanical properties of the material. The macropores (pores >50 nm) 
allow for the in-growth and homogenous distribution of cells and facilitate 
neovascularisation (57).  It is well accepted that for bone tissue engineering, macropores 
should be within the 150-900 µm range and minimum of 100-200 µm for macropore 
interconnectivity (10;56;58)  
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? Osteoconductive (Bone): Osteoconduction is a physical effect whereby the scaffold forms 
a three-dimensional architecture onto which bone cells and capillaries, from the host, can 
grow into and form new bone (59).  An osteoconductive material guides the repair of bone 
in a location where normal healing will occur if left untreated (60).  The surface properties 
of the material, both chemical and topographical, can control and affect cellular adhesion 
and proliferation and their downstream signalling pathways (61). 
? Osteoinductive (Bone): Osteoinduction is a chemical process in which stem or progenitor 
cells are recruited to a bone healing site, and are stimulated to undergo osteogenic 
differentiation (59).  This can be accomplished through the use of biomolecules, such as 
bone morphogenic protein (BMP), transforming growth factor (TGF-β), and fibroblast 
growth factor (FGF), incorporated within the material scaffold (62). 
The aim of this section is to explore recent approaches that combine varying degrees of synthetic, 
natural, and biomimetic materials and different fabrication techniques to construct highly tailored 
environments for bone and cartilage regeneration.  The following review of materials and material 
systems is not meant to be a complete overview of biomaterials to date, but rather, highlight 
exciting new advances in the field of musculoskeletal tissue engineering.  For an extensive review 
of novel materials for bone and cartilage regeneration, please refer to my review in Current 
Opinions in Chemical Biology (63). 
1.2.2.1 Ceramic scaffolds 
Ceramics are non-metallic, in-organic, materials with mechanical properties strongly related to 
their porous crystalline-like structure (64). Hydroxyapatite (HA), β-tricalcium phosphate (β-TCP), 
and Bioglass® are generally considered bone bioactive ceramics (Figure 1.4) (65).  These are 
materials which bond to surrounding osseous tissue and enhance bone tissue formation.  Bioglass®, 
originally developed by Larry Hench and colleagues in 1969, has enjoyed considerable clinical 
success over the years for applications such as bone grafting, spinal fusion, revision arthroplasty, 
and middle ear repair (marketed under the name Novabone) (66;67).  Bioglasses are interesting as 
they possess the ability to chemically bond with the host bone and form a bone-like hydroxyl-
carbonate apatite surface layer in-vivo.  Numerous studies have shown that bioglass® stimulates the 
growth and osteogenic differentiation of primary human osteoblasts and enhances bone formation 
in-vitro (68;69).  Currently, a new generation of bioactive glasses are being fabricated thanks to 
advances in sol-gel processing techniques(70). These sol-gel derived bioactive scaffolds bear a 
unique interconnected mesoporous structure with hierarchical pore morphologies similar to 
trabecular bone (71).  Further these bioactive sol-gel glasses have a number of advantages over 
traditional melt-derived glasses as tissue engineering scaffolds, including higher rates of hydroxyl-
carbonate apatite (HCA) layer formation, faster bonding with bone, improved purity and 
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homogeneity, and enhanced degradability and in vivo resorption (57).  Research is now focused on 
understanding the underlying reaction mechanisms between bioactive glasses and surrounding 
bone-derived cell types.  This knowledge could lead to development of a new generation of 
bioactive glass implants for guided skeletal tissue regeneration.  
 
Figure 1.4 Images of ceramic based materials. (A) Image of a melt-derived bioactive glass powder 
(compliments of Yann Fredholm).  (B) Image of a 3D porous hydroxyapatite scaffold fabricated for 
mandibular reconstruction (work of Professor Russ Jamison). 
1.2.2.2 Polymer scaffolds 
Polymers such as polylactic acid (PLA), polyglycolic acid (PGA), copolymers of PLA and PGA 
(PLGA), polyanhydrides, polyorthoesters, polycaprolactones, polycarbonates, and polyfumerates 
have many properties that are well-suited for the purposes of tissue engineering (55). They are non-
immunogenic, non-toxic, and bioresorbable, breaking down through hydrolysis into metabolic 
products (although the build-up of acidic degradation products is recognised to be cytotoxic (73)). 
They are also convenient to process into solid phase scaffolds for implantation or as solutions for 
injection and polymerisation at the site of damage. In-situ polymerizable compositions, including 
photocrosslinkable polyanhydrides and chemical crosslinkable polyfumerates (74;75), can be easily 
administered in the form of arthroscopically injectable gels and liquids, and have been shown to 
possess adequate initial mechanical properties, controllable degradation kinetics, and the ability to 
simultaneously incorporate cells and growth factors to promote wound healing and support bony 
in-growth in-vivo (76;77). 
Scaffolds fabricated from unmodified synthetic polymers tend to have limited bioactivity and 
provide minimal biological cues to guide tissue regeneration. This can be overcome by the 
reintroduction of these cues in various forms – from functionalisation which alters surface charge 
density, to matching the underlying tissue architecture and the incorporation of peptide sequences 
that convey highly specific biofunctionality (Figure 1.5). For example, surface functionalisation, 
such as hydrolysis to expose carboxylic groups and aminolysis to expose primary and secondary 
amine groups, can be used to increase surface hydrophilicity, and has been found to encourage 
stronger interactions with serum and ECM proteins through electrostatic effects and hydrogen 
bonding (78). The presence of this adsorbed protein layer transforms the implant surface into a 
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biological landscape that supports cellular interaction and is important to numerous cell-fate 
processes (79).  
 
Figure 1.5 Enhancing material biofunctionality.  Control over cellular interaction for bone and cartilage 
repair can be achieved through scaffold material design. A number of different examples are presented here, 
ordered by increasing biofunctional specificity. Unfunctionalised: Unmodified polymer surfaces non-
specifically absorb proteins through weak interactions between the protein-water and water-surface 
interfaces.  Functionalised with charged groups: Chemical modification of the polymer surface with different 
charged end-groups (e.g. -OH-, -S-, -COO-, -NH3+) will increase electrostatic interactions and may lead to 
stronger protein absorption and structural rearrangements – which may expose hidden binding sites for cell 
attachment. Peptide functionalised: The incorporation of peptide motifs (RGD) can be used to increase the 
binding of specific cell receptors, directing cell behaviour. Peptide-polymer hybrid systems: By including 
peptides, such as protease sensitive degradation sites, within the polymer backbone, the scaffolds can be 
further enhanced to permit cell-mediated migration and degradation. rDNA protein systems: Synthetic 
artificial proteins can be designed to structurally and functionally resemble specific biological ECM 
constituents using recombinant DNA technology. 
 
In addition to foams and fibres, synthetic polymer based scaffolds have also been formed into 
hydrogels.  Due to biological and structural similarities to ECM, hydrogels can be applied as space 
filling agents, as delivery vehicles for bioactive molecules, and as 3-dimensional structures that 
organize cells and present stimuli to direct the formation of a desired tissue (80). However, due to 
the relatively weak mechanical properties of hydrogels, they have been limited to non-load bearing 
orthopaedic applications, such as chondrocyte encapsulation (81) and delivery vehicles of BMPs 
(82). Plant-derived alginate hydrogel scaffolds (83;84) and hydrophilic polymers such as 
poly(ethylene oxide), poly(ethylene glycol), poly(vinyl alcohol), and their derivatives have also 
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attracted interest for cartilage regeneration (85-88). Their high water content creates a cartilage-
like, porous, water saturated, viscoelastic material which supports the chondrogenic phenotype, and 
enhances the synthesis of neocartilaginous extracellular matrix constituents. Additionally, 
incorporation of terminal acrylate groups within synthetic polymers permits in-situ photoinitiated 
polymerisation for non-invasive implantation and the safe encapsulation of cells and exogenous 
growth factors into the hydrogel. 
Strategies, such as use of densely cross-linked dendrimer hydrogels (89) may also help to maintain 
scaffold mechanical properties through-out degradation. Their multivalent highly-branched 
structures provide the capacity to achieve high mechanical strength and high water content, 
advantageous for cartilage repair. Specifically, in one study, a hybrid block-copolymer hydrogel 
consisted of a tetrafunctional poly(ethylene glycol) (PEG) core bound using anhydride coupling to 
biodegradable poly (glycerol succinic acid) wedges (90). Terminally methacrylated groups allowed 
for in-situ photopolymerisation of the dendrimer network. This hydrogel system not only 
demonstrated promising results of chondrogenesis in-vitro, but also has the potential for facile 
tailoring of physical, biochemical, and mechanical properties by tuning the dendrimer 
concentration and subsequent cross-linking density. 
1.2.2.3 ECM protein scaffolds 
Natural polymers are used as tissue engineered scaffolds because they are generally biocompatible, 
have potential bioactive behaviour, are chemically versatile, and have controlled degradation rates.  
Another major advantage is they are biodegrable and are degraded by endogenous enzymes (91).  
These natural polymers are derived from animal or plant sources, including collagen (92-95), 
fibrinogen (96;97), chitosan (98;99), starch (100;101), and hyaluronic acid (102;103). Of these 
materials, collagen-based scaffolds have received a bulk of the attention for musculoskeletal tissue 
engineered constructs due to collagen’s highly organised structure, abundance in the body, ability 
to support a majority of tissue types, and the fact it can be osteoconductive, osteoinductive, and 
osteogenic (104;105).  However, some drawbacks of these natural polymers are they have 
relatively weak mechanical properties, especially in compression, and can cause an immune 
response in patients due to their plant and animal derivation . 
To address these challenges tissue engineers have created synthetic proteins from the combination 
of structurally and biologically important motifs identified from the major constituents of the ECM 
(106;107). Advances in gene and protein engineering have led to the design and creation of 
artificial peptide sequences taken from ECM proteins, such as elastin (108;109), collagen (110), 
fibrin (111), and fibronectin (112), commonly found in bone, cartilage, and wound healing 
matrices. With this emerging class of materials, it has become possible to precisely control the size, 
composition, sequence, topology, and stereochemistry of macromolecular architectures to produce 
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well-defined structural elements found in nature, such as β-sheets and α-helices. Once important 
structural and biofunctional motifs have been identified, scaffolds which target specific 
biofunctionality can be produced such as cell binding sites and enzymatic degradation domains 
(113;114) (Figure 1.5). For example, enhanced chondrocyte migration was conferred onto a PGA 
fibre scaffold by an artificial protein composed of multiple repeats of the collagen II D4 domain 
(115). Protein segments can be coupled to synthetic polymers to form hydrogel networks with 
enhanced mechanical stability, through various chemical (i.e. radical polymerisation, reaction of 
functional groups, addition reactions) or physical (i.e. hydrogen bonding, electrostatic interactions, 
metal complexation) cross-linking methods (116).  
1.2.2.4 Hybrid materials 
To date no biomaterial has been able to demonstrate properties sufficient for all musculoskeletal 
applications, given the very unique biochemical and biomechanical properties associated with each 
application.  Therefore, recent research has concentrated on the fabrication of material hybrids.  
The properties of these composite materials can be widely varied based on the proposed 
application, and it is this versatility that makes them an attractive strategy for new musculoskeletal 
tissue engineering treatments.  Sherwood et al, have developed a PLGA/PLA/TCP heterogeneous 
composite consisting of different porosities and pore structures for uses as an osteochondral 
substitute (117). Chondrocytes were seen to preferentially attach to highly porous regions of the 
construct, and biochemical and histological analysis revealed hyaline-like cartilage formation after 
6 weeks in culture. The tensile properties were also similar to that cancellous human bone, 
suggesting that these scaffolds have desirable mechanical properties for in vivo applications.  
Another group has developed a multiphase composite for repair of osteochondral defects composed 
of  poly(D,L)lactide-co-glycolide combined with PGA fibres, 45S5 Bioglass® and medical grade 
calcium sulphate (118).  These additives were used to vary stiffness and chemical properties of the 
construct when implanted into goats.  Histological sections of the defect sites showed a high 
percentage of hyaline cartilage and good bony restoration, with new tissue integrating well with the 
native cartilage. 
Scaffolds can also be rationally designed with specific biofunctionality by combining synthetic 
polymers with short peptide sequences (Figure 1.5). The peptide sequence most actively 
investigated is the RGD- binding domain recognised by trans-membrane integrin receptors present 
on the cell surface (119). These short sequences are found within ECM proteins, such as collagen 
and fibronectin, and are known to promote osteoblast (120;121) and chondrocyte cell adhesion 
(122) and expression of ECM specific proteins (123). Recently, an RGD sequence found in bone 
sialoprotein (BSP), has been used to specifically promote osteoblast migration and adhesion 
(124;125). Receptor binding to RGD appears to be strongly influenced by the guanidine side group 
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of the arginine residue. A recent study demonstrated that it is also possible to synthetically 
approximate the binding affinity of the RGD peptide by including agmatine, the decarboxylation 
product of arginine, into synthetic polymer hydrogels, resulting in substantially increased cell 
adhesion (126). 
Hybrid multifunctional networks can be formed from bioactive precursors containing chemically 
reactive functional groups (such as amines, thiols, carboxyls) or end-functionalised hydrophilic 
polymers (such as PEG) that act as physical or chemical crosslinkers.  Additional structural control 
can be achieved by using monoacrylated derivatives for photocrosslinking or specific amino acid 
sequences to induce covalent or electrostatic protein-protein interactions. From their modular 
design, researchers have been able to create multifunctional networks that possess high levels of 
structural organisation and an array of biochemical and biophysical properties. Some of the most 
intelligent hybrid systems are focused on mimicking the ECM’s susceptibility to cell-triggered 
proteolysis, enabling cell invasion and subsequent remodelling of the matrix constituents. The most 
versatile and well-characterised of these bioresponsive systems are based on poly(ethylene glycol) 
(PEG)-peptide hydrogels (127-130). The peptides in these systems are designed as substrates 
sensitive to proteases, such as plasmin and matrix metalloproteinases (MMPs), expressed at the 
surfaces of migrating cells (Figure 1.5) (111;131;132). MMPs are a family of ECM degrading 
enzymes, with MMP-2, MMP-9, and MMP-13 implicated as the key players involved in ECM 
turnover during bone development and remodelling (133;134).  
In one approach, vinyl sulfone-functionalised 4-armed telechelic PEG macromers were reacted 
with thiol bearing MMP- and integrin (RGD)-binding peptides via highly selective Michael-type 
conjugate additions (128;130;135). Polymerisation was induced in-situ using a di-cysteine MMP-
sensitive peptide cross-linker. This is an effective system for influencing new tissue ingrowth and 
scaffold mechanics by way of controlled proteolytic degradation. Other methods of gelation and 
incorporation of bioactive molecules, such as enzymatic cross-linking (136) and 
photopolymerisation of acrylate-terminated precursors (111;137), have also been used to form 
PEG-based hydrogels. As an additional feature, exogenous growth factors, such as recombinant 
human bone morphogenic protein-2 (rhBMP-2) (130;135) and angiogenesis-inducing signal 
vascular endothelial growth factor (VEGF) , can also be incorporated into the hydrogel matrix via 
physical entrapment (128). By exploiting their MMP-mediated degradation activity, these networks 
better mimic the natural bone remodelling process by the release of osteogenic factors following 
bioactive matrix degradation. For bone repair, these synthetic materials demonstrated integrin- and 
MMP-dependent cell infiltration in temporal and spatial synchrony with endogenous bone 
regeneration. Metalloproteinase sensitive materials have also been successfully developed for 
Chapter 1: Introduction 
 
39 
cartilage repair and chondrocyte culture, showing a higher expression of matrix proteins as 
compared to gels insensitive to proteolysis (138). 
Looking to the future of biomaterials, complex approaches utilising materials and fabrication 
techniques can be used to impose new levels of control over scaffold nanostructure and mechanics.  
Novel approaches not covered in this review include electrospinning (139;140), peptide self-
assembly (141;142), and biomemetic mineralization(143;144).  Further, emerging high-throughput, 
analytical technologies, such as polymer (145) and protein (146) microarrays, can be combined 
with recent advances in genetic engineering, to identify and create novel biomaterials that meet 
specific mechanical requirements and illicit particular cell-specific interactions. Whether scaffolds 
are used chiefly as support structures which adsorb ECM proteins and encourage tissue in growth, 
or as synthetic extracellular matrices, providing the cues needed for tissue regeneration, will 
depend on the requirements of the tissue type and application. The continued development of 
biospecific materials is essential to each of these approaches. 
1.2.3 Cell Sources for Musculoskeletal Tissue Regeneration 
For the purpose of regenerating orthopaedic tissues, there are many options of cell sources (Figure 
1.6).  Today, the use of autologous cells is the obvious first choice as it can reduce problems due to 
immune rejection, inflammatory response, and pathogen transfer.  However, due to recent advances 
in stem cell research, the strict use of autologous cells is likely to change.     
1.2.3.1 Differentiated Cells 
Autologous cell transplantation is a widely accepted technique in the repair of skeletal tissues, 
particularly for treatment of cartilage defects.  Since 1995, autologous cartilage transplantation 
(ACT) has provided a major advancement  in the pursuit of joint surface engineering (147).  ACT 
therapy, Carticel®, was the first biological cell therapy to be licensed by the Food and Drug 
Administration in the US, and has recently attained a milestone of treating 10,000 patients 
(www.carticel.com).  In this process, articular chondrocytes are obtained arthroscopically from a 
minor weight bearing area of the joint, culturally expanded in a laboratory, and finally transplanted 
back into the patient’s knee and covered with a periosteal flap.  However, these procedures are not 
without their challenges.  Problems of reproducibility and consistency of results are faced due to 
variability in surgical procedure, cell culture expansion and manipulation using animal products, 
and loss of phenotype.  The expansion of chondrocytes, for example, is often hampered by 
problems of cell senescence and de-differentiation, which can cause the formation of dysfunctional 
cartilage when transplanted (148-150).  Furthermore, harvesting these cells results in an additional 
surgical site and increases the potential for another defect.  Alternatively, stem cells, such as adult 
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stem cells (ASCs) and embryonic stem cells (ESCs), have become of recent interest in 
musculoskeletal tissue repair due to their capacity to differentiate into multiple cell lineages. 
1.2.3.2 Stem Cells 
Stem cells are undifferentiated cells that are capable, to some degree, of undergoing both self-
renewal and differentiation into more functionally specialised mature cells (151). When a stem cell 
divides the daughter cells can, depending on the environmental stimuli, either remain a stem cell or 
become a more specialised cell called a progenitor cell,  for example a blood, bone or brain cell 
(152).  However, stem cells have varying degrees of differentiation potential, or plasticity.  
Embryonic stem cells are considered to be pluripotent, which means they can differentiate into 
almost all cell types arising from the three germ layers of a developing human (153).  Adult stem 
cells are thought to be multipotent, which means they  are only capable of giving rise to cells 
related to the germ layer in which they originated .  Although, the limit of this “multipotency” is of 
recent debate due to research suggesting that “transdifferentiation” of adult stem cells occurs 
(154;155).  Transdifferentiation is the ability of a cell of one tissue, organ or system to differentiate 
into a cell type characteristic of another tissue, organ, or system; e.g., for blood stem cells to 
become liver hepatocytes.   
 
Figure 1.6 Microscopy images of human embryonic stem cells (A), mouse embryonic stem cells (B), human 
mesenchymal stem cells (C), and human periosteal cells in monolayer culture.  Image A shows a colony of 
human ES cells growing on a feeder layer of mouse embryonic fibroblasts.  Image B shows colonies of 
undifferentiated mouse ES cells.  Image C shows a dense colony of human MSCs and image D shows a 
heterogeneous population of human periosteal cells growing in monolayer (scale bar = 200 µm).  
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1.2.3.2.1 Adult Stem Cells 
Adult stem cells (ASCs) are undifferentiated cells found among differentiated cells of a specific 
tissue. ASCs are more accurately called somatic stem cells as they can also come from foetuses, 
umbilical cords, and infants. Adult stem cells are believed to exist in small numbers in most organs 
throughout the body (including the bone marrow, liver, gut, blood and brain) and are called upon 
during biological repair mechanisms to replace damaged cells (156).  The bone marrow has been 
found to contain undifferentiated ASCs that have the ability to give rise to progeny of different 
tissue types. Two of most researched subpopulations of these bone marrow stem cells are 
Mesenchymal Stem Cells (MSCs) and Haematopoietic Stem Cells (HSCs).  MSCs capacity to 
differentiate into cells of the mesenchyme makes them an attractive cell source for musculoskeletal 
tissue engineering. 
Mesenchymal stem cells 
MSCs are non-haematopoietic, stromal cells that, under the appropriate stimuli, can differentiate 
into bone, cartilage, fat, tendon, and muscle cells (157).  Originally isolated from bone marrow and 
stroma of the spleen and thymus, MSCs have more recently been isolated from various other sites, 
including periosteum, synovium, synovial fluid, vasculature, muscle, and tendon (158-160).  MSCs 
are believed to be called upon during biological repair mechanisms to replace damaged cells, 
however, it is not yet clear to what extent they are responsible for this. Skeletal progenitor cell-
based therapies offer many advantages over fully differentiated cell sources, including; reliable 
isolation, ease of expansion, maintenance of phenotype, relative lack of senescence, and evidenced 
low immunogenicity (161).  In-vitro MSCs are characterised by their capacity for continuous self-
renewal and their functional ability to form distinct fibroblast-like cell colonies (termed colony 
forming unit-fibroblastic) with the ability to differentiate into multiple mesenchymal lineages 
(Figure 1.6) (162;163).  Utilising these advantages, musculoskeletal tissue engineering strategies 
can facilitate tissue regeneration by loading MSCs into prefabricated scaffolds tailored to fit into 
defect sites.   
MSCs seeded constructs have enjoyed successes in several animal models.  MSCs isolated from 
adipose tissue were seeded onto collagen-ceramic composites and implanted in large defects in rats 
(164). Healing was seen to occur after only 8 weeks. Similar results are seen in larger animal 
models, where MSCs loaded onto porous scaffolds were found to accelerate osteogenesis in large 
bone defects in both sheep and canine (165;166). MSCs have also been shown to elicit a healing 
effect in osteochondral defects.  Subchondral implantation of porous hydroxyapatite-synthetic 
polymer composites loaded with MSCs and bone morphogenic protein-2 have been shown to repair 
full-thickness cartilage defects within 6 weeks in rabbits (167).  More recently, these promising 
results from early animal models have championed for the use of MSCs in small-scale clinical 
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trials. Quatro et al. have shown complete restoration of limb function after 6-12 months when 
porous ceramic scaffolds loaded with MSCs were implanted into large bone defects in humans 
(168).   Although these studies are promising, the development of large-scale MSC-based clinical 
therapies has been limited. This is due to insufficient knowledge of long-term stability of the 
regenerated tissue and MSC’s tendency to differentiate towards unwanted lineages.   
Haematopoietic stem cells 
In fetal and adult mammals, haematopoietic stem cells (HSCs) predominately reside in the fetal 
liver (FL) and bone marrow (BM) and can be identified by the presence of surface glycoprotein 
CD34.  However, HSCs do not originate in FL or BM, but rather migrate from other tissues to 
these sites during embryonic development.  Due to their relatively short life-span, HSCs 
continuously differentiate into multiple lineages of different blood cell types, and replicate 
themselves through self-renewal.  The marrow contains specialised environments that regulate the 
balance of HSC self-renewal and differentiation and comprise what has been termed the stem cell 
niche.  The concept of stem cell niches was first proposed by Schofield  in the late 1970’s (169).  
However, it has been only recently that the HSC niches in adult BM were directly observed and 
partially dissected (170).  From this study, two types of HSC niches have been identified in BM; 
the endosteal niche located on the surface of trabecular bone, vascular niche at the BM sinusoids, 
which are blood vessels with a fenestrated endothelium located in the center of BM.  Osteoblasts, 
which are found lining the endosteal surface, were the earliest identified components of this stem 
cell niche.  Osteoblasts seem to regulate HSCs though a complex interplay between cell-surface 
molecules, signalling molecules, cell-to-cell contact, and interaction with ECM components, that 
promote the proliferation of hematopoietic cells in culture and support the in vitro maintenance of 
HSCs (171;172).  Direct evidence supporting osteoblasts as an essential component of the HSC 
niche comes from recent studies in which osteoblast numbers were experimentally increased or 
decreased, which resulted in the HSC number changing in a parallel manner.  These interactions 
have been shown to be partly regulated by osteoblast cell-adhesion molecules N-cadherin and β1-
integrin (173;174) and signalling ligands angiopoietin-1 (Ang-1), Notch ligand, Jagged1, Wnt 
proteins, and others (175-177).   
Although it is known that mesenchymal stem/progenitor cells and their descendents play a role in 
hematopoeisis, much less is understood about stem/progenitor cell regulation by hametopoetic 
cells.  Recently, in limiting dilution experiments of rat marrow stromal cultures, Jane Aubin found 
that osteoprogenitor cell populations are, in-part, regulated by non-osteogenic lineages in the bone 
marrow through both direct cell contact and secreted factors (178). Thus it is likely, that 
osteoprogenitor cell differentiation in the bone marrow stroma may be under the influence of a 
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complex hierarchy of cells and factors, not unlike the hierarchy of cells and factors controlling the 
differentiation and propagation of hematopoietic origins.   
Interestingly, several reports have suggested that bone marrow and bone tissues share a common 
progenitor cell that can give rise to both osteoblasts and hematopoietic cells and is present in the 
non-adherent fraction of bone marrow in humans (179).  Bone marrow, bone, and periosteum are 
anatomically contiguous tissues that show parallel age related changes and several genetic features, 
suggesting a close developmental cellular relationship (180-182). Thus a reasonable hypothesis is 
that haematopoietic cells present in the periosteum and surrounding vasculature harbour a stem cell 
with osteogenic potential or play an accessory role in the differentiation and self-renewal of 
periosteal progenitor cells through direct or indirect pathways.   
Periosteal Cells 
Periosteal cells can offer many advantages as a cell source for musculoskeletal tissue engineering.  
First,  perisoteal cells have demonstrated the potential for osteogenic and chondrogenic 
differentiation in numerous studies in-vivo and in-vitro (29;183;184;184-193).  Second, periosteal 
cells have an extensive self-renewal capacity; with the ability to undergo significant self-replication 
during subculture whilst maintaining a stable phenotype (Figure 1.6) .  Further, this phenotypic 
stability can be maintained after enzymatic liberation and cryopreservation (184).  On the basis of 
these studies, periosteal cells have been named multipotent mesodermal cells, osteoprogenitor cells, 
precursor cells, mesenchymal stem cells, and mesenchymal precursor cells.  Compared to bone 
marrow aspirates which only contain 103 progenitor cells/cm3, periosteal progenitor cell isolation 
is a safer, more efficient, and less painful clinical procedure (194). In addition, the potential for 
continuous expansion and osteochondral differentiation of periosteal cells has been demonstrated in 
elderly individuals (187), whereas, the number of progenitors in bone marrow is seen to decline 
with age (195). Despite the promise of periosteal cells as a regenerative cell source, attempts to 
functionally control and characterise periosteal cell populations have resulted in varying levels of 
success. The discrepancies seen between studies can be attributed to numerous variables, although 
the two major players seem to be differences in species and particular culture conditions.  I will 
now highlight some of these discrepancies. 
Arnold Caplan’s group was the first to study periosteal cells in-vivo as a potential bone tissue 
engineering cell source, using chick periosteal cells and human rib periosteal cells in a series of 
nude mouse experiments (159;184;185).  In the human periosteal cell study they found that cells 
isolated from donors younger than 19 years, consistently formed bone and/or cartilage.  In the case 
of donors older than 22 years, cultured cells formed neither bone nor cartilage in-vivo (184) These 
early studies are supported by more recent studies, in which the chondrogenic potential of 
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periosteal cells is dependent on donor age and cell passage in culture (196;197).  In the O’Driscoll 
rabbit periosteum studies this decline in chondrogenic potential is attributed to a decrease in the 
size of the precursor pool in the cambium layer, which is seen to thin during aging (198;199).   
Conversely, the periosteum is known to actively participate in fracture healing and bone 
remodelling in-vivo, by generating hyaline cartilage, which then undergoes endochondral and 
intramembranous ossification (see section 4.1.4).  These processes are seen to occur over the 
lifetime of the individual, regardless of age.  This observation is supported by Koshihara et al 
(187), who concluded that the mineralization potential of periosteal cells is not age dependent, and 
Sang et al (200), where human periosteal cells are shown to maintain their progenitor phenotype 
after extensive passaging,  regardless of donor age. 
Between these two extremes, a study performed by De Bari et al demonstrated that this relationship 
is more complex (201). He found early passage periosteal cells isolated from young (<30) human 
explants had the ability to undergo spontaneous chondrogenesis (without the use of chondrogenic 
growth factors, or other culture techniques).  This potential is rapidly lost after cell passaging and is 
not observed in donor older than 30 years.  However, this group also reported that independent of 
age and passage number, periosteal differentiation toward the chondrogenic phenotype could be 
elicited reproducibly and consistently when a micro-mass pellet culture system was combined with 
TGF-β1 treatments.  This suggests that periosteal cells isolated from elderly individuals and 
extensively passaged still posses the competence to respond to at least 1 chondrogenic signal.  
These studies reveal that a direct connection between age and osteogenic/chondrogenic potential 
becomes more complicated and less certain as more studies are published on periosteum biology 
and its varying functionalities.   Similar discrepancies are found regarding literature on the use of 
growth factors to enhance periosteal chondrogenesis and osteogenesis in-vitro.  The large 
differences in the results can be attributed to the fact that the influence of growth factors is 
dependent on cell species, cell passage number, dose amount, dose regime, antagonistic/synergistic 
effects with other biomolecules and factors, and the culture methods used.  
In highlighting these discrepancies found in literature, I am attempting to show that the research 
and understanding regarding the periosteum is still in its infancy.  The true versatility of periosteal 
cells and their therapeutic potentials have yet be elucidated, let alone harnessed.  Although 
investigations into the bipotentiality of animal and human derived periosteal cells cultured in-vitro 
serve as excellent models, there is still a need to establish a more accurate in-vitro model to control 
and predict the in-vivo behaviour of periostea for wide-spread clinical use.  To develop such a 
model, extensive characterisation studies are required to elucidate the heterogeneous phenotypes 
and properties of human periosteal cells in-vitro. 
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1.2.3.2.2 Embryonic Stem Cells 
 
While adult stem cells have been used successfully for over 30 years (bone marrow 
transplantation), embryonic stem cells  have only recently been isolated from humans in 1998 
(202). Pluripotent stem cells can be derived from the inner cell mass of blastocysts of 
preimplantation embryos (ES cells) or the primordial germ cells of embryos (EG cells) (202;203).  
Primordial germ cells can be first identified as a small cluster (~8 cells) within the proximal part of 
the epiblast in embryos that are 7 days post coitum.  Human ES and EG cells have unique features 
including unlimited growth capacity, expression of specific markers, normal karotypes, and an 
ability to differentiate into cells of all three embryonic germ layers (204-206).  Differentiation 
generally leads to the formation of teratomas in-vivo and embryoid bodies (EBs) in-vitro, which 
contain derivatives of all three germ lines (Figure 1.6). 
Human embryonic stem cells at the most immature stage  are characterised by expression of the 
globo-series glycolipids SSEA-3, SSEA-4 (207;208), the keratan sulphate-related antigens TRA-1-
60 and TRA-1-81 (209;210), and by a lack of expression of the lacto-series oligosaccharide SSEA-
1 (211;212).  Historically, SSEA-1 is a known marker of murine enbryonal carcinoma, embryonic 
stem and germ cells (213).  Recently, however, there is evidence to suggest that the SSEA-1 
antigen is a differentiation marker in human embryonic stem cell cultures, positively staining for 
early intermediate stem cells (214).  One group used the SSEA-1 marker for positive and negative 
selection of neural stem and precursor cell subpopulations in a hESC differentiation paradigm 
(215).   Within this study they also consistently found SSEA-1+ cell subsets to co-express the 
pentaspan membrane glycoprotein CD133, a known somatic stem cell marker (216-218). 
Concurrently, in SSEA-1+ human ES cell cultures differentiated cells present at the periphery of 
embryoid bodies stained strongly positive for SSEA-1, whilst undifferentiated cells at the centre 
were unstained.  
As compared to ASCs, ES and EG cells possess greater pluripotency and ability for self-renewal, 
which makes them a more versatile therapeutic option (219). Clinal applications of ES and EG cells 
remain restricted due to the potential of uncontrolled differentiation and proliferation and the 
ability to form tumours (220;221). The orthopaedic potential of ES and EG cells therefore relies on 
the directed differentiation of ESCs into skeletal cells, e.g. chondrocytes, osteoblasts, and 
tenocytes.  To prevent the spontaneous differentiation of ESCs in vitro, precise culture conditions 
must be maintained with feeder cell layers and specific growth factors, such as leukaemia 
inhibitory factor in mouse ES cultures. The signalling pathways underlying self-renewal and 
pluripotency of ESCs in culture have only recently begun to be unravelled.  The ability to guide 
ESCs towards a specific cell type without the use of animal products will require a further leap of 
understanding. 
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1.2.3.3 Stem cell enrichment methods 
Despite the recent experimental and clinical interests in stem and progenitor cells, defining the 
function and phenotype of these cell types remains a difficult task.  These difficulties stem from the 
low frequency of stem/progenitor cells in tissues (~0.001-0.01% in bone marrow aspirates) and 
their cellular heterogeneity; in terms of morphology, differentiation potential and lineage 
commitment (163;222;223).  To add to this variability, there seems to be a number of compounding 
peri-cellular factors that influence stem/progenitor cell numbers in culture and regulate the 
proliferation and further differentiation of their progeny (224-226).  As such, there are still few 
standardized methods for isolating and expanded pure stem cell populations.   This lack of 
knowledge presents a major obstacle to the widespread clinical exploitation of stem cells’ 
therapeutic potential.  Moreover, enrichment steps will be necessary when creating novel stem cell 
and gene therapies, which rely upon the selection and characterisation of rare stem cell populations 
identified in numerous adult tissues (227-232).  To resolve these issues, numerous groups are 
focused on the development of simple protocols to identify and enrich stem/progenitor cell 
populations based on numerous intra-cellular and extra-cellular features, including morphology, 
protein expression cytoplasmic granularity, and cell-cycle. 
To date, a variety of isolation strategies have been employed for this task, including fluorescent 
activated cell sorting (FACS), limiting dilution, density centrifugation, magnetic sorting, and 
adherence to glass and plastic surfaces (233;234). Most popular amongst these techniques is FACS, 
which is a specific type of flow cytometry that allows each cell to be characterised and sorted 
according to a range of distinct biochemical and biophysical characteristics (Figure 1.7A). 
Exploiting this strategy, rare cell types such as stem cells, antigen-specific B and T cells and 
circulating tumour cells have been identified and isolated (235-239). These successes are, in part, 
due to developments in fluorophore and antibody production and availability, which have led many 
researchers to focus their purification efforts on immunophenotypic assays utilizing cocktails of 
monoclonal antibodies (240-247). Of these antibodies, Stro-1 has been extensively utilised for 
enrichment efforts and is found to be expressed on a small population of clonogenic multipotent 
stem cells (248;249).  In this way, rare stem/progenitor cell populations are targeted based on the 
expression of intra-/extra- cellular molecules  
Although these popular techniques have enjoyed widespread use over recent years, new analytical 
technologies offer the promise of improved analytical performance, enhanced functionality and 
robust versatility in a variety of cell-based assays (250-255). Amongst these technologies, droplet 
microfluidic systems offer the possibility of rapid, specific and detailed analysis of cell 
populations. In these systems, picolitre-sized droplets generated from immiscible phases can be 
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produced at high frequencies (in excess of 1 KHz) and can act as discrete and isolated reaction 
compartments to study a number of biological and chemical processes (Figure 1.7B) (256).  
 
 
Figure 1.7 Schematic representations of rare cell identification and isolation techniques; flow activated cell 
sorting (A) and droplet microfluidics (B).  Both methods provide a means for sorting heterogeneous mixtures 
of cells based on specific light scattering and fluorescent characteristics. (A) In FACS, temporary voltages 
are applied to droplets carrying targeted cell phenotypes, after which the charged droplets then fall through 
an electrostatic deflection system that diverts the droplets into containers based upon their charge.  (B) 
Schematic of a microfluidics device which when combined with a fluorescent detection system provides a 
noval analytical platform to isolate and study single cells in aqueous droplets. (C) Microscopy image of 
droplets flowing though microchannels (50 µm wide, 50 µm deep, and 4 cm long) containing entrapped 
mammalian cells. 
 
In this context, droplet microfluidic systems have been used as an analytical tool to examine 
enzyme kinetics(257), libraries(258), and assays(259), protein crystallisation(260;261) and 
biological assays(262;263). More recently, droplet microfluidic systems have been successfully 
demonstrated to effect single cell encapsulation and manipulation (255;262;264). Accordingly, 
such droplet systems have the potential to define a new high-throughput screening platform that 
can sample, encapsulate, manipulate, process and detect single cells and more importantly the 
presence of rare stem cell phenotypes. For cell biologists and tissue engineers alike, the 
compartmentalization provided by the droplets is particularly valuable for precisely analyzing 
multiple cellular characteristics simultaneously. An initial demonstration of this biological potential 
was recently provided by Huebner et al (262) and Koster et al (265), where droplet-based 
microfluidic systems were able to quantify protein expression and cell viability and metabolism. 
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Further diagnostic studies are now needed to determine if microfluidics-based approaches can 
accurately identify and sort rare stem cell phenotypes without causing viability loss and changes to 
cell behaviour; both of which have plagued flow cytometry-based enrichment methods. 
1.2.4 Control of cell differentiation 
Cells interact with their local environment through a number of sensors, known as receptors, which 
mediate specific intracellular responses, including cell differentiation.  These signalling pathways 
are regulated by numerous autocrine and paracrine molecules, including ions, growth factors, and 
proteins, and biomechanical environments. 
Of the regulatory molecules, growth factors have received a great amount of attention. Growth 
factors are peptides that regulate cell growth, function, motility, and differentiation.  Bone and 
cartilage growth factors influence the synthesis of new bone and cartilage by acting on local or 
circulating populations of differentiated and/or progenitor cells.  Bone morphogenic proteins 
(BMPs) have been shown to play a critical role in modulating mesenchymal differentiation, 
inducing the complete sequence of endochondral bone formation (266).  Similarly, the 
transforming growth factor-beta (TGF-β) and fibroblast growth factor (FGF) superfamilies, have 
been implicated in the regulation of several biological processes, including cell differentiation, cell 
growth, and embryonic pattern formation (267;268).  There are vast amounts of cytokines, which 
could be talked about in the context of skeletal tissue development and maintenance; however this 
is beyond the scope of my project, which chooses to concentrate more on the role of mechanical 
stimulus. 
The conversion of external physical forces into biological signals and physiological responses, is 
known as mechanotransduction, and is contained within the broad field of mechanobiology (269).  
The influence of mechanical forces on bone adaptation has been of interest since 1870, when Wolff 
first discovered that bone responds to external mechanical stimuli to either reduce or increase its 
mass as required (25).   More recently, physical forces have been found to play a role in regulating 
not only functional adaptation, but also normal skeletal development and fracture healing on the 
organ, tissue, cellular, and molecular levels (270-273).   
At the organ level, mechanical signals can be characterised in terms of loading history, which 
includes force, displacement, and deformation characterisation.  At the tissue level, varying 
quantities of stress and strain have been related to differentiation (274-277).  Stress and strain are 
tensor quantities defined by six components and a reference coordinate system.  Pauwels et al, 
concluded that the important information for tissue mechanical signalling was contained in stress 
and strain invariants, which are scalar quantities (275).  These stress and strain invariants result in 
distortional and hydrostatic stress or strain. In elastic, isotropic materials hydrostatic stress causes a 
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change in material volume, or volumetric strain, but no distortion. Conversely, distortional stresses 
cause material deformation, or distortional strain, with no change in volume.  Building on these 
concepts, Carter et al and Giory et al, developed finite element models to relate mechanical loads to 
skeletal tissue differentiation (Figure 1.8) (278-280). 
 
 
 
 
 
 
Figure 1.8 Phase diagram established by Carter et al. concerning the role of mechanical loading history on 
skeletal tissue regeneration 
 
In this model, they formulated that compressive hydrostatic stress regimes guide cartilaginous 
matrix formation, whereas tensile strain regimes guide connective tissue formation.  Fibrocartilage 
is formed in regions of high tensile strain and hydrostatic compressive stresses.  Bone formation 
occurs in regions exposed to neither significant compressive hydrostatic stress, nor significant 
tensile strain. However, direct bone formation also requires vascularisation, so in the case of low 
oxygen tension, preosseous tissue can be directed to down a chondrocytic pathway (279).   This 
basic model has been applied to studies looking at fracture healing (270;272), bone implant 
interface (280), and fibrous tissue formation in tendons (278). 
Investigations into the mechanical environments of healing fractures and distraction osteogenesis, 
using finite element analysis, have revealed that the periosteal surfaces of bones experience a wide 
range of loading histories, which elicit different tissue differentiation patterns (281).  Results 
revealed that periosteal tissue outside the fracture gap is subjected to relatively low hydrostatic and 
tensile strains, which promotes intramembranous bone formation.  At the site of fracture, 
periosteum forms an osseous bridge across the gap, where it effectively shields the underlying 
softer, cartilaginous tissues of the callus from high stresses.  This reduction of stresses, facilitates 
endochondral ossification, which proceeds from the outer ossified callus, abut the periosteum, 
toward the centre-line.  If the fracture site is not well-immobilised high distortional strains can lead 
to high compressive stresses and tensile strains, which can lead to fibrous tissue formation and 
prevent effective tissue organization and vascularisation.  Results of the distraction osteogenesis 
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studies reveal that the mechanical states and tissue differentiation patterns are mirror images to 
those found in initial fracture healing (269). 
On the cellular level, changes in cell morphology (282;283), cell pressure (284-286), electric 
potentials (287)  and oxygen tension (288-290) have been related to changes in ECM and enzyme 
production.  The understanding of how gross mechanical forces translate into a cellular response 
requires an appreciation of the underlying mechanisms at the molecular level. The molecular level 
is the most complicated and least understood of the organisation levels.  Mechanical stimulus at 
this level is seen to effect cytoskeleton arrangement, integrin binding, growth factors, and stretch 
activated ion channels, which all lead to changes in intracellular signalling (291-294).  However, 
the exact mechanisms by which mechanical forces are transmitted across the cell membrane and 
translated into a response remain unknown.  
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Chapter 2  
Scope of Thesis 
The ultimate objective of this research is to develop novel therapies for the repair and regeneration 
of musculoskeletal tissues. Important to the success of regenerative strategies, is the ability to 
develop and combine biomimetic materials with reparative cell types to create novel constructs can 
interface with native tissues structurally, mechanically, and biofunctionally.  However, prior to the 
clinical marriage of cellular and material systems, extensive explorative research is required to 
characterise, understand, and control the biological behaviour of cell-based tissue engineering 
constructs.  Therefore, this thesis aims to develop and characterise material- and cell- based 
therapeutic models in-vitro using polymeric biomaterials, differentiated and undifferentiated 
skeletal cell types, and physico-chemical cell signalling cues.   
The purpose of Chapter 1 was to provide a background review of the field of musculoskeletal 
tissue engineering, including recent developments and challenges in biomaterial and stem cell 
research.  Chapters 3-8 discuss the main experimental results of this thesis, and also include 
application specific literature reviews, experimental methodologies, and suggestions for future 
work.  Final conclusions and general overview of future developments are presented in Chapter 9. 
The following sections will highlight the particular scope and aspects of each results chapter. 
2.1 Biomaterials 
The advent of injectable polymer technologies has increased the prospect of developing novel, 
minimally invasive arthroscopic techniques to treat a wide variety of ailments.  In Chapter 3, a 
novel polyurethane-based injectable, in-situ curable, polymer platform synthesized by PolyNovo 
Biomaterials Pty. Ltd. (Clayton South, Australia), is evaluated to determine its potential uses as a 
tissue engineered implant for osteochondral repair.  Films of the polymers were prepared by 
reacting two pentaerythritol-based prepolymers, and characterised for mechanical and surface 
properties, and cytocompatibility using primary human osteoblasts.  
2.2 Cells 
Periosteum and periosteum-derived cells are known to play an intimate role in the formation of 
bone and cartilage tissue during bone tissue development and repair and have demonstrated 
multilineage potential in-vitro.  As such, the periosteum represents an interesting new candidate for 
osteochondral tissue engineering strategies (30;31).  To date, however, only a few groups have 
sought to exploit this potential from periosteum tissue derived from human donors (160;295;296).  
Chapter 2: Scope of Thesis 
 
52 
Consequently, there are no standardised methods for the culture of adult human periosteum in-vitro 
and little information is available on the behaviour and characteristics of periosteal cells.  The full 
realisation of the periosteum’s regenerative capacity is contingent upon the development of model 
systems to study, explore, and characterise human periosteum and periosteal cells ex-vivo.  The 
knowledge gained from these systems will translate into more effective clinical therapies with 
reproducible outcomes.   
As a necessary first step in this research, Chapter 4 is dedicated to the design and optimisation of 
simple and reproducible methods to harvest and culture human periosteal tissue without 
compromising the viability and/or therapeutic potential of the cells.  Accordingly, this experimental 
process is broken down into two main parts, aimed at designing culture systems for human 
periosteum tissue explants and isolated periosteal cells respectively. 
Following on from these results, Chapter 5 is focused on elucidating the heterogeneous cellular 
characteristics and behaviours of isolated human periosteal cells in-vitro. Adherent periosteal cells 
isolated from multiple human donors are extensively expanded in monolayer and examined for 
changes in growth potential, morphology, and cell-cycle characteristics.  Additionally, flow 
cytometry and real-time RT-PCR are used to analyse immunophenotype and gene expression 
profiles.   
Building on the previous chapters’ characterisation studies, Chapters 6 and 7 are focused on the 
development of enrichment strategies to selectively identify, isolate, and further characterise 
therapeutic precursor cell populations present in human periosteal tissue.  In Chapter 6, a simple 
enrichment strategy to isolate periosteum cambium layer cells is developed using a series of four 
sequential digestions.  The efficacy of this enrichment strategy is confirmed by examining the 
growth rates, morphology, colony forming ability, and phenotype of the different cell isolates in 
culture.  Further, the ability of this system to preferentially isolate cell populations according to 
distinct periosteal cell layer is also investigated.   
In exploring alternative enrichment strategies, Chapter 7 concentrates on the isolation and 
characterisation of rare progenitor cell phenotypes from heterogeneous periosteal cell populations 
using droplet-based microfluidics.  In these systems, developed by Edel et al at Imperial College, 
picolitre-sized droplets generated from immiscible phases can be produced at high frequencies (in 
excess of 1 KHz) and can act as discrete and isolated reaction compartments to study a number of 
biological and chemical processes (256).  The biological capacity of this platform technology to 
encapsulate, detect, and quantify rare periosteal cell phenotypes is investigated.  Further the 
accuracy and reproducibility of this microfluidics systems is tested and compared to results 
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obtained using conventional flow cytometry. The advantages of this novel platform system over 
currently available biological sorting methods are also discussed. 
2.3 Physicochemical signalling cues 
In diarthroidal (synovial) joints, the development, maintenance, and destruction of bone, cartilage, 
and periosteum are regulated, in part, by mechanical forces.  Physical cues influence the biology 
and function of cells through a number of mechanotransduction pathways (282;294).  In previous 
studies, mechanical forces have shown the ability to induce lineage specific cell differentiation and 
extracellular matrix production in numerous skeletal cell types (297-299).  In Chapter 8 the 
influence of mechanical strain on periosteal cell differentiation is investigated in-vitro.  In 
collaboration with Queen Mary University London (QMUL), a 3D periosteal cell-agarose culture 
model is developed and tested for its ability to support cell viability, chondrogenesis, and 
mechanotransduction.  The chondroinductive potential of mechanical stimulation is examined by 
applying dynamic compressive strains to periosteal cell constructs using a mechanical straining 
apparatus previously designed at QMUL.  The temporal expression profile of early chondrogenesis 
is assessed by real time RT-PCR.  To elucidate the relationship between physical and chemical 
factors, cell-seeded constructs are supplemented with TGF-β and subjected to loading. 
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Chapter 3  
 
Synthesis of two-component Injectable 
Polyurethanes for Bone Tissue Engineering 
 
3.1 Introduction 
In recent years, skeletal reconstruction has become an increasingly common and important 
procedure for the orthopaedic community. Problems associated with joint disease and trauma may 
not always be severe, but their management can be complex.  Treatments often involve choices 
between non-operative management and varying degrees of surgical intervention (300).  Surgical 
treatments are extremely labour intensive, costing the patient both time and money, and often 
require bone grafting to restore normal function and physical integrity. 
The recent development of injectable, biodegradable, and in-situ crosslinkable biomaterials seek to 
alleviate many of the challenges associated with current surgical techniques and prefabricated 
tissue engineered implants. Injectable systems have the advantage of arthroscopic use in which a 
gel can be introduced into a defect with complex geometries to provide a strong bond with 
surrounding tissues.  Ideally, upon injection the material should (i) polymerise without detrimental 
effects to the surrounding tissue, (ii) have a cytocompatible environment, (iii) provide mechanical 
and physical integrity for selected application, (iv) guide cell attachment and growth, and (v) allow 
for diffusion of nutrients to the cells (301;302).   For this purpose, synthetic polymer-based systems 
offer some distinct advantages over metal, ceramic, and natural biomaterials.  Degradable polymer 
implants can provide initial structural integrity for damaged bone and subsequently degrade within 
a timeframe that allows for natural bone tissue in-growth and remodelling. The mechanical 
properties, degradation times, and chemical functionalities of synthetic polymers can be easily 
tailored to support the tissue type, providing issues such as cytocompatibility, sterilisation, and ease 
of handling are addressed (303). Thus, a key aim when designing injectable in-situ forming 
polymer systems is to select not only chemically and structurally versatile polymers but also ones 
that are cytocompatible.  
To date, very few synthetic polymer-based injectable systems have been developed that possess 
suitable properties for orthopaedic applications (e.g. high strength, and controlled degradation 
rates) (304;305).  The work of Mikos et al (8) and Anseth et al (74;304) has led to the development 
of two such in-situ polymerisable systems, based on the chemistries of poly(propylene fumerate) 
Chapter 3: Synthesis of two-component Injectable Polyurethanes for Bone Tissue Engineering 
 
55 
(PPF) and polyanhydrides.  These polymer systems have shown the ability to control both 
polymerisation and degradation rates, form highly cross-linked (strong) structures upon 
polymerisation, minimise exothermic temperatures during formation, and polymerise into 3-
dimensional complex structures (8;304;306-308)  Additionally, these systems were shown to be 
biocompatible in-vivo and  encourage cell attachment, proliferation, and differentiated osteoblastic 
function in-vitro (8;74;307;309).  
Polyurethanes can offer many advantages in the design of injectable and biodegradable polymer 
compositions. Polyurethanes have an established record of biocompatibility (310;311), the ability 
to be functionalised to improve cell growth and proliferation (311-315), and controllable 
degradation kinetics (316).  Additionally, the mechanical properties of polyurethanes can be 
tailored for uses as hard (317-319) and soft tissue (320-323) biomaterials. Currently, novel non-
toxic, biodegradable lysine-di-isocynate (LDI)-based polyurethanes are being developed for uses in 
tissue engineering.  Zhang et al (324), have developed a new generation of  peptide (LDI) based 
polyurethane foams that possess the versatility of polyurethanes, but lack the toxicology of other 
urethane products.  These peptide based polymer systems can incorporate active moieties, which 
promote cell adhesion, viability, and proliferation with no adverse effects on the surrounding 
environment (311;325). This polymer system, however, has been synthesised as spongy foam, and 
therefore does not have the advantage of being arthroscopically delivered and cured in-situ. 
This present study seeks to evaluate a novel two-component injectable and in-situ curable polymer 
system utilising LDI-based polyurethanes, developed by PolyNovo Biomaterials Pty Ltd. (Clayton 
South, Australia), for initial orthopaedic applications.   Here we have investigated the initial surface 
and mechanical properties of the synthesised polymers, and analysed the cytocompatibility and 
cell-surface interactions with primary human osteoblasts.  Preliminary results advocate for future 
investigation into the use of this injectable polymer platform as a bone cement, as the polymers 
have suitable mechanical properties and provide an adequate environment for osteoblast viability 
and proliferation.  
3.2 Materials and Methods 
Pentaerythritol, Glycolic acid (70% w/v in water) and Stannous Octoate were purchased from 
Aldrich (Sydney, Australia) and used as received. Ethyl 2,6-diisocyanato hexanoate was purchased 
from Kyowa Hakko Kogyo Co Ltd, Japan and β-tricalcium phosphate from Plasma Biotal Limited, 
UK.  
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3.2.1 Prepolymer synthesis 
3.2.1.1 Prepolymer A 
Pre-dried pentaerythritol (4.818 g) (Aldrich, Sydney, Australia) was weighed into a dry three-neck 
flask equipped with a magnetic stirrer, nitrogen inlet and drying tube. Ethyl 2,6-diisocyanato 
hexanoate (ELDI) (30.04 g) was then added to the flask followed by catalyst stannous 2-ethyl 
hexanoate (0.1 wt%) under nitrogen. The reaction mixture was stirred and heated to 50°C for 72h 
under nitrogen atmosphere.  In polymers 76-6, 76-6a (Table 3.1), the prepolymer A was prepared 
by replacing PE with a polyol prepared according to the method described below.  
3.2.1.2 Prepolymer B   
Pre-dried pentaerythritol (27.23 g) was weighed in a dry three-neck flask equipped with a magnetic 
stirrer, nitrogen inlet and air condenser attached to the flask through a distillation head. Glycolic 
acid (136.21g, 70% w/v) was then added to the flask. The flask was heated in an oil bath to 80ºC 
for about 3 hours until all pentaerythritol dissolved. The temperature of the flask was then 
increased to 160ºC and heating continued.  Nitrogen was bubbled through the reaction mixture for 
fast removal of water formed during the reaction. The reaction was stopped after 24h and the 
reaction flask removed from the oil bath after carefully turning off nitrogen flow. The polyol was 
then transferred to a single neck RB flask and degassed at 120ºC under vacuum (0.1torr) using 
Kuglerohor. Polyols PE-LLA and PE-DLLA were prepared using the same procedure, except l-
lactic acid and dl-lactic acid respectively were used in place of glycolic acid. 
3.2.1.3 Prepolymer molecular properties 
The viscosity of prepolymer A was measured using a Bohlin Rheometer (CSR10) at 23°C.  
Hydroxyl number of the polyols was determined by p-toluene isocyanate method in accordance 
with ASTM method E1899-02.  
The molecular weights of the prepolymers were determined using gel permeation chromatography 
(GPC).  Analysis was performed on a Waters Associates Liquid Chromatography system (Waters 
717, Rydalmere, Australia) equipped with a differential refractometer and four µ-Styragel columns 
(105, 104, 103 and 100Å). The mobile phase was tetrahydrofuran (THF) at a flow rate of 1 
mL/min. Prepolymer was dissolved in THF by warming the solution at 50°C for 1h and filtered 
through 0.45 micron filter before analysis. The system was calibrated with narrow disperse 
polystyrene standards and molecular weights are reported as polystyrene equivalents. 
3.2.2 Sample preparation for mechanical testing 
In a typical procedure, prepolymer A (1.0 g, 0.96 mmol) was mixed with prepolymer B (0.493 g, 
0.96 mmol ) along with stannous 2-ethyl hexanoate catalyst (0.1 wt%) using a spatula for few 
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minutes and degassed at ambient temperature under a vacuum of 0.1 torr 5 min. The degassed 
viscous polymer mixture (0.33 g) was then injected into cylindrical cavities [6 mm (D) x 12 mm 
(L)] of a Teflon® mould and cured at 37°C overnight. The polymer sample with β-tricalcium 
phosphate granules (10 wt%) was prepared by high speed mixing using Silversion Mixer (Chesham 
Bucks, UK) and cured similarly.  
The batch size of the reaction mixture was about 1.5 g with a gelling time of 15 minutes under 
these conditions. During the 15 minute ‘working time’ the mixture was injected into the moulds 
using a 14 gauge syringe needle. The temperature of the reaction mixture was monitored by 
inserting a thermocouple. The maximum temperature reached during the reaction was 
approximately 40ºC. 
3.2.3 Preparation of polymer films 
Four different types of in-situ cured polymers were prepared from different prepolymer mixtures 
(see Table 3.1), degassed, and dispensed through a syringe onto glass coverslips (~100µm in 
thickness). The cover slip was placed in an oven at 37˚C overnight with nitrogen circulation to cure 
the polymer film. The completion of curing was monitored by observing decrease in NCO 
absorption peak intensity using IR spectroscopy. The films were sterilized by gamma radiation (25 
kGy dose).  
 
Table 3.1 In-situ cured polymer films.  Where PE: Pentaerythritol; ELDI: ethyl lysine diisocyanate; GA: 
glycolic acid; LLA: L-lactic acid;  DLLA: DL-lactic acid, β-TCP:  β-tricalcium phosphate. *Prepolymer B 
molecular weight = 513 based on hydroxyl number. 
3.2.4 Mechanics 
The mechanical properties of Novosorb™ polymers 76-2 and 76-2 TCP were determined using an 
Instron Universal Testing System (model 5568, Instron corporation, Grove City, PA, USA) 
equipped with 5 KN load cell and carried out with cross head speed of 1 mm/min (ASTM F451). 
Cylindrical test specimens were prepared according to ASTM F451-95 and equilibrated for 24h at 
ambient conditions before testing. Tests were performed at ambient temperature (23°C) in 45-50 % 
Sample 
Code Prepolymer A Prepolymer B* 
Prepolymer A   
MW 
(Mn/PD) 
Additives 
76-2 PE-ELDI PE-GA 2250/3.21 - 
76-2 TCP PE-ELDI PE-GA 2250/3.21 10 wt%  β-TCP 
76-6 PE-LLA-ELDI PE-GA 2091/1.83 - 
76-6a PE-DLLA-ELDI PE-GA 1816/1.66 - 
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humidity to calculate the maximum compression stress, the elastic modulus, yield stress, and strain 
at break.  The results are presented as an average of five replicates.  
A standard screw pull-out test was also carried out according to ASTM F543-02. The test specimen 
was prepared by curing the liquid polymer sample 76-2 with a screw (3.5 mm diameter) so that 
17.5 mm of the screw was embedded in the polymer. The sample was mounted in a custom jig to 
ensure that the screw was pulled only along its long axis. The screw was pulled using an Instron 
Universal Testing System under displacement control, until failure, at a rate of 5 mm/min. Load 
and displacement data were obtained and the pull out strength (PS) was determined as the 
maximum force on the load-displacement curve. 
3.2.5 Wettability 
The wetting behaviour of ‘wet’ Novosorb™ films was quantified by dynamic contact angle 
analysis (DCA). To determine the wettability of each hydrated polymer film, captive bubble 
contact angle techniques were performed as described elsewhere (326) using a Drop Shape 
Analyser (DSA 10 MK2, Krüss GmbH, Hamburg, Germany).  Films cured to glass microscope 
slides were placed horizontally into the measurement cell and filled with Delbucco’s-modified 
phosphate buffered solution (D-PBS). Dynamic measurements were made as air-bubble volume 
was increased and decreased at a constant rate (40 μl/min), using a custom microsyringe pump unit.  
The captive bubble measurements at the three-phase (air/liquid/solid) interface were recorded by 
VCA Optima software (AST Productions, MA, USA) and displayed as a function of time, drop 
radius, drop volume, and drop angle, which was then converted to advancing (θadv) and receding 
(θrec) angles (Figure 3.1). 
 
Figure 3.1 Schematic representation of the Drop Shape Analyser apparatus used to determine dynamic 
contact angles of Novosorb™ samples and appropriate controls.  This is software controlled closed-loop 
system, where advancing (θa) and receding (θr) angles are determined by placing a sessile air drop onto our 
surface and mathematically assessing the three-phase contact angle with visual software. 
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Contact angle hysteresis, the difference between advancing and receding angles, was also recorded 
to highlight physicochemical heterogeneities present on the surfaces.  For controls, thermanox 
coverslips and poly-d,l-lactide (PDLLA) films were used.  Briefly, PDLLA (Purac Biochem 
Goerinchem, The Netherlands) was dissolved in chloroform to produce a polymer weight to solvent 
volume ratio of 4% (w/v) and the mixture stirred for 2-3 h to obtain a homogeneous polymer 
solution. The PDLLA solution was spread over glass cover discs and dried at room temperature. 
Films were sterilised by UV irradiation on each side for 1 h prior to testing for contact angle.  Each 
sample was characterised by mean values derived from 18 measurement profiles: 6 readings per 
sample surface (n=3).  To statistically assess differences in wetting behaviour between Novosorb™ 
films and controls a Mann-Whitney U test was used (p <0.05).  
3.2.6 Energy dispersive X-ray analysis 
Chemical analysis of samples 76-2 TCP and 76-2 was performed with a LEO 1525 scanning 
electron microscope equipped with an energy dispersive X-ray (EDX) detector (Carl Zeiss SMT 
ltd, Hertfordshire, UK).  To quantify the chemical content of small areas (~ 60 μm2) on the sample 
surface, 3 distinctly different topographical areas were chosen from 3 different sites per sample and 
examined at 10kV using INCA Energy 3000 software (Oxford Instruments, High Wycombe, UK).  
Results were corrected for the carbon coating used and are presented as weight percentage and 
Ca/P ratio averages ± standard deviation (n=3). 
3.2.7 Cell culture  
The primary human osteoblasts used in this study were isolated from the trabecular bone of femoral 
heads taken from patients undergoing total hip arthroplasty (age: 75 and 82) at The Chelsea and 
Westminster Hospital with full ethical consent (London, UK).  Cells were grown in monolayer 
until passage 2 in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% FBS, 2 
mM L-glutamine, 50 µg/ml penicillin, and 50 µg/ml streptomycin (all Invitrogen, Paisley, UK). 
The cells were maintained at 37°C and 5% CO2 and media was changed every two to three days.  
After three weeks of culture, cells were detached, counted, and seeded on the Novosorb™ films 
(1.3 cm2) at a density of 10,000 cells/cm2.  Media was changed every 2-3 days during the assay 
period.  Prior to the experimental use of these cells, the phenotype of the cells was confirmed using 
osteoblast markers Alkaline Phosphatase and Collagen Type I.  The results of the 
immunophenotyping examination are presented in Appendix A. 
3.2.8 Cell viability 
Cell viability on the films was demonstrated using the Live/Dead viability/cytotoxicity assay 
(Molecular Probes, The Netherlands). The experiment was run in triplicate, with each of the 4 types 
of polyurethane-based films and thermanox discs as controls, at 1, 4, and 7 days in culture. At each 
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timepoint assayed samples were incubated with Live/Dead solution (2µM Calcein-AM and 4µM 
ethidium homodimer) at room temperature in the dark for 20 minutes.  Microscopy was carried out 
using an Olympus BX-51 reflected fluorescence microscope (Olympus UK LTD., London). Six 
random fields were imaged at 10 times magnification with an Olympus DP070 digital camera and 
analysed using Olympus DP Controller software (Olympus Imaging, London, UK).  
3.2.9 Cell metabolic activity 
The effect of the polyurethane-based films on cell metabolic activity was investigated using Cell 
Titer 96® Nonradioactive Cell Proliferation Assay (MTS Assay, (Promega, UK) after 1, 4, and 7 
days.  Metabolic activity is assessed calorimetrically, using the tetrazolium compound MTS [3-(4, 
5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl-)-2H-tetrazolium, 
innersalt], which is bioreduced by metabolically active cells into a colored formazan product that is 
soluble in tissue culture medium. Metabolic activity was determined by optical density and analysis 
of data was performed using a one-way ANOVA, with a Tukey post-hoc test to establish 
significance (p <0.05). 
3.3 Results 
3.3.1 Prepolymer chemistry and properties 
3.3.1.1 Prepolymer A 
The reaction described in section 2.1 yields a viscous prepolymer consisting of a mixture of star 
and hyperbranched structures (Figure 3.2). The number average molecular weight and 
polydispersity of the prepolymer were 1348 and 1.73, respectively based on GPC analysis. The 
prepolymer instantaneous viscosity was 8.7x104 cSt.  
 
Figure 3.2 Schematic of prepolymer A synthesis - pentaerythritol end capped with ethyl lysine diisocyanate.  
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3.3.1.2 Prepolymer B 
In all cases Prepolymer B was a four arm polyol prepared form PE and glycolic acid (Figure 3.3) 
using condensation polymerisation as described in section 2.1.  The molecular weight and 
polydispersity of the polyol was determined to be 513.3 and 1.08 respectively, based on hydroxyl 
number determination.  
 
Figure 3.3 Schematic of prepolymer B synthesis: condensation reaction. 
 
The cured polymers are a cross-linked network formed by the reaction of terminal isocyanate and 
hydroxyl groups present respectively in prepolymer A and B. The main functional groups present 
in the polymer network are ester and urethane/urea, all susceptible to hydrolytic, enzymatic and 
other types of degradation pathways present in biological systems 
3.3.2 Mechanics 
The mechanical properties of samples 76-2 and 76-2 TCP were studied in compression and 
represented as stress, strain, and elastic modulus. In-situ crosslinked polymer networks 76-2 TCP 
and 76-2 exhibit excellent mechanical strength, with ultimate compressive strengths (UCS) of 139 
± 11 MPa and 136 ± 14 MPa and elastic modulus (E) of 2.3 ± 0.03 GPa and 2.0 ± 0.01 GPa, 
respectively.  By comparison, these samples had a UCS significantly greater than, and an E within 
the range of, cancellous bone (Table 3.2).  To further highlight the mechanical strength of the 
polymers, the UCS were compared to those of European and FDA approved acrylic bone cements 
(73-117 MPa) and injectable, photocrosslinkable polyanhydrides (30-50 MPa), recently developed 
for orthopaedic applications (304;327).  In measuring strain resistance, sample 76-2 and 76-2 TCP 
were found to have ultimate compressive strains of >40%, with recoverable elastic strains of ~5% 
(Figure 3.4).  
When compressed, the polymers demonstrated viscoelastic-like properties, evidenced by an initial 
linear elastic region and a plastic deformation region seen prior to failure (Figure 3.3). A similar 
type of viscoelastic behaviour is also demonstrated in natural bone (328). Stress-strain plots (Figure 
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3) revealed that the incorporation of 10 wt% β-TCP particles (5 µm) to sample 76-2 caused an 
increase (not significant) in E, yield strength, and UCS.  
Table 3.2 Initial mechanical properties in longitudinal compression of samples 76-2 and 76-2 TCP compared 
with properties of natural bone, widely used calcium phosphate based bone cements, and injectable and 
photocrosslinkable polyanhydrides. Values for mechanical properties were obtained from information 
contained in these papers: a(328;329), b(327), c(307). Some values were not reported in literature (---). 
 
Sample 76-2 was also tested for its pull out strength. The pull out force of sample 76-2,  5954 ±101 
N, was found to be significantly higher compared to the pull out force of screws in healthy bone 
and curable PMMA cements, demonstrated to be 1540 ± 361N (330) and 2301 ± 283 N (331) 
respectively. 
 
Figure 3.4 Stress-strain curves of cylindrical specimens 76-2 and 76-2 TCP loaded in longitudinal 
compression and measured using an Instron Universal Testing System. 
 
3.3.3 Wettability 
The wetting behaviour of each of the polymer films was assessed by dynamic contact angle 
analysis, previously evaluated as a sensitive method to detect interfacial changes at 
biomaterial/biosystem interfaces (332). The combination of captive bubble techniques with Drop 
Longitudinal Compression 
Material 
Ultimate Stress 
(MPa) 
Stress @ Yield 
(MPa) 
Modulus 
(GPa) 
76-2 136 (14) 84 (15) 2.0 (0.3) 
76-2 TCP 139 (11) 76 (13) 2.30 (0.01) 
Cortical Bonea 180-220 180  (13) 18.6 (3.5) 
Cancellous Bonea 5-10 --- 6.1 (5.4) 
Acrylic bone 
cementsb 73-117 --- 0.05- 0.1 
Polyanhydridesc 30-50 --- --- 
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Shape Analysis image processing, allowed for the accurate and objective measurement of dynamic 
contact angles in a wet, biologically relevant environment. The contact angle measurements of the 
polyurethane films and control films, Figure 3.5, are presented as advancing angle, θadv, and 
receding angle, θrec. 
In comparing receding contact angle results, we found all polyurethane films to be significantly 
less hydrophilic than thermanox (p<0.05).  The films, however were found to be significantly more 
hydrophilic than control film PDLLA (p<0.05). Cross comparing contact angles of the 
polyurethane films, suggested that sample 76-2 TCP is the most hydrophilic, followed by samples 
76-2, 76-6a, and 76-6, although these differences were found not to be significant.  
Additionally, all polyurethane films were found to have similar hysteresis values (~21°), with 
sample 76-2 TCP having a slightly higher value (21.85°).  Whereas, thermanox and PDLLA, 
expressed lower contact angle hysteresis, with values of 11.6° and 16.7° respectively.  This 
signified a more physically or chemically heterogeneous surface on the polyurethane films 
compared to controls. 
 
Figure 3.5 The advancing (θadv) and receding (θrec) dynamic contact angles of captive bubbles on 
Novosorb™ films and controls in dulbecco’s modified phosphate buffered solution (D-PBS).  The controls 
are poly (DL-lactic acid) (PDLLA) films and thermanox. The results are displayed as means ± SD and 
samples are arranged in terms of decreasing hydrophilicity, seen as an increase in the receding angle.  
Significance was assigned using a Mann-Whitney test (p <0.05). Thermanox was found to have a θrec 
significantly less than all other samples (*), Novosorb™ films were found to have a θrec significantly less than 
PDLLA (a,b,c,d) and comparable to one another. 
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3.3.4 Energy dispersive X-ray analysis 
SEM/EDX analysis of unseeded samples 76-2 and 76-2 TCP was employed to examine surface 
topography and determine chemical composition of film surfaces. This enabled correlations 
between chemical content and topographical heterogeneity on the sample surfaces. These two 
samples were compared because they have identical polymer chemistries and fabrication 
techniques, however sample 76-2 TCP was supplemented with β-TCP particles during film 
fabrication.  EDX results revealed that calcium and phosphorus were solely concentrated at 
topographically heterogeneous areas on the film surface of sample 76-2 TCP (Figure 3.6).  These 
areas of heterogeneity (sample areas 1 and 3 in Figure 3.6A) appeared as topographically raised 
areas, with inter-dispersed pore-like structures. In contrast, no calcium and phosphorus was 
detected on the adjacent flat and nonporous area on the same sample surface (sample area 2 in 
Figure 3.6A). Additionally, in sample 76-2, no calcium and phosphorus was detected on all surface 
areas scanned (sample areas 1, 2, 3 in Figure 3.6B). The Ca/P ratios of the heterogeneous areas on 
sample 76-2 TCP were averaged to be 1.61 ± 0.27 (n=9). 
 
Figure 3.6 SEM/EDX surface analysis of unseeded films 76-2 TCP (A) and 76-2 (B).  Concentrations of 
calcium (Ca) and phosphorus (P), represented as weight percentages, are found strictly on the topographically 
heterogeneous areas of sample 76-2 TCP (sample area A1 and A3).  Chemical spectral analysis of sample 76-
2 surfaces reveals undetectable concentrations of calcium and phosphorus present (sample area B1,B2, 
B3).(Scale= 20 µm). 
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3.3.5 Assessment of cell viability on Novosorb™ films 
Primary human osteoblasts were cultured on the polymer films for 1, 4, 7 days and evaluated for 
cytotoxicity using Live/Dead assay. By this qualitative method, live and dead cells were stained 
green and red, respectively. As indicated in Figure 3.7, a majority of the cells remained viable on 
the samples for periods of up to 7 days, seen as positive live to dead cell ratios (>95%).  The live 
cells adhered well to the films surfaces, and exhibited normal, healthy osteoblastic spindle-like 
morphology for periods of up to 4 days.  In comparing the samples, it is seen that sample 76-2 TCP 
maintained the best cell viability at longer time points.  In samples 76-2, 76-6, and 76-6a, good cell 
viability is seen for periods of up to 4 days and is followed by a slight decrease in cell viability.   
Osteoblasts on thermanox controls were found to have similar spindle-shaped morphology as 
compared to the polyurethane films, however cells were found to be confluent after 4 days in 
culture (data not shown). The images shown in Figure 3.7 are representative of the results seen for 
all polyurethane films at 6 different locations on the surface (n=3).   
 
Figure 3.7 Live/Dead analysis of Novosorb™ films seeded with primary human osteoblasts for 1, 4, and 7 
days.  Images show combined images of live (green) and dead (red cells) cells on all samples.  Non-cytotoxic 
surfaces are seen on all sample types for periods of up to 7 days, with images showing sustained cell viability 
and extremely positive live to dead cell ratios (>95%). (Scale bar = 200 µm). 
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3.3.6 Assessment of cell metabolic activity on Novosorb™ films 
Changes in the metabolic activity of primary osteoblasts cultured on the films were evaluated by 
MTS proliferation assay at 1, 4, and 7 days.  MTS measures metabolic function in cells via 
mitochondrial activity, where a higher absorbance signifies either an increase in cell proliferation 
or a higher rate of metabolism of the MTS. A reduction in cellular metabolic activity is an early 
indication of cellular damage, which could potentially lead to cell death.  Results for all films, 
presented in Figure 3.8, show a general increase in cell metabolism for a period of 7 days. This 
same cell proliferation profile was obtained on the thermanox control. In determining significance, 
it was found that sample 76-2 exhibited significantly decreased metabolic activity for each time 
point as compared to the thermanox control (p<0.05), although an increase in metabolic activity 
was noticed for a period of 7 days. Samples 76-6 and 76-6a were found to have comparable 
increases in cell proliferation to cells on thermanox for a period of 4 days.  Sample 76-2 (TCP) was 
comparable (no significant difference) to cells on thermanox over the entire period of 7 days.  No 
metabolic activity was observed from any of the unseeded samples, signifying that the samples did 
not react with the MTS reagents (data not shown).  
 
Figure 3.8 MTS assay for primary human osteoblasts cultured on Novosorb™ films and thermanox controls 
for 1, 4, and 7 days. Significance is assessed compared to thermanox control for each time point assayed (* = 
p< 0.05). 
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3.4 Discussion 
The preliminary evaluation of toxicity performed in this study indicated that the films provided 
generally cytocompatable surface characteristics that allowed for initial cell attachment, sustained 
viability, and increased cell proliferation profiles. Moreover, these results confirmed polymer 
synthesis and curing processes to be adequate for initial implantation, since cell viability and 
increased proliferation was noted for a 7 day period. 
Results of Live/Dead and MTS suggested that in-situ sample 76-2 TCP provided an optimal 
environment for osteoblast attachment, sustained viability, and proliferation as compared to the rest 
of the films. A possible explanation for this result was the incorporation of β-TCP granules during 
polymer film synthesis.  β-TCP is a resorbable bioceramic material and can be used in the form of 
blocks, granules, or cements in scaffolds for bone regeneration. Previous literature suggests that 
TCP may enhance osteoblast function and overall bone formation (333;334).  Although the exact 
mechanisms whereby this happens presently can not be elucidated, evidence suggests that TCP 
fillers increase the initial anchoring and spreading of serum proteins on polymer surfaces (335).  
Therefore, one can assume that sample 76-2 TCP should have a more osteoconductive environment 
compared to a similar sample film without β-TCP (i.e. sample 76-2).  This was observed in this 
study, as sample 76-2 TCP demonstrated enhanced viability and proliferation of osteoblasts over a 
7 day period compared to sample 76-2.  Additionally, β-TCP is also believed to act as a buffering 
agent, neutralising any acidic by-products and maintaining pH (308), which could be another 
explanation as to why better viability and proliferation were found on this film. 
Initial mechanical support and bonding of an implant to the surrounding tissue, is of particular 
importance to biomaterials for orthopaedic applications.  It is integral that these mechanical 
properties are analogous to the properties of the tissue being repaired.  While many properties are 
important when characterising materials for orthopaedics, compressive properties are most 
consistently recorded in literature, and therefore provide for a better comparison between materials 
.  After cured, samples 76-2 and 76-2 TCP attained compressive strengths of 136 and 139 MPa 
respectively.  Although insignificant, the slightly enhanced mechanical properties found in sample 
76-2 TCP (Table 3.2 and Figure 3.4) are most likely due to the incorporation of β-TCP particles; a 
typical reinforcement effect noted previously (302). Both samples, however, had compressive 
strengths well above those for cancellous bone (5-10 MPa) and are nearly within the range of 
cortical bone (180-220 MPa) in compression (328). These compressive strengths are almost twice 
the critical minimum (70 MPa) permitted under  standard ISO 5833, regulating injectable bone 
cements (336).  Similarly, both polyurethane samples exhibited elastic modulus (~2 GPa) in 
accordance with permitted minimums under the same standard (>1.8 GPa).  Additionally, the 
polymers are found to exhibit mechanical properties better than those of a novel calcium phosphate 
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based bone cements and widely used acrylic cements, both of which have gained FDA and 
European approval for uses in distal radius and tibial plateau fractures, craniofacial applications, 
and screw fixation (327;337;338).   
Further comparisons of mechanical properties of the polyurethane polymers to natural bone, 
revealed that polymers 76-2 and 76-2 TCP were designed to withstand the peak compressive strains 
in limb bones incurred during rigorous functional loading.  In bone, principal compressive strains 
have been found to reach peak magnitudes of  2000 µε (339), well within the elastically 
recoverable strain range of polymers 76-2 and 76-2 TCP (<50,000µε) .  Undoubtedly, the result of 
plastic deformation to a weight bearing implant will lead to loss of form and function, and will 
eventually fail, resulting in both pain and an additional surgical procedure for the patient. 
Moreover, the ratios of ultimate compressive strength to elastic modulus, are comparable in both 
bone and our polymer constructs (~1/100) (327). This analysis showed that the polyurethane 
constructs, although not mechanically identical to cortical bone, possess a similar balance between 
compressive elasticity and strength found in natural bone.   
Mechanical screw pull-out tests, showed sample 76-2 to have a fixation strength greater than that of 
bone and PMMA bone cements, found to be 1540 ± 361 N and 2301 ± 283 N respectively 
(330;331).  This strong initial bonding strength possessed by polymer 76-2 may act to reduce 
interfacial failure and bond loosening by strengthening the cement-implant and cement-bone 
interface (340). The strength of this interface with the surrounding host bone tissue is of paramount 
importance to the clinical success of injectable polymer systems in orthopaedic applications.  The 
strong initial bonding of this injectable polymer gel to the host bone will allow for quick restoration 
of voids; leading to immediate fracture stability, an earlier return to full-weight bearing, and faster 
restoration of tissue function.  
The wetting behaviour was assessed by dynamic contact angle analysis, previously evaluated as a 
sensitive method to detect interfacial changes at biomaterial/biosystem interfaces (332) Dynamic 
contact angle analysis is considered a valuable technique for characterising the wetting behaviour 
of rough biomaterial surfaces, because the three-phase contact angle is sensitive to the outermost  
3-20 Å of a surface and its chemistry (341).  This same area is also important to many cell-surface 
interactions including adhesion, motility, and signalling.  It is known that surface wettability plays 
a vital role in the cell-biomaterial interface, modulating both protein adsorption and cell adhesion 
(342), where cell adhesion and motility increases on more hydrophilic surfaces (343). In this study 
an increase in the value of the receding contact angle provided a reliable indication of a less 
hydrophilic surface (344). All polyurethane films were found to have receding angles significantly 
more hydrophilic than PDLLA; a biodegradable polymer approved for in vivo orthopaedic 
applications by the Food and Drug Administration of the USA (61;345). This surface 
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hydrophilicity, correlated with the favourable cell viability and proliferation results seen for all 
samples.  
To better understand the wetting characteristics of these films, hysteresis values obtained from 
DCA, were used to assess surface roughness.  The heterogeneity of the surface can be observed 
indirectly when measuring contact angles.  If a surface is not smooth, large deviations in attainable 
contact angle measurements will be seen as the three-phase contact line is moved, leading to large 
hysteresis values (346). These irregular contact angles arise from a phenomenon known as pinning 
(stick/slip).  It was previously shown, that if size of the heterogeneity (347) or roughness feature 
(348) was larger than 0.1µm, the three phase contact line had a tendency to be stopped by a pinning 
mechanism on local surface imperfections and could not move without introducing additional 
external force (i.e. rapid influx of air into the captive bubble).  This creates a series of metastable 
states, with contact angle hysteresis used as indicator as to the extent of these surface 
heterogeneities.  All polyurethane films were seen to be rough, heterogeneous surfaces, evidenced 
by significantly larger values of contact angle hysteresis (~21°) compared to smooth, homogeneous 
thermanox surface (11.6°).  Sample 76-2 TCP was found to have a slightly higher hysteresis value 
as compared to the other films.  This was most likely due to the fact that sample 76-2 TCP, was 
composed of two regions, having different wetting characteristics: the guest material (β-TCP 5µm 
particles) and the primary host material (LDI-based polyurethane).  The different chemistries 
present on this surface likely influence the wetting behaviour by causing both morphological and 
chemical changes in the system (341).  Although not statistically significant, this suggested that 
sample 76-2 TCP had a rougher surface with more heterogeneity, in support of SEM micrographs 
of the surfaces of samples 76-2 and 76-2 TCP (Figure 3.5), which showed a more topographically 
heterogeneous surface on sample 76-2 TCP.  Although surface roughness was not quantitatively 
assessed in this study, one can assume that the surface roughness of sample 76-2 TCP has created a 
more hydrophilic environment, shown as a reduction in contact angle. This observation is in 
agreement with previous investigations, which concluded that roughness makes hydrophilic 
surfaces (contact angle < 90°) more hydrophilic and hydrophobic surfaces (contact angles > 90°) 
more hydrophobic (349).  
EDX analysis confirmed the presence of calcium and phosphorous on the surface of sample 76-2 
TCP whilst these elements were undetectable on sample 76-2.  Furthermore, results revealed 
calcium and phosphorus to be solely concentrated at topographically heterogeneous areas on the 
film surface of sample 76-2 TCP (Figure 3.5B).  The fact that no concentrations of calcium or 
phosphorous were found on sample 76-2, suggested that β-TCP had a role in creating topographical 
heterogeneity. This demonstrates a possible correlation between the β-TCP filler and increased 
chemical and physical heterogeneity. These areas of chemical heterogeneity were found to consist 
Chapter 3: Synthesis of two-component Injectable Polyurethanes for Bone Tissue Engineering 
 
70 
of Ca/P ratios (1.61 ± 0.27) similar to native bone (1.71) and natural stoichiometric HA (~1.67), 
known to have osteoinductive and osteoconductive capacities (350;351). More studies, however, 
are needed to examine the extent of the relationship between physiochemical heterogeneity and 
osteoblast behaviour in sample 76-2 TCP. 
3.5 Conclusions 
This study presents a novel two component polyurethane platform that can be administered 
arthroscopically, polymerise at biological temperatures in-situ, and provide appropriate bonding 
strength and mechanical support, with mechanical properties superior to widely used bone cements. 
These novel polymers provided a favourable in-vitro environment for initial cell adhesion, 
maintained cell viability, and normal rates of proliferation of human osteoblasts for periods of 7 
days.  Physicochemically, this biocompatibility can in-part, be attributed to the hydrophilic surface 
characteristics of these polymers, and, in the case of sample 76-2 TCP, the combined presence of 
heterogeneous topographies and chemical moieties on the surface.  The addition of β-TCP filler 
during film fabrication enhanced cell viability, increased surface heterogeneity and mechanical 
properties in compression, and significantly increased cell proliferation 
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Chapter 4  
 
Development of an in-vitro Human Periosteum 
Tissue Culture System 
 
 
In the previous chapter, I discussed the development of a novel synthetic polymer platform which 
can be used to create scaffolds that support cells and incorporate cues which guide tissue repair.  In 
the next 4 chapters, I will shift my focus to the cellular aspects of the tissue engineering paradigm.  
In particular, my aim is to isolate, culture, and extensively characterise adult human periosteal cells 
for the development of new and interesting stem/progenitor-cell therapies.  The necessary first step 
on this path to wide-spread clinical use is the design and optimisation of methods to harvest and 
culture human periosteal tissue without compromising the viability and therapeutic potential of the 
cells.  Therefore, this chapter is dedicated to the intensely iterative process of developing a simple 
and reproducible human periosteum tissue culture system.  Accordingly, this chapter is broken 
down into 2 main sections, or mini-chapters, for the purposes of designing culture systems for 
periosteum tissue explants and isolated periosteal cells respectively 
4.1 Harvest and Culture of Human Periosteal Explants: An 
Organ Culture Model  
4.1.1 Introduction 
The rapidly growing interest in cell and tissue transplantation for cartilage repair stems from the 
well-known fact that damaged articular cartilage is incapable of healing itself.  Full-thickness 
osteochondral defects that penetrate the subchondral bone, if left untreated, can ossify or fill with 
fibrocartilage  and cause clinical symptoms such as pain and joint dysfunction that can lead to the 
development of osteoarthritis (352;353).  In-vivo, cartilage regeneration has been shown to in 
experimental animals (354-357) and human patients (17;358) by whole tissue transplantation using 
periosteum.  The regenerative potential is associated with the presence of undifferentiated 
mesenchymal stem cells resident to the cambium layer of the periosteum (31;159;160;359).  
However, the in-vivo results are not always predictable or reproducible and do not result in the 
regeneration of fully functional hyaline-like cartilage (352).   
Therefore, the development of periosteum-based osteochondral composites in-vitro would serve as 
a promising alternative approach for cartilage repair and a novel means to study chondrogenesis.  
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Advantages of exploiting periosteum over cell cultures for skeletal tissue engineering include the 
fact that it is a source of intrinsic chondrogenic growth factors and can serve as three-dimensional 
template for directional evolution of neotissue (360).  Towards this end, periosteal explant culture 
systems have been developed for cartilage tissue engineering platforms and chondrogenesis models 
(190;361;362).  However, these culture models have utilised explants harvested from animals and 
may not accurately reflect the characteristics and behaviour of human tissue. Therefore, we aimed 
to develop a periosteal organ culture model using human donor derived tissue to engineer osseous 
and cartilaginous tissues in-vitro. This preliminary study will validate this model by assessing the 
viability and chondrogenic potential of human periosteal explants in culture.    
4.1.2 Materials and Methods 
4.1.2.1 Harvest of periosteal explants 
Periosteal explants, measuring 1.0 x 1.5 cm2, were harvested by subperiosteal elevation from 
patients undergoing elective knee surgery at The Chelsea and Westminster Hospital.  In each case, 
explants were harvested from the medial proximal tibia of patients by the same skilled surgeon.  
Explants were cleaned of fat and blood tissue in theatre and immediately transported to laboratory 
in Earl’s balanced salt solution (EBSS; Gibco, Paisely, UK). 
4.1.2.2 Histological evaluation of periosteal explants 
To identify the quality and variability of the harvested tissue, histological examination of periosteal 
explants was performed.  Tissue samples were fixed in 10% v/v neutral buffered formalin (Agar 
Scientific, Stanstead, UK) for 12 hours at room temperature, dehydrated through an increasing 
alcohol series and cleared with xylene (Sigma-Aldrich, Poole, UK) before being embedded in 
paraffin wax. Each sample was cut perpendicular to the bone-interfacing surface, into four 5μm 
thick histological tissue sections at equal intervals from the proximal to distal end, and stained with 
haematoxylin and eosin (both Sigma-Aldrich, Poole, UK).  Photomicrographs (x100) were taken of 
each section, to identify the presence distinct cellular layers and determine any donor-donor 
variability present.  
4.1.2.3 Preparation of explant-agarose constructs 
To study the viability and therapeutic potential of human periosteal explants a modified agarose 
culture system was designed based on previously developed 3-dimensional culture systems 
(184;190;361;362)  Harvested explants were rinsed three times in PBS and cut into ~3 mm2 pieces 
under aseptic conditions.  To create the agarose-explant constructs a specially designed Perspex® 
mould consisting of 6 x 5 x 4 mm3 wells was used.  Each well of the mould was pre-coated with 
approximately 60 µl of molten low gelling temperature agarose (type VII; Sigma) and allowed to 
gel for 5 minutes at RT.  Agarose suspensions were prepared in Earl’s Balanced Salt Solution 
Chapter 4: Development of an in-vitro Human Periosteum Tissue Culture System 
 
73 
(EBSS; Gibco Ltd., Paisley, UK) at concentrations varying from 2-5% (w/v) depending on the 
study performed.  After this time an explant was placed into each well and another 60µl of molten 
agarose was used to cover the explant and complete the mould.  The full constructs were then 
allowed to gel in the mould at 4°C for 10 minutes.  Agarose/explants constructs were cultured for 
periods of up to 28 days in a 24 well-plate, one construct per well, in one millilitre of medium.   
4.1.2.4 Explant viability 
Cell viability within periosteal explants and agarose-explant contructs was examined, first, to 
determine the negative effects of explant isolation and transport, and second, to establish the 
feasibility of this agarose-explant culture system.  The LDH cytotoxicity test is based on lactate 
dehydrogenase (LDH) leakage upon cell membrane injury. LDH release into the culture medium 
indicates compromised membrane integrity of dead or dying cells (363-365).  Cell death was 
quantitated by measuring the release of cytoplasmic enzyme lactate dehydrogenase (LDH) using 
the CytoTox 96® Non-Radioactive Cytotoxicity Assay kit (Promega, Madison, USA) that is based 
on a coupled enzymatic reaction that results in the conversion of a tetrazolium salt into a red 
formazan product. The increase in the amount of formazan produced in the culture supernatant 
directly correlates with the increase in the number of lysed cells. Formazan was quantified 
spectrophotometrically by measuring its absorbance at 490 nm. Explant cytotoxicity was measured 
directly after explant transport from theatre (t=0) and after 1 and 4 days in static culture in 2%, 3%, 
4%, 5% (w/v) agarose gels and in explants not in gel constructs (no gel). Cell death was expressed 
as a ratio (%) of released LDH/total LDH (content in medium+ cells) (n=3 per time point).  To 
measure the amount of LDH in media, aliquots were taken of culture media from each 
experimental well.  This data was then combined with the measures of LDH released from the 
accompanying cell lysate obtained by homogenising (hand-held homogeniser, Fisher, UK) the 
explant in 1% Triton-X100 lysis solution.  Due to the interference of phenol red (λmax ≈550 nm) 
with the coloration of the LDH assay (λmax ≈ 490 nm), phenol red-free DMEM was used in all 
cultures assayed for LDH release.  To assess statistical differences in cell death within data from 
individual donors the Mann-Whitney U test was employed (p<0.05). 
4.1.2.5 Chondrogenesis 
To assess the chondrogenic potential of periosteal explants,  3% (w/v) explant/agarose constructs 
were cultured for 2 and 4 weeks in  DMEM containing 10% FBS, 1 mM proline, 50 µg/ml ascorbic 
acid, penicillin/streptomycin (50 U/ml/50 µg/ml) and either 10 ng/ml of TGF-β1 and FGF-2 or no 
growth factors (361). The cultures were maintained in 5% CO2 in air at 37° C with the culture 
medium replaced every other day.  This experiment was performed on explants harvested from 2 
different donors, with 3 explant/agarose constructs per experimental group per time pt (n=3).  At 14 
and 28 days the constructs were rinsed with phosphate buffered saline (PBS), and cleaned of any 
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residual agarose gel remaining on the explant.  Each explant was then fixed in 10% neutral 
buffered formalin for 12 h before paraffin embedding. 
4.1.2.6 Histochemical and immunohistochemical analysis. 
Safranin-O and hematoxylin/eosin staining of the explants was performed at each time point.  
Sections of 5 µm were cut perpendicular to the cambium surface at regular intervals from medial to 
distal end.  Immunohistochemical analysis was performed using monoclonal antibodies obtained 
from Chemicon (MAB8887, Millipore, UK) to detect the presence of collagen Type-II.  Prior to 
staining, an enzymatic retrieval of antigens was completed using 1% (w/v) pepsin and rinsed 2x in 
PBS.  Primary staining was performed at a 1:200 dilution for 1 hr at RT.  For secondary staining, 
horseradish peroxidase was used at the same concentration.  In all cases, positive staining was 
assessed visually and images were taken using an Olympus BX51 reflected microscope fitted with 
a Olympus DP070 digital camera (Olympus Imaging, London, UK).  Sections of human nasal 
cartilage were used as positive controls. 
4.1.3 Results and Discussion 
4.1.3.1 Explant histology 
To preserve viability and reduce inter-donor variation, explant harvest procedures were carefully 
performed as described previously (366) using sub-periosteal elevation by an experienced 
orthopaedic consultant.  Additionally, explants were only harvested from the medial proximal tibia 
of visually healthy periosteum in non-osteoporotic patients.  This anatomical location was selected 
as the optimal donor site due to due to its easy accessibility during both arthroscopic and open-joint 
surgery and enhanced therapeutic potential (359;367).  This procedure is advantageous to other 
autologous tissue harvest procedures, such as bone marrow aspirates, which often involve painful 
surgeries and face heightened risks of donor-site morbidity.  The isolation procedure detailed here 
results in a small wound-site, which is easily repaired by normal wound-healing processes and does 
not affect the integrity or functionality of the underlying bone (observations by orthopaedic 
consultant Mr. Williams).  Haematoxylin and eosin staining of the periosteum tissue explants 
reveals the presence of two distinct tissue layers in all donors (Figure 4.1). The cambial layer is 
visible as a cell rich outer layer adjacent to the bone, with the fibrous layer, consisting of widely 
dispersed cells on the outside of the cambium.  Cambium layer thicknesses varied between 84-111 
µm, with the mean for all donors found to be 95.5 ± 13.4 µm.  Fibrous layer thicknesses 
demonstrated larger donor-to-donor variation, with mean values ranging from 1061.7-1525.5 µm.  
Further, a network of blood vessels was found in the fibrous layer of explants that were surrounded 
by a dense collection of cells.  A full evaluation of the cellular and extracellular characteristics of 
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the individual periosteal tissue layers is performed in Chapter 6 and includes an analysis of age-
related changes in tissue architecture. 
4.1.3.2 Explant culture 
For both short-term and long-term culture periosteal explants were further dissected into small 
tissue pieces, measuring 1.5 x 2 mm, as cartilage formation was found to be significantly better in 
smaller explants (368).  The use of growth factors TGF-β1 and FGF-2 were used to promote 
chondrogenesis in long-term explant cultures.  In-vivo, TGF-β has a broad range of cellular 
activities including the control of the proliferation and expression of differentiated phenotype of 
several cell types specific to bone, among them mesenchymal precursor cells, chondrocytes, 
osteoblasts, and osteoclasts (369;370).  Due to this TGF-β plays a central role in regulating the 
complex cascade of cellular events involved in soft-tissue and the formation of cartilage and bone, 
as occurs during fracture healing (371;372).  In-vitro,  studies have suggested that both TGF-β1,2, 
and 3 may regulate osteogenesis and chondrogenesis by affecting replication, gene expression, and 
structural protein synthesis in nearly all cell types associated with bone formation (373-375).  
Importantly, TGF-β1 has been shown to not only induce the differentiation of periosteal 
mesenchymal stem cells into osteoblasts and chondrocytes but also stimulate these cells to 
proliferate and synthesize the ECM proteins characteristic of bone and cartilage tissue 
(31;190;362;376;377).  FGF-2 is another important factor found within the cartilage matrix and has 
been shown to be a potent mitogen for chondrocytes and primitive marrow stromal cells (378-381).  
In combination with TGF-β1, FGF-2 was recently shown to support efficient expansion of articular 
chondrocytes while maintaining their capacity to differentiate (382).  Recently, FGF-2, during the 
early stages of periosteum explant culture in the presence of TGF-β1, significantly enhanced 
periosteum cellularity and chondrogenesis by increasing the number of committed cells (361).  In 
this way, the addition of growth factors into in-vitro cultures is considered as an adjuvant in bone 
and cartilage tissue engineering.   
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Figure 4.1 Representative photomicrographs of haematoxylin and eosin staining of human periosteum 
explants harvested from four different donors (A, B, C, and D).  In each image, two distinct tissue layers are 
seen:  a cell-rich cambium layer (letter c in image A) and ECM-rich outer fibrous layer (letter f in image A).  
The underlying bone (b) was harvested with the explant (Image A) to highlight the true thicknesses of the 
cambium and fibrous layers.  This histological analysis reveals the high quality of the periosteal explants 
obtained from each donor and the effectiveness of the isolation procedure. 
4.1.3.3 Explant viability 
Extra-cellular LDH concentrations were measured as a means to quantify the cytotoxic effects of 
periosteal explant isolation, transport, and culture on cells in the tissue.  The mechanical processes 
of explant isolation and transport resulted in the release of large amounts of LDH from membrane 
damaged, dead or dying cells. Across the 4 explants (4 donors) examined we see initial percentage 
of total cell death range from 11-43% (Figure 4.2).  Upon culture, the cell death initial found in the 
explants was found to stay consistent or rise over a period of 4 days.  Although, in explants 
harvested from a 28 yr old female we found a consistent increase in cell death over the 4 day 
culture period in each of the experimental conditions (Figure 4.2C).  We hypothesized that nutrient 
and metabolite diffusion limitations would lead to increased cell death in agarose gels in a 
concentration dependent manner. However, we were unable to establish any significant differences 
between the different agarose gel concentrations analysed and found that the added 3-dimensional 
support of agarose gels neither improved nor worsened the cell viability of the explants. Equally, 
we also did not find differences in LDH release between explants cultured in the presence or 
absence of agarose over the culture period (Figure 4.2A and B).  The inability to extract statistically 
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significant differences between the experimental conditions is due to the large deviations in LDH 
release measured.  This variability is demonstrated between both donors and dissected tissue pieces 
derived from one explant.  The high levels of cell death and variability found in periosteal explants 
shown here highlights the potential limitations in the use of a periosteal explant culture model and 
warrants further analysis 
 
Figure 4.2 LDH released from periosteal explants after harvest and transport (t=0) and following 1 and 4 
days in culture in the presence (2%, 3%, 4%, or 5% w/v) or absence (no gel) of agarose.  Cell death is 
expressed as a ratio (%) of released LDH/total LDH (content in medium+ cells) with an n=3 per time point.  
Results collected from 4 donors of different ages (16-73 yrs.) and sexes are shown to highlight donor-donor 
variations.  
4.1.3.4 Chondrogenesis 
In the normal, homeostatic state, defined here as time 0, the cambium layer contains a 
heterogeneous population of spindle-shaped cells, 5-6 cell layers in thickness (~80-100 µm).  
Whereas, the fibrous layer is much less cellular and is composed of mainly fibroblastic-like cells.  
In the presence of growth factors TGF-β1 and FGF-2, it was observed that the cellularity of both 
layers increased substantially over the 14 and 28 day period (Figure 4.3B-D).  In Figure 4.3, only 
day 28 images are shown as they are representative of results found in explants examined at 14 
days.  Although it was not quantified, the increase in the cellularity within the cambium layer was 
more pronounced than in the fibrous layer in the donors tested.  This stimulation of cell 
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proliferation in each layer is reflective of the early stages of chondrogenesis noted in previous 
periosteal explant studies (190;361;362).  
However, unlike previous studies there appeared to be no concomitant increase in the weight or 
thickness of the periosteum explants studied here.  Equally, we did not observe the sequential 
progression of cell morphologies related to developing neochondrocytes during periosteal 
chondrogenesis (383).  This lack of morphologically distinct hypertrophic and mature chondrocytes 
in our explants is in agreement with the absence of positive safranin-O and collagen type II staining 
noted in each section of each explant examined (Figure 4.3F-H & J-L).  Although, the explants 
displayed an abundance of collageneous matrix, as evidenced by fast green staining, there was no 
synthesis of cartilage-specific proteoglycans or collagen type II.   The specificity of the safranin-O 
and collagen type II staining was confirmed by the use of human nasal cartilage as a positive and 
negative control (Figure 4.3E & I). Therefore, the combination of agarose with growth factors 
TGF-β1 and FGF-2 did not favour the differentiation of chondrogenic cells or formation of 
cartilage-like matrix within all periosteal explants across all donors. This negative result is made all 
the more unique given the use of proven differentiation factors TGF-β1 and FGF-2 and 
demonstrated chondrogenic potential of the periosteum ex-vivo.   Within similar culture conditions, 
the appearance of neo-cartilaginous tissue was noted after 2 weeks in rabbit periosteal explants 
(361).  This may reflect species related differences in periosteal cell characteristics and 
functionality noted previously in periosteal cultures in-vitro (384). 
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Figure 4.3 Histochemical and immunohistochemical images of haematoxylin and eosin (A-D), safranin-O (E-H), and collagen type II (I-L) staining of human perisoteal 
explants and nasal cartilage. Periosteal explants embedded in 3% (w/v) agarose were cultured for 28 days in chondrogenic media supplemented with TGF-β1 and FGF-2.  
Representative images of stained explant sections from 3 donors have been selected to show the cellular and extracellular features of cultured explants.  Safranin-O stains 
proteoglycans red, fast-green stains fibrous tissue green, and positive collagen type II staining is seen as dark brown.   Human nasal cartilage was used as a control to show 
positive staining of cartilaginous matrix and negative staining of the perichondrium. Scale bars = 200 µm. 
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4.1.4 Conclusion     
The organ culture model examined here demonstrated compromised cell viability and an inability 
to induce chondrogenesis in human periosteal explants in-vitro.  The interpretation of these 
findings were influenced and further complicated by the inherent inter- and intra- donor variation 
that is apparent in these explants.  To circumvent the issues surrounding this explant culture system 
we must consider the use of isolated and ex-vivo expanded periosteal cells in the treatment of a 
wide range of skeletal abnormalities.  However, for such a cell-based system to enter wide-spread 
clinical use it will be necessary to identify conditions of culture that support the rapid expansion of 
periosteal cells with therapeutic potential.   From this prospective, further studies will now focus on 
the development of an isolated human periosteal cell culture model.  The layout of the next 
experimental mini-section in this chapter will follow the iterative process of design optimisation 
outlined in Figure 4.4. 
 
 
Figure 4.4 Schematic outline of iterative experimental process towards the development of an optimal 
isolated human periosteal cell culture model.   
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4.2 Isolation and Culture of Human Periosteal Cells: A Cell 
Culture Model 
4.2.1 Introduction 
Although in-vitro multilineage differentiation of periosteal cells has provided proof of principle for 
the creation of an autologous tissue engineered implant (159;160;190), we still lack a well-defined 
protocol for the isolation and expansion of these cells to make this technique available for clinical 
purposes.  For tissue engineering applications, therapeutic cell types need to isolated, purified, and 
expanded to large numbers whilst controlling cell fate.  For example, on the basis of using a 
scaffold containing 8 million cells/mL (385), 20 mL of tissue engineered implant used for spinal 
fusion surgery would require about 160 million cells.  Since the cell expansion of primary human 
cells is a labor intensive and expensive process, the use of an optimal culture system is desirable.  
Surgical skill (386), explant size (368), donor site (359) and donor age (387) have been found to 
significantly influence the quality of functionality of periosteal grafts previously.  Additionally, 
micro-environmental factors such as media composition, cell density, growth factors, and culture 
time are all known to influence the propagation of colony forming mesenchymal progenitor and 
stem cell types in-vitro (225;246;388).  Therefore, it was necessary to determine the optimal cell 
isolation and monolayer culture conditions for the expansion of viable periosteal cell populations of 
interest.  For this purpose, we examined different enzymatic isolation methods and the effects of 
cell culture media and cell seeding density on cell phenotype, initial cell adherence, short-term 
growth characteristics, and colony forming ability.   
4.2.2 Materials and Methods 
4.2.2.1 Enzymatic isolation of human periosteal cells (experiment I) 
To establish the optimal cell isolation protocol in terms of cell yield, viability, and time, a series of 
13 periosteal explants were harvested from patients aged between 25-84 yrs and subjected to a 
variety of different isolation methods based on enzymatic digestion protocols developed 
previously.  In each case, the explant was transported back to laboratory in Earl’s balanced salt 
solution at 37oC in a mini-portable incubator and was processed within 1.5 hrs of harvest.  After 
being cleaned of fat and blood tissue, the explants were rinsed 3x in PBS and finely minced into 2 x 
2 mm pieces. 
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Isolation Method 1 
 
This isolation protocol is based on methods developed by Nakahara et al for isolating rabbit 
periosteal cells (186).  Finely minced explants were transferred into a 15 ml conical tube and rinsed 
three more times with Tyrode's salt solution (T 2145: Sigma, UK).  A 0.25% (w/v) Collagenase 
solution (CLS Type II, Worthington Biochemical, Reading, UK) was added to the tube and the 
periostea were incubated for ten minutes in a 37 °C water bath.  After the incubation the periostea 
had settled to the tip of the conical tube so that the collagenase solution could be removed and 
discarded, followed by two rinses with Tyrode’s salt solution solution. Fresh 0.25% collagenase 
solution was then added and the periostea were incubated for two hours at 37 °C with vortexing for 
ten seconds every 30 minutes.  After this incubation trypsin was added to a final concentration of 
0.2% (w/v) (TRL-3: Worthington Biochemical, Reading, UK) and the periostea were further 
incubated for 30 minutes at 37 °C. After the incubation the collagenase-trypsin solution was 
inactivated by adding an equal volume of fetal bovine serum. The digestate was passed 
successively through 100-, 70-, and 50-µm cell filters (Falcon; Fisher Scientific, Loughborough, 
UK). The cells were centrifuged and rususpended in complete medium (DMEM containing 10% 
foetal bovine serum, 1% L-glutamine, 1% antibiotic/antimicrobial).  
Isolation Method 2 
 
This isolation protocol is based on manufacturer’s instructions and modified methods developed to 
enzymatically isolate periosteal cells (201;389).  Finely minced explants were transferred into a 15 
ml conical tube and digested by 0.25% collagenase D solution (Roche Applied Science, West 
Sussex, UK) in Earl’s Balanced Salt Solution for 3 hrs at 37 °C at 5% COz.  The resulting digestate 
was passed successively through 100- and 70-µm cell filters (Falcon; Fisher Scientific, 
Loughborough, UK), centrifuged, and the pellet was washed two times in complete medium.  
Isolation Method 3  
 
This protocol is identical to method 2, except that a 0.6% collagenase solution was used to 
enzymatically digest the periosteal explants for periods of 2-3 hrs. The digestate was processed as 
above. 
Isolation Method 4  
 
This digestion method was developed to optimise and improve upon the previous enzymatic 
protocols examined here.  Finely minced explants were placed in a enzymatic solution consisting of 
3 mg/ml collagenase D (Roche Applied Science, West Sussex, UK) and 3 mg/ml collagenase type 
II (Sigma, Poole, UK) and 5mM CaCl2 in 5 ml complete media (DMEM containing 10% foetal 
bovine serum, 1% L-glutamine, 1% antibiotic/antimicrobial).  The tissue was placed in an 
incubator at 37 °C and 5% CO2 and allowed to incubate for periods between 4.5-8.0 hrs under 
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gentle agitation.  Following incubation, the cell digestate was passed through a 70 µm cell filter, 
collected by centrifugation, washed twice and resuspended in complete media.   
4.2.2.2 Cell counting 
After each isolation method, the cells were resuspended in 5 mls of complete medium (DMEM 
containing 10% foetal bovine serum, 1% L-glutamine, 1% antibiotic/antimicrobial) and live/dead 
cells were counted using a haemocytometer and trypan blue dye.  These numbers were then used to 
determine total cell yield, cell release rate (cells/hr), and percentage cell death. Mononuclear, red 
blood cells were not counted.   
4.2.2.3 Effects of culture medium on cell expansion (experiment IIa) 
Two different growth media solutions were selected from literature for their well-defined ability to 
propagate isolated periosteal cell cultures whilst eliciting minimal influence over the cells’ 
differentiation profile.  The growth media solutions used in this study are shown in Table 4.1. 
 
Media 
Name 
Media Contents References 
1 DMEM, 10% FBS, 1 mM proline, 50 µg/ml ascorbic acid, and penicillin/streptomycin (100 U/ml/100 µg/ml) 
(361) 
2 DMEM, 10% FBS, 1% L-glutamine, penicillin/streptomycin (100 U/ml/ 100 µg/ml) 
(190;201) 
Table 4.1 Description of periosteal cell growth media examined. 
 
To study the effects of different culture environments on cell expansion, periosteal cells were 
isolated from a tissue explant using enzymatic isolation method 4, described above, and cell 
migration methods described previously (296;390).  Briefly, a periosteal explant (750 g) was 
harvested from the proximal tibia of a 37 yr old male undergoing ACL revision surgery at The 
Chelsea & Westminster Hospital.  The explant was cut in two equal pieces by weight and the cells 
were isolated by enzymatic digestion and explant migration methods.  The 9.3 x 105 enzymatically 
liberated cells were separated into seperate T75 tissue culture flasks containing 15 mls of either 
growth medium 1 or 2 (Table 1).  The remaining explant was minced into 1mm2 pieces and were 
equally distributed into two T75 tissue culture flasks containing 15 mls of either growth medium 1 
or 2 (Table 1).  All flasks were then cultured at 37°C and 5% CO2 where the medium was changed 
every 2-3 days to remove non-adherent cell subsets.  To assess the initial adherence, viability, and 
proliferation of the cells in each condition, light microscopy images were taken 4 days post-tissue 
harvest (termed passage 0 cells) and 7 days after the first passage (termed passage 1 cells).  
4.2.2.4 Effects of culture medium on population phenotypes (experiment IIb) 
To assess the effect of the effect of the growth medium on the propagation of specific cell 
populations, flow cytometry was performed on enzymatically liberated passage 2 cells using 
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fluorescently-conjugated monoclonal antibodies directed against Stro-1 (progenitor cells), ALP 
(osteoblasts), CD34 (haematopoietic cells), and CD45 (leukocytes).  This cocktail of antibodies 
examined here identify all populations of progenitor, osteogenic, and haematopoietic cell types 
present in the periosteum and represent the largest populations of cells isolated from human tissues.  
This is based on results in this thesis.  A full analysis and description of each mAb, including the 
preparation and labelling of the cells for flow cytometry will be discussed in full detail in Chapter 
5.  Cell fluorescence was evaluated by flow cytometry using a FACSCalibur instrument (BD 
Biosciences, Oxford, UK) and data analysed using FlowJo software (Tree Star Inc, Ashland, USA). 
At least 30,000 cells were collected per sample and percentage positive expression for each mAb 
was defined as the level fluorescence >99% of the isotype-matched control antibodies. 
4.2.2.5 Effects of cell seeding density (experiment III) 
To allow for a more standardised and reproducible periosteal cell culture system, it was important 
to establish the effects of plating density on total cell yields and proliferation rates. Passage 2 
isolated periosteal cells from a 31 yr old male and a 39 yr old male were cultured at 10 cells/cm2, 
50 cells/cm2, 500 cells/cm2, and 5000 cells/cm2 in 78 cm2 petri dishes for a period of 12 days in 
growth media 2. Every 2 days, cells from 3 plates from each culture density were harvested and 
counted on a haemocytometer.  This data was then used to calculate average cell yields, fold 
increase, population doublings, and cell doubling times of each culture.   
4.2.2.6 Colony forming ability (experiment IV) 
To study the effects of plating density and culture time on cell growth and colony formation, 
passage 1 periosteal cells were plated at 500, 103, 104, 105, 106 cells per 78 cm2 petri-dish (Falcon, 
Fisher Scientific, UK) in  3 dishes per cell concentration in growth media 2 (n=3). After 7 and 12 
days, the dishes were stained with 0.5% (w/v) crystal violet in methanol for 5 minutes, rinsed twice 
in distilled water and the number of colonies per dish counted by 2 independent observers. Based 
on previously described criteria (391) colonies < 1 mm in diameter (~50 cells) and faintly stained 
colonies were discounted.  Mean values for each ech density for each time point were derived from 
three Petri dishes  
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4.2.3 Results and Discussion 
4.2.3.1 Cell isolation (experiment I) 
Since human periosteal tissue is a dense connective tissue composed mainly of collagen and 
reticular fibers, cell isolation required the use of bacterial collagenases to digest the extra-cellular 
tissue.  The collagenase most commonly used for tissue dissociation is a crude preparation 
containing clostridiopeptidase A in addition to a number of other proteases and peptidases. Crude 
collagenase is well suited for tissue dissociation since it contains the enzyme required to attack 
native collagen and reticular fibers in addition to the enzymes which hydrolyze the other proteins, 
polysaccharides and lipids in the extracelluar matrix of connective and epithelial tissues.  Bacterial 
collagenase is a protease with specificity for the X-Gly bond in the sequence Pro-X-Gly-Pro, where 
X is most frequently a neutral amino acid. Such sequences are often found in collagen, but only 
rarely in other proteins. While many proteases can hydrolyze single-stranded, denatured collagen 
polypeptides, clostridiopeptidase A is unique amongst collagenases in its ability to attack and 
degrade the triple-helical native collagen fibrils commonly found in connective tissue.  
To evaluate the efficacy of each isolation method a minimum of 2 explants (2 donors) were used 
per method.  Further, to reduce the potential for experimental variation explants, measuring ~ 1.0 x 
1.5 cm, were harvested from the same donor site by the same skilled surgeon and were processed 
immediately.  Data from the 4 different isolation methods examined in this study is displayed in 
Table 4.2 and critically analysed in Figure 4.5.   
The protease solution in method 1 utilised a combination of collagenease and trypsin and resulted 
in a digestate containing low cell yields and large populations of dead cells (>25%).  In isolation 
method 2, we switched to a collagenase with greater enzymatic activity and suspended the use of 
potentially harmful trypsin in order to improve cell yields and lower cell death.  Therefore, 
Collagenase CLS 2 (Worthington Biochemical), with enzymatic activity of 278 U/mg Mandl, was 
replaced with Collagenase D (Roche Applied Science), with an enzymatic activity of 432 U/mg 
Mandl.  For comparison purposes, collagenase activities reported here were converted into Mandl 
units (1 µmol leucine liberated from collagen in 5 hrs at 37 °C).  Isolation method 2 resulted in 
enhanced viability, however, did not significantly increase the numbers of cells isolated.  To 
improve upon this result, we increased the concentration of this collagenase D solution from 0.25% 
to 0.60% (w/v), in hopes of increasing cell yields.  As hypothesized, isolation method 3 resulted in 
more than doubling cell yields.  However, this increased collagenase concentration caused a 
significant amount of cell death (>80%) during the isolation process regardless of incubation time.  
For isolation method 4, we reduced the concentration of collagenase D to 0.3% and added 0.30 % 
(w/v) of the less proteolytic, collagenase Type I (Gibco, Invitrogen, UK), to this solution. 
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Table 4.2 Human periosteal explant digestion methods and results 
Digestion method  Donors 
age (sex) 
Wet weight  
mg 
Digestion time  
hrs 
Isolation Yield 
total cells 
Isolation rate 
cells/hr 
Dead cells  
(% of total) 
68 (f) 338 3.5 161,000 46,000 46,000 (28.6%) 
1 
 
0.25% Collagenase Type II  
0.20% Trypsin  media (186) 
 
58 (f) 331 3.5 120,000 34,285 30,000 (25.0%) 
30 (m) 483 3.0 283,000 94,333 5,200 (1.8%) 2  
0.25% Collagenase D 
(201;389) 
 
84 (f) 513 3.0 210,000 70,000 2,800 (1.3%) 
56 (m) 480 3.0 720,000 240,000 620,000 (86.1%) 3  
0.60% Collagenase D 
 64 (f) 440 2.0 512,000 256,000 430,000 (84.0%) 
43 (f) 615 4.5 630,000 140,000 15,500 (11.1%) 
31 (m) 312 4.5 920,000 204,444 18,000 (2.0%) 
74 (f) 421 4.5 710,000 157,778 70,200 (9.9%) 
62 (m) 628 4.5 666,667 148,148 14,100 (2.1%) 
72 (f) 357 5.0 810,000 162,000 142,000 (17.5%) 
25 (f) 431 8.0 1,450,000 181,250 980,000 (67.5%) 
4 
 
0.30% Collagenase D  
0.30% Collagenase Type I  
5 mM CaCl2 
 
39 (m) 660 7.5 1,230,000 164,000 733,200 (59.6%) 
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In addition we added 5 mM CaCl2 (molecular biology grade, Sigma, Poole, UK) to EBSS, as > 
5mM of Ca+2 ions are necessary for adequate collagenase activation.  EBSS alone only contains 2.4 
mM CaCl2 and thus requires supplementation.  The resulting collagenase cocktail (pH= 7.29), 
utilised in method 4, allowed for increased cell yields while limiting cell death in incubations of 4.5 
hrs (circled in Fig 1).  After 4.5 hrs, cell death and total cell yields are found to increase 
proportionately with time in solution.  Long incubation times of 7.5-8.0 hrs are found to result in 
the complete disaggregation of periosteal explants and led to higher cell yields and an equally high 
level of cell death.  Taken together, this data showed that isolation method 4 combined with 
incubation times of 4.5 hrs provided the optimal environment for the release of large populations of 
viable cells from human periosteal explants (Figure 4.5).  The donor cells isolated using this 
optimised method can now be placed into monolayer culture and expanded for future 
characterisation studies. 
 
Figure 4.5 Plot of periosteal cell isolation results from 13 human donors.  To determine the efficacy of each 
of the 4 enzymatic digestion methods, the data is categorised according to percentage viability and total cell 
yield.  Isolation method 4 at 4.5 hrs incubation represents the optimal conditions for isolating the largest 
numbers of viable cells (circled data). 
 
4.2.3.2 Effects of culture media on periosteal cells (experiment II) 
Visual assessment of isolated periosteal cells from both enzymatic digestion and explant migration 
cultures reveal a faster rate of proliferation and enhanced cell viability in early passage cells 
cultured in growth media 2 (Figure 4.6).  Representative images of cells cultured in growth media 1 
show a large proportion of the cells to be round, floating “dead” cells and small, non-proliferating, 
attached cells (Figure 4.6A, B, C, D). Due to this unsuitable environment, cultures propagated in 
growth media 1 never reached confluence and did not survive past passage 2.  This is compared to 
cultures propagated in growth media 2, which reached confluence between 7-12 days, and were 
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cultured for more than 20 passages without arrested growth (see Chapter 5 for results).  To further 
highlight the superiority of growth media 2 over growth media 1, the unattached cells found in the 
growth media 1 culture supernatant were collected and recultured in growth media 2.  After 24 
hours in growth media 2, the cells attached and spread on the culture plate and subsequently 
reached confluence after 7 days in culture.    
 
Figure 4.6 Representative images taken of periosteal cells, isolated by enzymatic digestion or explant 
migration methods, from a 37 yr old male and cultured in two different growth medias.  Early passage cells 
isolating using both methods are seen to attach and proliferate better (E, F, G, and H) in growth media 2.  The 
majority of the cells cultured in growth media 1 (A, B, C, and D) did not adhere to the culture plate and did 
not proliferate normally. Scale bar = 100 µm. 
 
To further investigate the impact of culture conditions on periosteal cell cultures, we compared the 
presence of numerous cell subpopulations in cells grown in both growth media.  The cocktail of 
cell specific mAbs used in this flow cytometry study was selected to identify cell types of interest; 
namely progenitor cells (Stro-1+/ALP-), haematopoietic stem cells (CD34+), preosteoblasts (Stro-
1+/ALP+), and osteoblasts (ALP+/Stro-1-).  As shown in Table 4.3, periosteal cells cultured in 
growth medium 1 contain dramatically smaller populations (≥ 50% less in each case) of the cell 
types investigated as compared to cells grown in medium 2.  The capacity to propagate each cell 
subpopulation during subculture is integral to our ability to fully and extensively characterise 
isolated periosteal cells in future studies.  Therefore, it is observed that growth medium 2 provided 
optimal culture conditions to allow for the expansion of heterogeneous cell types in monolayer.  A 
complete analysis of these specific cell types and the long-term effects of subcultivation on their 
growth and differentiation is demonstrated in Chapter 5. 
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 Cell 
Population 
Stro-1+ 
ALP- 
ALP+ 
Stro-1- 
Stro-1+ 
ALP+ 
CD34+ CD45+ 
Growth 
Media 
      
1  5.9% 21.1% 4.4% 2.5% 0% 
2  15.8% 41.2% 8.2% 8.8% 0% 
Table 4.3 Summary of flow cytometry data showing the effect of the different media conditions on the 
presence of distinct cell populations within passage 2 human periosteal cells isolated from a 38 yr old male.  
Data represents the number of cells staining positive for 5 different cell type/lineage specific mAb(s) (top 
line) as a percentage of the total cell population examined.  To establish positive events from background 
staining, individually matched isotype controls were used for each mAb.  More than 30,000 total events were 
recorded to determine the percentages in the table. 
4.2.3.3 Effects of plating density on expansion of periosteal cells (experiment III) 
To determine the short-term proliferation rates and examine the impact of the microcellular 
environment on the growth capabilities of heterogeneous periosteal cells, cultures were plated at 
four different densities.  Passage 2 periosteal cells isolated from two different donors were plated at 
densities ranging from low (10 cells/cm2) to high (5000 cells/cm2) and cultured for 12 days under 
identical conditions.  Calculations of total cell yields and fold expansion rates (Figure 4.7) shows 
that periosteal cell growth rates and behaviour are extremely sensitive to plating density in cultures 
derived from both donors. Cells (31 yr old male) plated at densities of 5000 cells/cm2 and 10 
cells/cm2 both expanded approximately 5-fold in 12 days.  However, cells plated at 5000 cells/cm2 
yielded 630,000 cells per 25 cm2 culture plate, whereas cells plated at 10 cells/cm2 yielded only 
1300 cells.  Expansion rates of cells from the other donor (39 yr old male) displayed similar results.  
Densities of 5000 cells/cm2 showed a 7-fold increase in cell number over 12 days, yielding over 
900,000 cells.  This fold increase was slightly higher than the remaining densities, 500 cells/cm2, 
50 cells/cm2, and 10 cells/cm2, which saw 6-, 2-, and 4-fold increases respectively. 
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Figure 4.7 This figure shows the relationship between initial plating density and expansion of periosteal 
cells.  Passage 2 periosteal cells from 2 donors were plated in 25 cm2 culture flasks at 10, 50, 500, 5000 
cells/cm2.  The cells were harvested and counted every 2 days for 12 days.  Total cell yield (A and C) and 
fold increase (B and D) per flask are shown for each donor.  Data are expressed as mean ± standard deviation 
(n=3). 
 
In both donors, the peak doubling rate per day for the three lowest plating densities (10, 50, 1000 
cells/cm2) was between day 2 and day 4 (Figure 4.8).  Cell doublings per day (CD) was calculated 
using equation 4.1, where Nf = final cells counted and Ni= initial cells seeded. 
)ln(
)2ln(*48
24
Ni
Nf
hrs
hrsCD =             (4.1) 
The fastest doubling rate was noted in cultures seeded at 10 cells/cm2 at day 2, with an average 
doubling time of 24 hrs for both patients.  This initial burst of cell proliferation found in the 3 
lowest seeding densities was subsequently followed by periods of arrested growth, seen as periods 
of 0 population doublings and decreased cell numbers.  Comparatively, cultures seeded at high 
density (5000 cells/cm2) expanded at a consistent rate until confluence, which occurred between 10 
and 12 days in both donors.  Although their peak doubling rates were found to be low, high density 
(5000 cells/cm2) cultures maintained the most consistent expansion and doubling rates during the 
12 day growth period.  Due to the increased cell yields and consistent and reproducible growth over 
a single passage, the plating density of 5000 cells/cm2 was selected as the optimal density for our 
periosteal cell culture model. 
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Figure 4.8 Figure shows the effect of plating density on periosteal cell doublings per day.  Passage 2 
periosteal cells from two donors were plated in 25 cm2 culture flasks at densities of 10, 50, 500, 5000 
cells/cm2.  Every other day for 12 days, cells were harvested and counted to calculate cell doublings. 
 
4.2.3.4 Colony forming efficiency (experiment IV) 
Colony-forming-units fibroblasts (CFUs) were initially referred to in seminal work by Friedenstein 
and collegues, who demonstrated the in-vitro growth  of adherent colonies of cells morphologically 
resembling fibroblasts derived from explants of bone marrow (222;392;393).  These colonies are 
formed by the rapid proliferation of stem-cell like precursors from non-haematopoietic tissues and 
as such these cells are often referred to as mesenchymal stem cells or mesenchymal progenitor 
cells.  Since the colony forming efficiency of cultures is highly dependent on the microenvironment 
(225;388), a range of seeding densities (500 to 106 cells per 78 cm2 Petri-dish) was preliminarily 
examined to establish the optimal cell density for cell growth and distinct colony formation in our 
periosteal cell culture system.   It is well known that adult stem cells are highly sensitive to plating 
density, and early progenitors are rapidly lost if the cultures are grown to confluency (224).  The 
results demonstrate that periosteal cells seeded at 10,000 cells/Petri dish and cultured for 12 days  
produce the greatest number of distinct colonies (>1 mm) and did not suffer from colony growth 
inhibition as the higher seeding densities did (Figure 4.9).  Indeed, the optimal conditions, 
established here, allows for the expansion of periosteal progenitor cell populatons, which is 
important for the development of cell-based therapies.  More comprehensive functional colony 
forming efficiency studies are demonstrated in Chapter 5 across multiple passages using cells 
isolated from multiple patients.  
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Figure 4.9 Crystal violet staining (0.5% w/v) of passage 1 periosteal cell colonies seeded at varying densities and cultured for periods of 7 or 12 days.  To highlight the effects 
of seeding density and time in culture on colony formation, representative images of the stained dishes are displayed and the number of colonies quantified for each respective 
condition (n=3). 
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4.2.4 Conclusion 
To consider human periosteal cells as a viable cell source for cell and tissue therapies they need to 
posses the ability to be expanded in culture relatively quickly under conditions in which they retain 
their potential to proliferate and differentiate into multiple cell lineages.  However, as seen in MSC 
cultures, as the cells are expanded they lose their proliferative and multilineage differentiation 
capacity; both of which are sensitive to cellular microenvironment, particularly plating density 
(224;225;228).  It is apparent that a large number of variables and parameters must be considered 
in expanding adult stem cells for clinical purposes.  In human periosteum, which is composed of 
two-distinct anatomical layers, cellular and extracellular heterogeneities are intrinsic to the tissue.  
These in-vivo heterogeneities are further complicated in-vitro by age-, donor site-, species-, explant 
size-, and isolation method- specific variations in cell characteristics and differentiation potential 
in-vitro (359;368;384;386;387;394).  Therefore, the development and optimisation of cell isolation 
and culture methods, presented here, was fundamental to the production of a simple, reproducible 
and robust human periosteal culture model to study and influence cell behaviour and function. 
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Chapter 5  
 
In-vitro Expansion and Characterisation of Human 
Periosteal Cells 
 
5.1 Introduction 
The periosteum is a specialised connective tissue forming the outer lining of long bones and is 
intimately involved in driving the cell differentiation processes of bone development and repair 
(47;395;396). The periosteum itself is comprised of two discrete layers; an outer fibrous layer and 
an inner juxta-osseous cambial layer (29). The outer fibrous layer appears to be composed of 
fibroblastic cells immersed in a matrix of collagen and elastin fibres, along with a distinct nerve 
and microvascular network (39;397). The inner cambium layer is highly cellular and contains a 
variety of different cell types including fibroblasts, osteoblasts, and osteochondral precursor cells 
(398). Mesenchymal precursor cells in the periosteum differentiate into neochondrocytes to 
produce cartilage tissue during embryogenesis and contribute to bone apposition during 
intramembraneous ossification by differentiating into osteoblasts (399).  
A number of studies have aimed to utilize this potential, using either periosteal explants 
(191;361;387) or isolated cells (384;390;400) to generate bone (30;401) or cartilage 
(31;361;362;402;403).  Periosteal cell phenotype and properties are influenced by numerous 
factors, including sex steroids (404;405), endogeneous growth factors (406;407), and mechanical 
loading environment in vivo (408;409) and isolation (386), culture methods (30;190;201;361;376), 
and the donor site (359) in vitro. While the osteo- and chondrogenic capacity of periosteal cell 
cultures has been investigated using functional assays in growth-factor supplemented media, little 
quantitative work has been performed on the initial phenotype of isolated periosteal cells and their 
behaviour during prolonged culture. Examination of these cells as reported here has numerous 
benefits. New information regarding putative undifferentiated mesenchymal precursor cells in the 
periosteum could aid in understanding bone formation and fracture healing in vivo. Additionally, 
for successful cell-based tissue engineering and regenerative medicine strategies, changes in 
growth pontential and protein and gene expression during expansion need to well-studied and 
controlled. Thus, the aims of this study were to isolate and expand periosteal cells derived from 
adult human donors using a simple, well-defined culture technique that uses enzymatically 
liberated cells, and to characterise changes in growth kinetics, morphology and phenotype in the 
heterogeneous cell populations during subculture.  
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Here we obtained periosteal tissue from a number of patients undergoing scheduled knee surgery. 
Cells were then enzymatically liberated and expanded in monolayer to analyze proliferation, cell 
division, and morphology. To evaluate the phenotypic changes that occur in culture, we performed 
dual-colour flow cytometry and real-time reverse transcriptase polymerase chain reaction (RT-
PCR) to determine the expression patterns of target proteins and genes using a panel of monoclonal 
antibodies and genetic probes (Table 5.1); indicative of haemapoeitic cell types, osteoblasts, 
chondrocytes and mesenchymal stem cells. The presence of additional cell types, such as primitive 
stem cells, smooth muscle cells, and adipocytes was also investigated. Following the seminal work 
of Friedenstein and colleagues (222;391;392), the presence of highly proliferative, progenitor cell 
phenotypes, were further examined by staining and counting colony forming units (CFUs). The 
osteogenic potential of the Stro-1+ subpopulation was confirmed by selectively depleting the cell 
population of Stro-1+ cells, and comparing the capacity of the two poulations to form bone 
5.2 Materials and Methods 
5.2.1 Harvest of periosteal tissue and isolation of cells 
This study was approved by the NHS ethical committee (project RREC2700). Periosteal tissue 
specimens were obtained from patients providing informed consent (25-74 years old) undergoing 
elective knee surgery at The Chelsea and Westminster Hospital, London.  Explants were harvested 
from the proximal tibia using a periosteal elevator, and transported in Earl’s Balanced Salt Solution 
at 37oC. Explants were weighed, finely minced, and enzymatically digested with 3 mg/ml 
Collagenase D (Roche Applied Scienc, West Sussex, UK) and 3 mg/ml collagenase type II (Sigma-
Aldrich, Poole, UK) and 5 mM CaCl2 in growth medium (high glucose Dulbecco’s Modified Eagle 
Medium containing 10% v/v foetal bovine serum, 1% v/v L-glutamine, 100 units/ml penicillin, 100 
µg/ml streptomycin [all from Invitrogen, Paisley, UK]). After incubation at 37 °C for 4.5 hours, the 
cell suspension was washed, passed through a 70µm cell strainer (Falcon, Becton Dickinson, 
Oxford UK), and counted. A proportion of the freshly isolated cells were analysed using flow 
cytometry, the rest being placed into culture and allowed to attach to tissue culture plastic for a 
period of four days. The media was changed after 2 days to remove non-adherent cells and the 
attached cells were further cultured as passage 0 until confluence. All characterisation experiments 
were carried out using isolated periosteal cells serially expanded from passage 0 through to at least 
passage 15. 
5.2.2 Cell culture 
To investigate the growth characteristics of periosteal cultures, cells isolated from 8 donors aged 
25-74 yrs were separately expanded in monolayer in growth medium.  Upon confluence, adherent 
periosteal cells were harvested with 0.25% trypsin and 1mM EDTA for 5 minutes at 37°C, and 
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replated at the optimised density of 5000 cells/cm2 in a T75 flask containing 15 mls of growth 
medium; this process was repeated every 7-14 days for at least 15 passages.  Viable cell number 
was determined using trypan blue dye exclusion and a haemocytometer.  Based on the cell counts 
cumulative cell number, population doublings, and fold increase were calculated. Cultures were 
terminated after seeded cells failed to double for three consecutive passages.  
5.2.3 Cell cycle analysis 
To further characterise the growth characteristics and study the effects of passaging on proliferation 
rates in human periosteal cell cultures, cell cycle analysis was performed to determine the 
percentage of quiescent (G0) and proliferating (G1, S, G2/M) cells.  Periosteal cells at passages 1, 7, 
and 15 from a young (25 yrs female) and old (62 yrs female) donor were plated at 5000 cells/cm2 in 
T-25 tissue culture flasks (n=2) (Corning, Fisher Scientific, UK) and cultured for a period of 12 
days in standard growth medium.  Every 2 days, cells were collected by trypsinisation, counted 
using a haemocytometer, and fixed in methanol.  The fixation method employed here was adapted 
from procedures optimised by Jacobberger et al for intracellular antigen staining (410;411).  This 
method allows for the long-term preservation of cell morphology without covalently modifying 
cellular DNA, RNA, or proteins.  Additionally, the use of methanol results in significantly less cell 
debris and aggregates.  Briefly, 90% (v/v) methanol, pre-chilled to -20 °C, was added drop-wise to 
the cell pellet during gentle agitation on a vortex.  The cells were stored at -20°C until cells from all 
time points and donors were collected.  For immunofluorescent staining, cells in fixative were 
washed 2x-times in flow buffer containing 2 mg/ml bovine serum albumin (Sigma, Poole, UK) and 
0.1% Sodium Azide (Sigma, Poole, UK) in PBS.  Cells were thoroughly resuspended in 100 µl 
flow buffer at densities between 1.0 - 4.0 x 106 cells/ml.  Cells were then incubated with FITC-
conjugated monoclonal antibody against proliferation marker Ki-67 (clone B56; BD Pharmingen, 
UK) at a concentration of 20µl/106 cells for 30 min at RT.  Isotype controls were stained in parallel.  
After rinsing, cells were counterstained in 100 µl of 0.1% (v/v) Triton X-100 in PBS containing 20 
µg/ml PI (propidium iodide, Invitrogen, UK), and 2 mg/ml RNase A (Sigma, Poole, UK) for 20 
minutes at 37 °C.  DNA content and expression of Ki-67 were measured on a FACSCalibur 
instrument (BD Biosciences, Oxford, UK), where at least 20,000 events were collected per sample.  
The resulting data was analysed using a combination of FlowJo (Tree Star Inc, Ashland, USA) and 
WinMDI software (The Scripps Instititute, La Jolla, CA, USA).  DNA content was assigned to 
G0/G1, S, or G2\M phases based on the method of Ormerod (412) 
5.2.4 Evaluation of cell morphology 
Changes in cell morphology were progressively examined in passage 0-20 human periosteal 
cultures derived from 6 donors aged 31-64 years.  At each respective passage, photomicrographs 
were taken randomly of cell areas that were roughly 60-70% confluent under a phase contrast 
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microscope at 10x magnification. At this level of confluence, periosteal cells were found to be in 
the log-phase of growth.  An important experimental condition, considering that confluence level is 
known to influence the morphology and frequency of cell populations in heterogeneous cultures 
(226). Post-digital image processing and measurement were performed using ImageJ software 
(NIH, Frederick, USA).  From the projected cell area and perimeter measurements it was possible 
to determine the cell shape factor coefficient (Sfc).  As described by Allen et al (413), Sfc is a 
measure of cell shape and is given by the equation: 
2
4
Perimeter
AreaSfc ×= π
                             (5.1) 
By definition, an Sfc value of 1 corresponds to a perfect circle,  
whereas a straight line has a value of 0. Thus, the more elongated the cell 
shape is, the lower the Sfc value.  The number (n) of cells measured per passage was determined in 
each culture using the formula: 
2
2/ ⎥⎦
⎤⎢⎣
⎡ ×=
E
zn σα
                             (5.2) 
where, 
zα/2 is the positive value that is at the vertical boundary for the area of α/2 in the right tail of the 
standard normal distribution. 
σ is the population standard deviation. 
n is the sample size. 
This formula was used to determine the sample size necessary to establish, with a confidence of 
95% (z= 1.96), mean cell areas within an error margin of ± 10%.  Samples sizes ranging from 50 to 
100 single cell measurements were used to statistically determine changes due to passaging and 
also compare morphologies across donors.  In all cases mitotic cells were ignored.   
5.2.5 Phenotypic analysis 
5.2.5.1 Immunofluorescence 
Early and late passage periosteal cells from two donors were grown on four-well chamber slides 
(Bectin Dickinson Falcon) at 5,000 cells/well for one week.  Cultures were washed twice with 
0.01M, pH 7.4 phosphate buffered saline (PBS), then fixed and permeabilized in cold acetone: 
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methanol (1:1 v/v) for 20 minutes at 4°C.  Cells were then washed with PBS and blocked with PBS 
containing 2% (v/v) BSA, 0.1% (v/v) normal mouse serum, and 0.1% (v/v) foetal bovine serum for 
45 minutes at room temperature (RT).  After blocking, the cells were stained for 30 minutes at 37 
oC with the primary antibodies anti-α-smooth muscle actin (10 µg/ml) and phycoerythrin 
conjugated anti-SSEA-1 (5 µg/ml) (Both R&D systems).  Cells stained for α-smooth muscle actin 
were further incubated for 30 minutes at 37° C with a secondary goat F(ab’)2 anti-mouse IgG-FITC 
(5 µg/ml) (R&D systems).  Both incubations were followed by thorough washing with PBS.  The 
chambers were then detached from the culture slide, and coverslips were mounted with Vectashield 
containing DAPI (Vectashield).  Images were taken using an Olympus BX-51 reflected 
fluorescence microscope (Olympus UK LTD., London) fitted with an Olympus DP070 digital 
camera and analysed using Olympus DP Controller software (Olympus Imaging, London, UK).  As 
a positive control for Ssea-1 reactivity, passage 15 mouse embryonic stem cells (mES) were 
cultured for 4 days on gelatin (0.1% w/v) coated chamber slides in the presence of leukaemia 
inhibitory factor and stained in parallel. Secondary antibody controls, devoid of primary antibodies, 
were processed simultaneously using the same protocol and were found to be negative for staining.  
To determine the percentage of cells expressing α-smooth muscle actin, positively stained cells 
were counted per chamber well and divided by the total number of cells per well, which was 
calculated using a haemocytometer (n=4). 
5.2.5.2 Oil-Red O staining  
To demonstrate the presence of adipocytes (figure S2B), Oil-Red O staining was employed using 
early and late passage periosteal cells grown for ten days in complete medium. The cells were then 
fixed in 4% w/v paraformaldehyde for 20 min and stained with filtered Oil-Red O solution (6 parts 
0.5% v/v Oil-Red O stock: 4 parts dH2O) for one hour at room temperature.  Nuclei were 
counterstained with Harris Haematoxylin (Sigma; Poole, UK) for 1 min. and mounted with 10% 
v/v glycerol in PBS.  A series of washes with PBS were performed after each step.  As a positive 
control, human epithelial lung carcinoma (A549) cells were cultured for 4 days and stained as 
above.   
5.2.5.3 Flow Cytometry 
Antibodies were tested for their specificity, titrated, and used at concentrations varying from 1-2.5 
µg/106 cells. Details of all monoclonal antibodies (mAbs) are given in Table 5.1, but briefly, mAbs 
used were raised against Stro-1, human bone/liver/kidney alkaline phosphatase (ALP), CD34, 
CD31 and CD45. Approximately 1-3 x 105 periosteal cells of passages 0-15 were incubated in 1 ml 
of blocking buffer (phosphate buffered saline pH 7.4 0.01M (PBS) containing 2% (w/v) bovine 
serum albumin (BSA), 0.1% (v/v) foetal bovine serum, and 0.1% (v/v) normal mouse serum) (all 
Sigma-Aldrich) for 30 minutes at room temperature to limit non-specific binding. For direct 
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staining, cells were then incubated with conjugated mAbs for 45 minutes at 4oC, washed in PBS 
containing 2% BSA (w/v) + 0.1% (w/v) Sodium Azide (flow buffer), centrifuged, and resuspended 
in 300 µl of flow buffer prior to analysis. For indirect staining using primary mAb Stro-1, the cells 
were first incubated with the primary mAb (45 min at 4oC), washed, and incubated with a 
fluorescein isothiocyanate (FITC)-conjugated fragment F(ab’)2 goat anti-mouse secondary Ab 
(Jackson ImmunoResearch, Suffolk, UK) for 45 minutes at 4oC. Matched isotypes were used as 
negative controls and prepared at the same concentrations as their matched primary Ab. Cell 
fluorescence was evaluated by flow cytometry using a FACSCalibur instrument (BD Biosciences, 
Oxford, UK) and data analysed using FlowJo software (Tree Star Inc, Ashland, USA). At least 
20,000 events were collected per sample and percentage positive expression for each mAb was 
defined as the level fluorescence >99% of the isotype-matched control antibodies. 
5.2.6 Real-time Reverse Transcriptase Polymerase Chain Reaction 
Total RNA was extracted from monolayered periosteal cells by the addition of 10μl β-
mercaptoethanol in 1ml RLT-buffer (QIAGEN, West Sussex, UK). Total RNA was isolated using 
the RNeasy mini kit, treated with RNase-free DNase 1 (both QIAGEN), according to the 
manufacturers protocol and quantified using the ND-1000 UV-Vis Spectrophotometer 
(Nanodrop®, Wilmington, USA). 1000ng of total RNA was reverse transcribed (RT) into cDNA 
and a mastermix prepared for each reaction containing; 10μl Taqman universal mastermix (Applied 
Biosystems, CA, US), 7μl 0.1% v/v diethylpyrocarbonate (DEPC) water (Invitrogen Ltd, Paisley, 
UK), 2μl extracted cDNA and 1μl Taqman® probe (Applied Biosystems, CA, USA). TaqMan® 
Gene Expression Assays used to amplify genes are detailed in Table 5.1, but include Runx 2, Sox 
9, bone-specific ALP and Col 1A. 18S was used as a control gene. Each reaction was carried out in 
triplicate. The PCR reaction was initiated by a 2 minute 50˚C and 10 minute 95˚C step to optimise 
thermal cycling conditions for the ABI Prism 7700 sequence detection system (Applied 
Biosystems, Ca, USA) used to detect relative quantification of gene expression. This was followed 
by PCR amplifications performed for 40 cycles in a Corbett Rotor-Gene 6000 (Corbett Life 
Science, Sydney, Australia) at 95˚C for 15 seconds and 60˚C for 1 minute. The target signal was 
plotted against the number of cycles and the threshold level was set at 0.05. Comparison of all data 
was taken at the intercept, where sample reactions crossed this phase of amplification. Our results 
were correlated using the comparative CT method (414). Fold changes in gene expression are 
presented as mean ± SE change relative to passage 1 cells from 3 different patients.  
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Table 5.1 Antibodies and Taqman™ gene probes used in this study, with details of their sources and 
specificities. 
 
Antibodies 
Antigen Concentration 
[µg/106 cells] 
Catalogue 
number 
Manufacturer Cell specificity 
Stro-1 2.5 MAB1038 R&D Systems Progenitor cells 
 
Alkaline phosphatase 
(ALP) 
2.5 FAB1448A R&D Systems Osteoblastic 
cells 
CD45 1.0 MCA87APC Abd Serotec Leukocytes 
 
CD34 1.0 MCA1578PE Abd Serotec Haematopoietic 
stem cells 
CD31  
(PECAM-1) 
1.0 MCA1738F Abd Serotec Endothelial 
cells 
SSEA-1  
(stage specific antigen-1) 
5.0 FAB2155P R&D Systems Primitive stem 
cells 
α-smooth muscle actin 10.0 MAB1420 R&D Systems Smooth muscle 
cells 
     
Taqman™ gene probes (Applied Biosystems) 
Gene name Symbol Catalogue 
number 
Accession 
number 
Chromosome 
location 
Alkaline phosphatase ALP Hs00758162  NM000478 Chr. 1 
21769385 - 
21772879 
SRY (sex determining 
region-y)-box 9 
Sox9 Hs00165814 NM000346 Chr. 17 
67,630,455 -
67,634,156 
Collagen Type 1, alpha 1 Col1A1 Hs00164004 NM000088 Chr. 17 -
45,632,113 - 
45633974 
Runt-related transcription 
factor 2 
Runx2 Hs00298328 NM001015051 Chr. 6 
45,622,542 - 
45,626,797 
Bone gamma-
carboxyglutamate protein 
Osteocalcin Hs01587813 NM199173 Chr.1 
154,478,629 – 
154,479,006 
Platelet/endothelial cell 
adhesion molecule 
CD31 Hs00354641 NM000442 Chr. 17 
59,754,724- 
59,754,902 
Eukaryotic 18S rRNA 18s Hs99999901 X03205 
 
N/A 
Collagen Type 2, alpha 1 COL2A1 Hs00156568 NM001844.4 Chr. 12 
46,649-46,688 
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5.2.7 Colony forming unit assay 
A range of seeding densities (500 to 106 cells per 78 cm2 Petri-dish) was examined previously to 
establish the optimal cell density for cell growth and distinct colony formation (Chapter 4). Based 
on these results, periosteal cells from 4 donors were seeded at 10,000 cells/dish and cultured in 
growth medium for 12 days.  After 12 days, the cells were stained with 0.5% crystal violet in 
methanol for 5 minutes, rinsed twice in distilled water and the number of colonies per dish counted 
by 2 independent observers. Based on previously described criteria (391) colonies < 1 mm in 
diameter (~50 cells) and faintly stained colonies were discounted. Mean values for each passage for 
each patient were derived from three Petri dishes.  Cells of passages 0-5, 7, 10 and 12 from four 
different patients were used.  
5.2.8 Cell Sorting 
Stro-1+ cells were selected from passage 10 periosteal cells (32 yr old male) using a cell-sorting kit 
utilising Streptavidin coated magnetic beads (Biotin binder kit, Invitrogen, UK) according to 
manufacturer’s instructions. Briefly, 107 periosteal cells were incubated with the primary mAb 
(anti-human Stro-1, R&D systems, UK) at a concentration on 2.5 µg/106 cells for 1 hr at 4°C.  
Following a wash in 2% (w/v) BSA buffer, cells were incubated with Biotin-SP-conjugated 
fragment F(ab’)2 goat anti-mouse secondary antibody (Jackson ImmunoResearch, Suffolk, UK) at a 
concentration of 1.5 µg/106 cells  for 45 min at 4°C. After washing, biotin-conjugated magnetic 
beads were added to the cell suspension and incubated for 20min. The bead-cell suspension was 
placed into a magnetic field and Stro-1- cells collected. The Stro-1- population was counted using a 
haemocytometer and the viability determined using the trypan blue dye exclusion assay.   Both the 
viability and purity of the sorted population were determined to be >98%.  
5.2.9 In-vitro mineralisation  
To study the differential osteogenic potential of late passage periosteal cells, both unsorted (total 
population) and sorted (Stro-1-) cell populations were seeded at 10,000 cells/cm2 in 48-well plates 
(n=6) and induced to mineralise.  Cells were maintained at 37 °C and 5% CO2 in standard growth 
medium until confluence, when mineralization was induced by addition of osteogenic supplements, 
10 mM β-glycerophosphate, 50 mg/L L-ascorbate, and 10 nM dexamethasone (all Sigma-Aldrich, 
Poole, UK). Alizarin Red was used to assess the formation of mineralised matrix after 28 days.  
Cell cultures were rinsed with PBS and fixed in 4% formaldehyde in PBS for 15 min at RT, rinsed 
with distilled water, then stained with 1 ml of 40 mM Alizarin Red Stain (pH 4.1) per well for 30 
minutes at RT with gentle shaking.  After aspiration of unincorporated dye, the wells were washed 
5-times with dH2O and finally rinsed in a water bath.  Images of stained nodules were immediately 
taken using both phase-contrast and fluorescent microscopy at 10x magnification (DP-70 Olympus 
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Microscope, Watford, UK) and the number of fluorescent nodules per well counted. To quantify 
the amount of mineralised matrix per well we modified a dye extraction protocol developed 
previously (415). Briefly, 800 µl of 10% (v/v) acetic acid was added to each well, and the plate 
incubated at RT for 30 min on a plate shaker.  The monolayer was scraped from the well using a 
pipette tip and transferred to a 1.5-ml microcentrifuge tube with a wide-mouth pipette.  After 
vortexing for 30 seconds, the slurry was overlaid with 500 µl mineral oil (Sigma-Aldrich), heated 
to 85 °C for 10 min, and transferred to ice for 5 min. The slurry was then centrifuged at 20,000g for 
15 min and 500 µl of the supernatent removed to a new 1.5-ml microcentrifuge tube.  Then 200 µl 
of 10% (v/v) ammonium hydroxide was added to neutralise the acid.  Aliquots of 150 µl of the 
supernatant were read in triplicate at 405 nm in a 96-well plate using opaque-walled, transparent-
bottomed plates (Fisher Lifesciences, Loughborough, UK). 
5.2.10 DNA assay 
To normalise mineralization data to average cell number per well, total DNA was determined in 
sorted in unsorted periosteal cell populations with the use of Hoechst 33258 (Sigma, Poole, UK) 
dye. DNA was extracted from cell lysed by one freeze\thaw cycle (30min at -80oC and 20min at 37 
oC). Hoechst 33258 was added to the lysate and allowed to react for 5 minutes in the dark. 
Fluorescence was measured using a fluorescent plate reader set to 360nm (Excitation wavelength) 
and 460nm (Emission wavelength). To quantitate the amount of DNA per well, Calf Thymus DNA 
was used (Sigma, Poole,UK) at concentrations of 0, 0.78, 1.56, 3.13, 6.25, 12.5, 25 and 50ug/mL in 
TNE buffer (pH7.4) to determine a standard curve 
5.2.11 Statistics 
SigmaStat and SPSS statistical software packages were used to analyse the data. Unless otherwise 
stated all data is presented as mean ± SD.  A two-way analysis of variance (ANOVA) was applied 
to flow cytometry, quantitative RT-PCR, and CFU data with a Tukey post-hoc test.  To identify 
statistical differences in morphology and mineralization data, the non-parametric Mann-Whitney U 
test was performed.  In all cases, p-values < 0.05 were deemed statistically significant.  For 
morphology data the following symbols were used to display significant differences (p<0.05) with 
(*) passage 0, (♦) passage 1, (†) passage 2, (□) passage 5, ($) passage 10, (‡) passage 15, and (○) 
passage 20 cells.   
Linear regression analysis was performed on cell morphology and proliferation data to find the 
Pearson’s product-moment correlation coefficient or, in the instances of unequal variances between 
variables, Spearman rank correlation coefficient.  A one-way ANOVA was used to establish the 
statistical significance of the Pearson’s product-moment correlation between the two variables.  
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Whereas, a two-tailed student t-test was used to statistically compare Spearmans rank correlations.  
All correlations were deemed statistically significant at p-values < 0.05. 
A Pottfoff analysis was used to test the statistical homogeneity of growth rates (slopes of 
population doubling/culture time) between donor periosteal cultures.  The Pothoff method is 
essentially an Analysis of Covariance (ANCOVA) that utilizes a multiple regression model of the 
form: Y = a + b1C + b2G +b3C*G, where Y is the criterion variable (population doublings), C is the 
continuously distributed variable (culture time), G is the grouping variable (donor) and C*G is the 
interaction between C and G.  To test the null hypothesis that the slope for predicting growth rates 
is the same in each donor, we compared the full regression model (all variables) to the reduced 
model (no interaction term) to determine the partial F-statistics between donors.  
full
reducedfull
MSErf
SSSS
F
)( −
−=
                    (5.3) 
In this model, SS is the sum of squares for each model, (f-r) is the degrees of freedom, and MSE is 
the mean square that is equivalent to the pooled error variance.  From the partial F-statistic the 
associated p-value was determined and deemed significant at p<0.05. 
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5.3 Results 
5.3.1 Cell culture 
The in-vitro growth patterns of periosteal cells during culture expansion were analysed to assess 
their long-term self-renewal capacity.  Periosteal cells were expanded ex vivo by successive cycles 
of trypsination, seeding at 5000 cells/cm2, and culturing for periods of 7-14 days.  Upon plating, 
periosteal cells experienced a lag phase of 1-4 days before entering the log phase of growth, where 
cells proliferated with an average population doubling time of 72.0 ± 9.4 hrs over 15 passages 
(Figure 5.1A & B and Figure 5.2A & B).  This growth period was followed by a confluent growth-
arrested phase.  Under these conditions, there was an average 2.8-fold increase in cell number after 
each passage.  However, across all donors early passage cultures demonstrated heightened growth 
rates compared to late passage cultures.  Early passage cultures (passage 0-5) experienced a 3.7 ± 
1.7 –fold increase in cell number after each passage compared to cultures at passage 6-10 and 11-
15, which experienced lower increases of 2.6 ± 0.8 - and 2.5 ± 1.0 -fold respectively.   
The growth curves of periosteal cells from donors of various ages were linear for > 20 population 
doublings, with no progressive donor age-associated decline in their growth rates (Figure 5.1B).  
Statistical analysis of periosteal cell growth profiles, however, did reveal significant differences in 
cell proliferation rates between donors (Figure 5.1B & C).  Regression lines fit to each culture 
expansion profile were used to identify Pearson’s product-moment correlation coefficients (R-
values) and growth rates (slope ± standard error) for each donor-derived periosteal cell culture. 
This information was then used to conduct a Pothoff analysis (ANCOVA) of slope homogeneity 
between donors to identify differences in cell proliferation (Figure 5.1C).  Cultures derived from a 
59 yr old female demonstrated growth rates that were significantly slower than all other donors 
examined (p<0.05).  Whereas, cultures derived from a 74 yr old female and a 52 yr old male 
demonstrated growth rates that were significantly faster than all other donors.  The remaining 
donors had similar growth rates between 0.125 - 0.164 PD/day.   
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Figure 5.1 Growth characteristics of human periosteal cells from 8 donors of different ages.  Growth kinetics 
are displayed as accumulated cell number (A) and total population doublings (B) calculated from passage 0.  
Cells were plated at 5,000 cells/cm2 and expanded in monolayer with serial passages upon confluence.  In all 
donors, except 59 yr old female, growth curves were linear for over 20 population doublings. To assess donor 
dependent differences in growth, regression lines were fit to growth data (B) to determine growth rates 
(slope), standard errors, and pearson’s product-moment coefficients (C).  From this information an analysis 
of covariance was used to determine statistical differences in growth rates (slopes) between donors. 
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5.3.2 Cell cycle analysis 
To more accurately determine the fraction of actively dividing cells during expansion, detailed cell 
cycle analysis of proliferating and quiescent cell populations was performed in periosteal cultures 
isolated from 2 donors using flow cytometric analysis combining FITC-labelled anti-Ki-67 
antibodies and PI DNA staining.  Ki-67 is a nuclear antigen present exclusively in proliferating 
cells, including cells in the G1, S, and G2 phases of the cell division cycle as well as mitosis (416).  
Quiescent or resting cells in the G0 phase do not express the Ki-67 antigen and thus represents an 
excellent operational marker to determine the growth fraction of a given cell population.  The 
multi-step analytical method used to analyse the DNA cell cycles and calculate the percentages of 
cells in G0 and G1 is described in full in Appendix B 
DNA cell cycle analysis revealed that a vast majority (>75%) of periosteal cells from both donors 
were in the G0/G1 phases of the cycle.  In further separating proliferating and non-proliferating 
populations, we found 76.9 ± 12.0% of the cells in the quiescent, G0, phase of the cell cycle at each 
passage (Figure 5.2E & F).  The proportion of proliferating, Ki-67+, cells were seen to peak 
between 2-6 days after seeding in culture and decrease non-monotonically thereafter (Figure 5.2C 
& D).  This expression profile correlated with the log and confluent phases of growth found in 
cultures derived from both donors and highlights the influence of confluence level on growth rates 
(Figure 5.2A & B).  Additionally, this temporal pattern of Ki-67+ expression did not change 
drastically with increasing passage number passaging and was markedly similar between donors.   
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Figure 5.2 Growth pattern and cell cycle analysis of human periosteal cells in culture.  To identify the 
growth fraction and study the effects of subculture, passage 1, 7, and 15 periosteal cells from two different 
donors were grown in monolayer for a period of 12 days and stained with propidium iodide and proliferation 
marker Ki-67.  Cell counts were performed every other day to determine the changes in growth profiles over 
12 days (A, B).  Dual staining periosteal cells with PI and Ki-67 allowed for the examination of cell cycle 
distribution and the identification of proliferating (Ki-67+) (C, D) and quiescent (G0) (E, F) cell populations.  
Each data point on figures C, D, E, and F represents the percentage of total cells analysed using flow 
cytometry (> 20,000 events). 
5.3.3 Cell morphology 
Periosteal cells obtained from enzymatic dissociation and maintained in adherent culture consisted 
of a morphologically heterogeneous population.  Two major subpopulations were observed (Figure 
5.3A): 1) small cells with an elongated, spindle-shape with two processes that extend in opposite 
directions from the cell body, and 2) large cells with a flattened, polygonal shape and a plainly 
visible nucleus with or without short processes.  Based on these morphological classifications, 
Chapter 5: In-vitro Expansion and Characterisation of Human Periosteal Cells 
 
108 
periosteal cells in early passage (P0-P2) cultures were mainly (>70%) small, spindle shaped cells.  
During cultivation, however, a progressive change in cell morphology was observed, with cells 
becoming wider and flatter with more projected podia.  At passage 15, small spindle-shaped cells 
represented <15% of periosteal cells in cultures across all donors. 
 
Figure 5.3 Characterisation of the cell morphology of human periosteal cells during long-term subculture.  
(A) Representative images taken of periosteal cultures derived from a 52 year old male are used to highlight 
the heterogeneous cell morphologies present across 15 passages. (B) Distribution histograms of periosteal 
cell areas measured digitally between passage 0-15 in cultures derived from 6 different donors.  Together 
these data demonstrate the shift in cell morphology during culture from small spindle-shaped cells to large 
flat cells. 
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Cell size measurements reveal a definitive positive correlation between cell area and time in culture 
(R-values ≥ 0.88, p< 0.05), where average cell areas are found to significantly increase during 
expansion in each donor examined (Figure 5.4).  Early passage cultures derived from each donor 
contain a smaller, more homogenous, distribution of cell areas, as highlighted in cell area 
frequency histograms in Figure 5.3B and standard deviations in the bar graphs displayed in Figure 
5.4.  Consequently, the heterogeneity of cell areas increased with time in culture, with the largest 
distributions and standard deviations in cell area found at passages 10 and 15 (Figure 5.3B and 
Figure 5.4).   
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Figure 5.4 Characterisation of cell areas in human periosteal cell cultures from 6 donors between passages 0-
20.  At each passage, areas of 50-100 cells were measured at 60-70% confluence using ImageJ digital 
software.  For each donor, cell areas (mean ± SD) are displayed as both bar graphs and scatter plots versus 
passage and time in culture, respectively.  Bar graphs demonstrate the significant differences in cell area 
between two passages. Symbols represent statistically significant differences (p < 0.05) with (*) passage 0, 
(♦) passage 1, (†) passage 2, (□) passage 5, ($) passage 10, (‡) passage 15, and (○) passage 20 cells.  Scatter 
plots display results of linear regression analysis, which shows a significant positive correlation between cell 
area and time in culture (R-values ≥ 0.89 and p < 0.05 in all donors). 
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Equally, this pattern of increasing morphological heterogeneity can be seen in pooled cell area data, 
where the mean value of cell area for each donor and all donors combined is plotted versus passage 
number (Figure 5.5A).  Here we found very small donor-donor variations in cell areas in early 
passage (P0, P1, P2) cultures, however, these inter-donor variations increased substantially at later 
passages.  In further comparing changes in cell area to donor age, we found no significant positive 
or negative correlations at any of the passages examined (t-test, p > 0.05) (Figure 5.5B). 
 
Figure 5.5 Analysis of the changes in periosteal cell area due to time in culture and donor age.  (A) Scatter-
plot summarising the effects of subculture on periosteal cell area.  Each symbol represents the mean of data 
from single donor between passages 0-20.  The mean effect (-○-) of all data is shown to highlight the 
cumulative trend in periosteal cultures. (B) A table summarising the influence of donor age on cell area at 
each passage.  Linear regression analysis reveals no significant correlation between donor age and cell area at 
all passages examined (two-tailed t-test, p < 0.05).  Non-parametric Spearmen’s rank correlation coefficients 
ranged from -0.80 to 0.26. 
 
To study changes in cell shape we calculated the shape factor coefficient of cells, which is a 
measure of cell circularity.  Linear regression analysis of each of the donor derived periosteal 
cultures, apart from those of the 31 yr old male, showed no significant time-dependent increase or 
decrease in cell circularity during culture (one-way ANOVA,  p > 0.05) (Appendix C).  Between 
donors correlation coefficients were found to vary from -0.33 to 0.98.   
5.3.4 Antibody titration and specificity 
Due to the heterogeneous nature of periosteal cells, it was neccesary to titrate each monoclonal 
antibody and establish their exact binding specificities using a range of different cell types.  Full 
results and figures of this optimisation study using flow cytometry are presented in Appendix D.  
Importantly, Stro-1, a progenitor cell marker, showed a high level of reactivity in MG63 cells 
(>98%) and low to undetectable levels of expression in Saos-2 cells and primary osteoblasts and 
fibroblasts (<2%).   This profile of tissue specificity is similar to a previous study which 
extensively characterised the Stro-1 antibody in a panel of normal and transformed cell types.  
Although Stro-1 reactivity is not restricted to bone derived cells, the screening process shown here 
demonstrated that the Stro-1 antibody defines a population of developmentally immature cells of 
the osteoblast lineage.   
0 
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5.3.5 Periosteal cell phenotype 
Immunocytochemical staining of passage 0 periosteal cells revealed the presence of a very small 
population of smooth muscle cells (<1% of total cell population) and no positive staining for 
primitive stem cell marker SSEA-1 (Figure 5.6A & C). Additionally, Oil-Red O staining of passage 
0 cells demonstrated the presence of adipocyte-like cells (<2% of total cell population) containing 
large deposits of lipids (Figure 5.6B). The lack of expression of lipid deposits in late passage 
periosteal cells demonstrates that these cell types are quickly lost in culture. For a full display of 
cytochemical staining micrographs of periosteal cells from multiple passages and donors see 
Appendix E, Figure E.1 and E.2. 
 
Figure 5.6 Expression of cell specific and developmental markers in passage 0 human periosteal cells 
cultured on 4-well chamber slides for 1 week in complete media.  Using immunofluoresence and oil-red O 
staining, small populations were found to be positive for α-smooth muscle actin (A) and cytoplasmic lipid 
droplet accumulation (B) and completely negative for primitive stem cell marker SSEA-1 (C).  On 
immunofluorescent images nuclei were stained with DAPI (blue) to show the presence of cells. 
 
In passage 0 cells we detected the expression of Stro-1, CD34, CD45, CD31, and ALP in all donors 
(Figure 5.7). Cumulative bar graphs of flow cytometry results (Figure 5.7) derived from 
fluorescence dot-plots (Appendix E, Figure E.3) revealed that ALP+ and CD34+ cells represented 
the two largest populations within freshly isolated periosteal cells.  Together they constituted 27.9 
± 4.5% and 26.6 ± 6.1% (mean ± SE) of the total cell population, respectively (Figure 5.7).  
Antibodies for CD31, an endothelial cell marker, and CD45, leukocyte common antigen, 
demonstrated low levels of binding (<3%) in passage 0 cells.  Additionally, a distinct 
subpopulation of granulocytes was identified within the CD45+ population of passage 0 cells 
(Appendix E, Figure E.3B). 
After placing the isolated periosteal cells into culture and allowing them to adhere and proliferate 
for periods of 7-12 days (passage one), we found a significant decrease in the expression of CD34+ 
cells to 5.3 ± 1.9% and a complete loss of CD31+ and CD45+ positive cell types. The largest cell 
population over 15 passages was Stro-1-/ALP+, which was significantly higher than all other cell 
types (p<0.001, 2-way ANOVA). 
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Figure 5.7 Flow cytometry results detailing the phenotypic heterogeneity and donor-donor variations in 
antigen expression levels on freshly isolated, passage 0, human periosteal cells.  Periosteal cells 
enzymatically isolated from 6 different donors were stained with cell specific mAbs against Stro-1, ALP, 
CD45, CD34, and CD31 and analysed using dual-color flow cytometry.  Individual values are shown as 
percentage positive expression of total cells analysed (>20,000 events), with positivity defined as the level 
fluorescence >99% of the isotype-matched control. 
 
The continuous passaging of human periosteal cells had little effect on the population of Stro-1+ 
cells, with no significant changes measured across the 15 passages (2-way ANOVA) (Figure 5.8). 
Stro-1+/ALP- cell populations comprised 5.4 ± 1.5% of the total cell population for all donors. 
Additionally, individual values only ranged from 1%-16% over the 15 passages, indicating that the 
exact proportion of Stro-1+/ALP- cells is donor independent for the patient samples studied.  
In contrast to Stro-1+/ALP- expression, the profile of ALP+/Stro-1- populations peaked at passages 
1 and 2 (2-4 weeks in culture) and declined subsequently, with the lowest frequency of ALP+ cells 
occurring at passage 15 (8.4 ± 2.6%). This profile of increased and then decreased ALP expression 
was seen in all donors (Figure 5.8). In addition, a small population of cells were also found to 
coexpress the ALP and Stro-1 (Stro-1+/ALP+). As with the (Stro-1+/ALP-) population, the double 
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positive cell population (Sto-1+/ALP+) was maintained throughout 15 passages in culture at 
consistent expression levels (5.7 ± 1.9%).  
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Figure 5.8 Bar chart of flow cytometry data showing cell surface marker expression as a function of passage 
number. Mean change in expression of cell surface proteins on periosteal cells isolated from 6 patients. 
Values are shown as percentage positive expression of total cells analysed using flow cytometry (>20,000 
events).  Positivity for each antibody was defined as the level fluorescence >99% of the isotype-matched 
control antibodies. CD45+ and CD31+ expression are displayed as the same data set, as those antibodies 
were expressed by periosteal cells in almost identical numbers and temporal profiles. 
 
5.3.6 Real-time Reverse Transcriptase Polymerase Chain Reaction 
Real-time RT-PCR confirmed the increased expression of osteoblast markers ALP and collagen I 
(Col I) in human periosteal cells cultured for up to 15 passages (Figure 5.9).  At passage 2 we 
observed a rapid, 5.0- and 7.2- fold, increase in ALP and Col I expression, respectively. After long-
term expansion, however, these levels were found to decrease slightly to 1.7- and 2.1-fold.  
Expression levels of osteogenic transcription factor, Runx2, were found to transiently increase over 
15 passages, although these changes represented nominal differences compared to passage 2 cells.  
In contrast, expression of chondrogenic transcription factor, Sox9, decreased steadily from passage 
1 to passage 15. No mRNA expression of osteocalcin, collagen II or CD31 was detected (data not 
shown). 
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Figure 5.9 Real-time RT-PCR data showing mRNA expression profiles of human periosteal cells derived 
from 3 donors (25f, 38m, and 74f) cultured for 15 passages.  Expression levels of selected osteogenic and 
chondrogenic transcription factors and proteins were normalised to the 18s housekeeping gene and compared 
to passage 1 expression levels. Average change ± standard error of repeated experiments (n=3) are presented. 
5.3.7 Colony forming unit assay 
At passage one, periosteal cells from four donors formed the highest numbers of colonies as 
compared to subsequent passages (mean for four donors ± SD: 41.5 ± 7.7) (Figure 5.10). During 
the subculture of periosteal cells, we found a significant decrease in the colony forming ability of 
plated cells (all samples p<0.001, two-way ANOVA of passage one vs all other passages). This 
was seen as a relative decline in the number of colonies counted (per 10,000 plated) at different 
passages during expansion for each of the four different donors (Figure 5.10). In comparing the 
colony forming ability of periosteal cells to the percentage of progenitor, Stro-1+, cell populations 
in culture we found no significant positive correlation (R=0.26, p>0.05). 
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Figure 5.10 CFU assay of the number of colonies (mean ± SD) formed per 10,000 cells seeded into 78 cm2 
petri dish (n=3). Colony scoring was performed by 2 independent observers and was based on colony size 
being > 1mm in diameter and not inhibited by contact with other colonies. Results are displayed to show the 
change in colony forming ability over passaging for four different patients. 
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5.3.8 Mineralisation 
Both counting of nodules (Figure 5.11B) and measurement of the intensity of alizarin red dye 
extracted from stained cultures (Figure 5.11A) showed that significantly more mineralised tissue 
had been formed by cultures which retained Stro-1+ cells compared with those that had been 
depleted of Stro-1+ cells. Micrographs showed a greater number and size of positively stained 
nodules within total population cultures that contained Stro-1+ cells (Figure 5.11C).  Secondly, this 
result demonstrates that periosteal cells retain their functional ability to mineralise during long-term 
subculture. 
 
Figure 5.11 Graphs of alizarin red dye desorbed from wells, normalised to total DNA content (A) and the 
numbers of fluorescent nodules counted  per well (B) (* = p ≤ 0.05).  The lower micrographs show 
representative images of unsorted (C) and sorted (Stro-1 depleted) (D) cell populations grown for 28 days in 
the presence of osteogenic media and stained with alizarin red dye.  Scale bar on images = 1.0 mm. 
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5.4 Discussion 
The periosteum serves as a reservoir of osteochondral precursor cells (417) and represents an 
interesting new candidate for tissue engineering and cell-based therapies.  To fully exploit this 
therapeutic potential, new work must concentrate on exploring the link between in-vitro periosteal 
phenotype and properties, and in-vivo functionality.  Perhaps most importantly, this knowledge 
could provide powerful new insight into musculoskeletal development, aging, and healing 
processes.   
Using a simple and well-defined culture model, human periosteal cells were easily isolated from 
small tissue explants and expanded for 15-20 passages, equivalent to 20-30 population doublings, 
without growth arrest.  Although significant variations in proliferative potential were noted 
between particular donors, similar growth kinetics were measured throughout expansion regardless 
of donor age.  This robust proliferative capacity might be attributed to the length of telomeres in 
periosteal cell populations or telomerase-independent mechanisms (418), as telemorase activity 
was not detected in adult human periosteal cells previously (160).  This level of ex-vivo 
amplification allowed us to identify heterogeneities present in human periosteal cell populations 
and study the effects of prolonged passaging on periosteal cell properties and phenotype.   
Morphologically, two distinct cell subpopulations of small spindle-shaped cells and large flat cells 
were identified throughout expansion in varying proportions.  In early passage cultures, spindle-
shaped cells represented >70% of periosteal cells. Serially passages, however, resulted in the 
progressive decrease in the proportions of spindle-shaped cells in concert with the appearance of 
large flat cells.  The downstream effects of this morphological transition were seen in the growth 
rates and colony forming efficiency of periosteal cells.  This suggests that cell-cell interactions, 
and/or exposure to autocrine or paracrine factors secreted in the culture medium are responsible for 
this transition. 
We found that the growth potential of periosteal cells was inversely related to cell size, across all 
donors (Figure 5.12). The progressive increase in average cell area found during expansion resulted 
in a concomitant decline in the cell yield per passage (R = -0.81, p = 0.00).  Interestingly, a 
significant inverse correlation was also identified between the rate of increase in cell area and the 
rate of expansion for each donor (R = -0.87, p = 0.03) (Figure 5.13).  Donors that maintained larger 
proportions of small cells (<3000 cm2) during expansion exhibited the greatest rates of growth.  In 
support of this, small spindle-shaped cells were previously classified as “immature”, rapidly-
cycling, multipotent phenotypes in MSC cultures, while large flat cells were characterised as 
“mature”, slowly-cycling, cell types with diminished differentiation potential (225;226;228;419).  
In further agreement with Prockop et al (247), we also found large-flat cells to have an inhibitory 
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effect on the propagation of small, rapidly dividing periosteal cell populations in colony forming 
unit and expansion cultures. Interestingly, however, this does not seem to affect the long-term 
proliferative ability of adult periosteal cells. 
 
 
Figure 5.12 Effects of periosteal cell area on growth rates.  Mean periosteal cell area and fold increase in cell 
number were calculated in the same culture between passages 0-20 for each donor and plotted against 
eachother.  Each data point represents the mean values at one passage in one donor.  In total 6 donors were 
examined between passages 0-20.  Non-parametric correlation measurements revealed a significant inverse 
relationship between cell size and growth (R-value = -0.81, p =0.00).  
 
 
Cell cycle analysis of quiescent (G0) and actively dividing (G1, S, G2/M) cells identified a small 
fraction (23 ± 10%) of proliferating cells that remained comparable in early, intermediate, and late 
passage cultures. This small, yet consistent fraction of mitotically active cells demonstrates that the 
average doubling time (72.0 ± 9.4 hrs) observed in monolayer expansion cultures is not 
representative of the actual cell cycle time of the proliferating population.  Additionally, this result 
also highlights certain features unique to adult stem cell cultures.  In many tissues, stem cells rest in 
a quiescent state for extended periods of time and are responsible for the self-renewal potential of 
the tissue microenvironment in-vivo (420).  They re-enter the cell cycle only when stimulated by 
signals to promote repair or regeneration processes. In the bone marrow, this stem cell niche is 
regulated by accessory cell types, which function to maintain and regulate quiescent 
haematopoietic stem cells (421). Although this has not been clarified here, our data suggests that 
the ex vivo expansive potential of periosteal cultures resides on the self-renewal capacity of a 
subset of quiescent cells.  Additionally, the small, yet consistent population of Stro-1+ progenitor 
cell populations identified in periosteal cells throughout expansion, adds further support to this 
claim.  
Phenotypically, initial periosteum-derived cell isolates present a mixed cell population, but with 
subsequent passages we observed a reduction in the population of haematopoietic cell types from 
31.8 ± 6.9% to 3.5 ± 1.6% of the total population, and the disappearance of adipose, endothelial, 
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leukocyte, and smooth muscle cells. The cell population contained both osteogenic and 
chondrogenic cells. In the absence of specialised cell media, the expression of sox9 decreased 
linearly with passage, leaving the cultured cells largely osteogenic; with cells expressing Stro-1-
/ALP+ accounting for ~40% of the cell population and Stro-1+/ALP+ a further 10%. These 
population percentages, particularly the measures of Stro-1+ cells, are consistent with early passage 
cells derived from known mesenchymal stem cell sources; such as the trabecular bone explants 
(242), bone marrow, synovium, adipose tissue, muscle, and most relevant, periosteum (422). Our 
research however, examines the cell phenotype changes over 15 passages, while the previous study 
examines cells from a single passage. Although, a definitive marker set for the identification and 
enrichment of a “pure” population of multipotent stem cells has remained a difficult and elusive 
task, recent developments in antibody technology, have led several laboratories to produce mAbs 
targeted for stromal stem cell populations.  Of these, Stro-1 has been the most extensively 
characterised and found to be expressed on a small population of clonogenic multipotent stem cells 
(240;248;249;423),  
 
 
Figure 5.13 Relationship between rate of periosteal cell expansion and rate of increase in periosteal cell area.  
For each donor the respective rates were calculated from linear regression analysis of cell growth (population 
doublings/day) and cell area (µm2/day) profiles during subculture; where the slope of the regression line = 
rate of change.  Correlation statistics for 6 donors, reveals a significant inverse relationship between the rate 
of increase in cell area and the rate of expansion in human periosteal cell cultures (R-value = -0.87, p = 0.03). 
 
The overriding osteogenic phenotype of cultured periosteal cells was not surprising, given the 
periosteum’s anatomical position adjacent to bone and developmental origins. The presence of a 
consistent Stro-1+ population was a more striking feature of the periosteal cultures studied. Two 
Stro-1+ cell subpopulations were identified, Stro1+/ALP+ and Stro1+/ALP-. Based on the study of 
developmental phenotypes of stromal cell cultures, it has been suggested that Stro-1+/ALP- cells 
represent a less differentiated osteoblastic phenotype, Stro-1+/ALP+ cells represent an intermediate 
cell stage, and Stro-1-/ALP+ cells are the most mature (242;424). Other researchers have also 
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identified primitive precursor populations within periosteal cultures using primitive osteoblast and 
mesenchymal stem cell markers CD105, CD166, and HOP26 (295;425;426).  In contrast to 
previous studies where Stro-1 expression was found to vary between 2-80% in 28 day bone marrow 
stromal cultures (427), the proportion of Stro-1+ cells in this study was donor independent (for 6 
donors). Most importantly, we did not find that the proportion of Stro-1+ cells decreased with time 
in culture. The difference between our results and those of Simmons and Torok-Storb (248) who 
found the percentage of Stro-1+ cells to decrease to 15% of their maximum frequency after six 
weeks of culture, reflects the difference between cell types and culture conditions used. Removing 
Stro-1+ cells from the general cell population resulted in a decrease in overall culture osteogenicity, 
and further confirmed the importance of these progenitor cells in bone formation. 
Historically, the colony forming unit (CFU) assay has been used to reflect the number of MSCs or 
precursor cells in a sample population. Each adherent colony is thought to be derived from the 
rapid proliferation of a single non-haematopoietic stem-cell, morphologically resembling a 
fibroblast, and as such are often referred to mesenchymal stem cells or mesenchymal progenitor 
cells (162;222;392). Interestingly, however, we found no correlation between CFU number and the 
presence of Stro-1+ progenitor populations (R=0.26, p>0.05). Recently Bruder et al and Banfi et al 
found that the multipotentiality of human bone marrow derived CFUs  was progressively lost 
during subculture, with progenitor cell populations retaining only their osteogenic differentiation 
potential at late passages (26;428), consistent with the pattern of expression of osteogenic markers 
and mineralisation capacity noted here. This progressive shift from multilineage potential to 
osteoblastic phenotype has been shown to be associated with a progressive change in cell 
morphology, from small, rapidly dividing spindle-shaped cells to large, flat slowly proliferating 
cells (419). This is consistent with the significant changes in cell area and morphology shown here.  
The decrease in the colony forming efficiency of periosteal cells is therefore the likely result of this 
morphological transition.  
These results emphasize an important feature of CFUs, namely, that changes in observed CFU 
progenitor quantity or colony forming ability may be dependent on environmental conditions such 
as the presence of growth factors and changes in cell population rather than an actual reduction of 
stem cell numbers (178;429). Due to rich heterogeneity of periosteal cells characterised here, it 
seems plausible that CFU efficiency is affected by combination of cell-cell interactions and 
secreted factors present in the medium.  It is interesting to note that CFU efficiency is highest in the 
early passage cells, which contain large proportions of haematopoietic non-mesenchymal cell 
types. Hematopietic cells, commonly regarding as contaminants in mesenchymal stem cell cultures, 
may play a critical role in the regulation and development of progenitor cells and their descendents 
during expansion. In bone marrow stromal cultures containing both MSCs and HC populations, a 
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significant increase in the numbers of CFU-F and CFU-O colonies was found when non-
haematopoietic (CD45-) cells were grown in the presence of haematopoietic (CD45+) cells (429).  
This suggests the existence of positive interactions between CD45+ and CD45- cells, which is 
likely mediated by their respective endogenous secretion of soluble factors, similar to what is 
observed between early haematopoietic cells and their progenitors (430).  Haematopoietic cells 
secrete regulatory molecules that form the basis of intracellular cross-talk networks, which in turn 
regulate the survival, growth, and function of mesenchymal progenitor cells in an autocrine or 
paracrine manner (430;431).   
In the absence of cell specific media supplements, the shift of periosteal cell populations to a more 
osteogenic phenotype was confirmed by quantitative measurements of RNA expression (real-time 
RT-PCR) which show steady or increased expression of bone related genes Runx2, ALP, Col I and 
decreased expression of chondrogenic gene Sox-9 after initial plating. Gene expression of collagen 
II, a marker of mature chondrocytes, was not found. This low initial chondrogenicity of isolated 
periosteal cells, confirms results in the literature (432), and indicates that the chondrogenic cells in 
non growth factor supplemented media are derived from precursor cells, rather than from mature 
cells in the periosteum. As this population remains stable over a number of passages, this helps 
explain previous findings that show that periosteal cells in chondrogenic media retain their 
cartilage-forming capacity over a number of generations, which would be required to support 
chondrocyte populations (201).  
5.5 Conclusions 
In conclusion, we have identified a number of cell types within enzymatically liberated human 
periosteal cells based on the expression of distinct morphological features and cytosolic and surface 
proteins. Periosteal cells expanded for over 20 population doublings in the absence of 
differentiation stimuli experienced time-dependent changes in cell area and morphology and 
exhibited stable growth kinetics, a large expansive potential, and a small, but consistent subset 
(23%) of proliferating cells.  Further, we were able to identify cells at different stages of osteoblast 
differentiation and demonstrate phenotypic changes over passaging based upon the expression of 
the Stro-1 and/or ALP antigen and lineage specific genes. As shown here, a population of 
progenitor cells can be initially isolated in viable form from human periosteal explants and cultured 
for up to 10 passages without a loss in population numbers or ability to form mineralised tissue. 
The existence of a large subpopulation of quiescent (G0) cells in periosteal cell cultures seems to be 
important, since their number and properties should be enough to sustain a steady supply of cells 
that upon differentiation and commitment may serve as precursors for a number of non-
haematopoietic tissues. Whether late passage periosteal cells are fully committed to the osteogenic 
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pathway remains to be elucidated in our culture model, however, there is evidence to suggest that 
these precursor cell populations retain the potential for multilineage differentiation (160).  
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Chapter 6  
 
Sequential Digestion of Human Periosteum 
 
6.1 Introduction 
The periosteum is a specialized connective tissue that covers all surfaces of long bones except 
articulating joints and is known to play a major role in bone apposition during development and 
fracture healing (433;434).  During healing, the periosteum provides cells, bioactive factors, and a 
blood supply that aids in the formation of the cartilage-like soft callus which is eventually replaced 
by calcified bone matrix (45;435;436).  This role is substantiated in early distraction studies, which 
show that new bone formation is less likely to occur when the periosteum is severely damaged 
(437-439).  In addition to osteogenic potential, the periosteum has also demonstrated significant 
chondrogenic potential in-vivo (31;185;402), as exploited for the repair and resurfacing of large 
bone and articular cartilage defects  (354;358;440-442). 
Anatomically, the periosteum is a bilayered membrane consisting of an outer fibrous layer and an 
inner cambial layer, which lies against the bone (396;443).  The outer fibrous layer is composed 
mainly of fibroblast-like cells scarcely distributed in a dense matrix of collagen and elastin fibers 
and a network of microvasculature, nerves, and lymphatic vessels (39;397;444) . The inner cambial 
layer, is a thin (3-5 cell layers) highly cellular layer containing a variety of cell types, including 
mesenchymal stem cells, progenitor cells, fibroblasts, and osteoblasts (29;445;446).  The 
regenerative capacity of the periosteum appears to be well correlated to the presence of primitive 
precursor cells (i.e. multipotent stem cells and lineage restricted progenitor cells) resident to the 
cambium layer. 
To harness the therapeutic potential of the periosteum, research is now focusing on elucidating the 
biological mechanisms regulating cambial cell osteogenesis and chondrogenesis.  To this end, 
periosteal grafts, explants, and enzymatically liberated cell isolates have shown promising results in 
numerous animal models and in-vitro culture systems.  Most interesting, isolated periosteal cells 
have compared favourably to bone marrow stromal cells in terms of growth kinetics and 
multilineage potential (160;422;447)  and have been successfully applied to bone tissue 
engineering applications with various scaffold materials (448-452).  As such, cultured periosteal 
cells may represent an attractive alternative to existing cell-based regenerative therapies.  However, 
the isolated periosteal cells examined in these studies represent a mixed cell population of multiple 
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cell phenotypes liberated from both the fibrous and cambial layers.  The inability to clearly identify 
and isolate specific cell types with reparative potential could lead to reduced functional control and 
reproducibility, thus posing a significant hurdle towards the development of periosteal cell-based 
tissue engineered therapies.  Previously, we observed that enrichment techniques based on selective 
adherence to tissue culture plastic is an inadequate method to isolate homogenous periosteal cell 
populations and target specific cell phenotypes (Chapter 5).  Therefore more efficient enrichment 
strategies are needed to purify the reparative cell types from heterogeneous periosteal cell isolates.  
To date, a number of enrichment strategies exist for purifying heterogeneous populations, including 
fluoresecent activated cell sorting (FACS), magnetic cell sorting, limiting dilution, and density 
centrifugation.  Such strategies, however, are time-consuming and rely on the purchase of 
expensive equipment and/or antibodies and regents.  A fast, simple and reproducible enrichment 
method would considerably benefit on-going periosteal cell research and aid in the development of 
clinical applications.  
The objective of this present study is to develop and characterise a sequential digestion method to 
selectively isolate human cell types present in the cambium layer of periosteal explants.  Using this 
technique, we aim to identify the optimal digestion time necessary for the enrichment of highly-
proliferative progenitor cells types. Based on the thickness and cellularity of the cambium and 
fibrous layer, we hypothesized that periosteal cells isolated from each of the digestion steps would 
contain tissue layer specific differences in population phenotypes and behaviour, with early 
digestions isolating a unique population of cambial progenitor cells.  In this context, this sequential 
isolation approach would not only allow for the enrichment of therapeutic cell types but would also 
enable us to target, separate, and extensively characterise distinct human periosteal cell populations 
from each distinct tissue layer.  This level of cellular information would be useful for dissecting the 
heterogeneities present in human periosteal cell cultures and designing improved periosteal cell-
based therapies.  Therefore, isolated and monolayer-expanded cells from each of sequential 
digestions, from one donor, were examined and compared for their proliferative capacity, 
morphology, colony forming ability and surface protein expression using flow cytometry.   
6.2 Materials and Methods 
6.2.1 Assessment of thickness and cellularity of human periosteum 
To develop an accurate and reproducible isolation method, the thickness and cellularity of the 
individual periosteal layers was measured and compared across a number of donor explants.  A 
total of 7 periosteal explants were harvested from the medial proximal tibia of female patients aged 
between 16-91 undergoing knee surgery at The Chelsea and Westminster Hospital. The explants all 
measured approximately 1.0 x 1.5 cm and were elevated by subperiosteal dissection with a sharp 
Chapter 6: Sequential Digestion of Human Periosteum 
 
125 
periosteal elevator by the same skilled surgeon. The explant was then cut into two pieces; a 5 x 5 
mm piece for histology, with the rest being used for a preliminary digestion study.  For histology, 
tissue samples were fixed in 10% v/v neutral buffered formalin (Agar Scientific, UK) for 12 hours 
at room temperature, dehydrated through an increasing alcohol series and xylene (Sigma-Aldrich, 
Poole, UK) before being embedded in paraffin wax. Each sample was cut perpendicular to the 
bone, into four 5μm thick histological tissue sections at equal intervals from the proximal to distal 
end, and stained with haematoxylin and eosin (both Sigma-Aldrich, UK). Three photomicrographs 
(x40, x100, x200 magnifications) were taken of each section, for a total of 36 photomicrographs 
per donor.  All histological sections were cut and stained by one person.  The total thickness of the 
periosteum and the thickness of the individual fibrous and cambium layers were measured in 
micrometers from photomicrographs taken at 40x magnification.  The cell density of the respective 
layers was determined using a modification of a previously described technique (359).  For the 
cambium cell density, a photomicrograph measuring, 436 x 328 µm2 (area), was taken twice, at 
random, over the cambium layer of each section.  To determine cell density (cells/µm2), all nuclei 
within the imaging area were counted and the result was divided by the sampling area (thickness of 
the cambium x width of the photomicrograph).  For the fibrous layer cell density, the same 
procedure was employed in photomicrographs measuring 880 x 663 µm2. 
6.2.2 Cell isolation and culture 
6.2.2.1 Sequential enzymatic digestion 
A periosteal explant was harvested from the medial proximal tibia of a 71 yr old female during 
total knee replacement surgery at the Chelsea and Westminster Hospital.  The explant, measuring 
approximately 1.0 x 1.5 cm and weighing 0.293 g, was elevated by subperiosteal dissection with a 
sharp periosteal elevator.  The explant was transported to the laboratory in Earls balanced salt 
solution at 37oC in a mini-portable incubator.  After being cleaned of fat and blood tissue, the 
explant was subjected to a sequence of digestions in a enzymatic solution consisting of  3 mg/ml 
collagenase D (Roche Diagnostics) and  3 mg/ml collagenase type II (Sigma) in 5 ml complete 
media (DMEM containing 10% v/v foetal bovine serum, 1% v/v L-glutamine, 1% v/v 
antibiotic/antimicrobial).  To optimally design a sequential digestion technique, we conducted a 
pilot study to examine the average time needed to enzymatically digest a periosteal explant, using 
our standard collagenase solution.  Based on this pilot study and the aims of this study, a sequence 
of four serial digestion steps were performed at 37oC in 5% CO2 for 30, 60, 90, and 90 minutes for 
a cumulative digestion time of 4.5 hours (Figure 6.1). The digestions from steps 1-3 were kept at 
37°C in 5% CO2 until the last digestion (step 4) was complete, so as to negate the potential for 
time-dependent differences of collagenase exposure on cellular behaviour. After 4.5 hours, 5 ml of 
FBS was added to each digestate, passed through a 70µm filter, and centrifuged.  The cell pellets 
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from the individual digestions were then rinsed in PBS, counted, and the dissociation rates 
calculated.  Based on the dissocation rates, cells from isolation 1 and 2 were pooled together and in 
this study will be termed “initial digestion cells”.  Isolated cells from digestion step 4 were also 
kept, and will be termed “final digestion cells”.   
 
Figure 6.1 Schematic diagram of sequential enzymatic digestion method and results.  A periosteal explant 
was treated for 4.5 hours in 0.6% (w/v) collagenase solution. Collagenase solution was replaced at 30, 60, 90, 
and 90 minutes and cell release rate was measured by counting cells after each of the digestion steps. The 
majority of the cambium layer cells were liberated during the first 1.5 hrs of digestion (Step 1+2).  The 
remaining cambium and fibrous layer cells were isolated during the final 3 hrs of digestion (Step 3+4) with 
digestion step 4 consisting of mostly of fibrous layer cells.  This was confirmed by histology and by 
determining the numbers of cells released per digestion step and converting this into a cell release rate (cells 
released/hr). 
6.2.2.2 Full enzymatic digestion 
For comparison purposes, an equally sized periosteal explant (0.255 g) was harvested as above 
from the medial proximal tibia of a 74 yr old female undergoing total knee replacement surgery.  In 
this instance, however, the explant was subjected to a full 4.5 hour digestion in the same enzymatic 
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solution and environment as above, after which the liberated cells were strained, washed, and 
counted as above. These cells will be termed “full digestion cells”. 
6.2.3 Cell proliferation- Standard density 
To investigate the proliferation characteristics of the different cell isolates, the harvested cells were 
separately plated at the standard density of 5000 cells/cm2 in complete media into a 24 well-plate.  
For continuous subculture and expansion, adherent cells were harvested with 0.25% (v/v) trypsin 
and 1mM EDTA for 5 minutes at 37°C, and replated at 5000 cells/cm2 in a T75 flask containing 15 
ml of complete media; this process was repeated every 7-14 days (~90% confluence) for 5 
passages.  Cells were fed every other day. Viable cell number was determined using trypan blue 
and a haemocytometer.  Based on the cell counts, cumulative cell number, population doublings, 
and fold increase were calculated.  
6.2.4 Cell proliferation- Low density 
To study the effects of cell density on cell proliferation, the cell isolates were also plated separately 
into T75 culture flasks at 50 cells/cm2 and cultured for periods of 7 and 14 days (n=3 per time 
point).  At both time points, cells were harvested and counted as above and the growth curves were 
determined for each digestion using the average number of cells per flask.  
6.2.5 Cell morphology 
The differences in initial cell morphology between the cell isolates was examined in passage 0 
standard density cultures at day 11 under a phase contrast microscope.  Photographs were taken of 
at least 8 random sites on each culture plate.  The cell areas and circularity of individual cells were 
measured quantitatively, as performed previously (Chapter 5), using imaging software (NIH Image 
J).  In all cases mitotic cells were ignored. 
To further determine differences in cell size and granularity, passage 0, 1, and 5 cells from each of 
the isolates were detached with 0.25% trypsin/EDTA, resuspended in PBS containing 2% (w/v) 
bovine serum albumin (BSA) and assayed using flow cytometry (FACSCalibur; BD Biosciences, 
Oxford, UK).  The forward- and side-scattering (FSC and SSC) properties were measured on a 
linear scale of 1024 channels.  The forward threshold was set to 55 to eliminate small particulate 
debris.  Data from all the digestions was collected under identical parameters and analysed by 
collecting 20,000 events.  
6.2.6 Colony forming unit assay 
Based on previous optimization studies (Chapter 4), freshly isolated cells from each digestion step 
were plated at 10,000 cells per petri dish (78 cm2) in complete medium. After 12 days in culture, 
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the dishes were stained with 0.5% (w/v) crystal violet in methanol for 5 minutes, rinsed twice in 
distilled water and the number of colonies per dish counted by 2 independent observers. Based on 
previously described criteria (391) colonies < 1 mm in diameter (~50 cells) and faintly stained 
colonies were discounted. Mean values for each cell digestion were derived from three petri dishes 
(n=3). To estimate colony proliferation rate, colony area was examined using low magnification 
(1.5x) microscopy.  Average colony area for each digestion, was determined by imaging 5 
randomly selected colonies per Petri dish (n=15), and subsequently measuring total area using 
Motic imaging Software (Motic, Ipswich, UK).  
6.2.7 Immunophenotype  
The following antibodies were tested for their specificity, titrated, and used at concentrations 
varying from 1-2.5 µg/106 cells: mAbs against mesenchymal progenitor cell surface antigen Stro-1 
(R&D Systems, Abingdon UK), phycoerythrin (PE) conjugated CD34 hematopoeitic precursor cell 
marker and CD31 endothelial cell marker (Abd Serotec, Oxford UK), allophycocyanin (APC) 
conjugated anti-human bone/liver/kidney alkaline phosphatase (ALP) and leukocyte adhesion 
molecule CD45, and fluorescein isothiocyanate (FITC)-conjugated α-smooth muscle actin 
Approximately 1-3 x 105 periosteal cells of each digestion between passages 0-5 were incubated in 
1 ml of blocking buffer (phosphate buffered saline pH 7.4 0.01M (PBS) containing 2% (w/v) 
bovine serum albumin (BSA), 0.1% (v/v) foetal bovine serum, and 0.1% (v/v) normal mouse serum 
(all Sigma-Aldrich) for 30 minutes at room temperature to limit non-specific binding. For direct 
staining, cells were then incubated with conjugated mAbs for 45 minutes at 4oC, washed in PBS 
containing 2% BSA (w/v) + 0.1% (w/v) sodium azide (flow buffer), centrifuged, and resuspended 
in 300 µl of flow buffer prior to analysis. For indirect staining using primary mAb Stro-1, the cells 
were first incubated with the primary mAb (45 min at 4oC), washed, and incubated with a FITC-
conjugated fragment F(ab’)2 goat anti-mouse secondary Ab (Jackson ImmunoResearch, Suffolk, 
UK) for 45 minutes at 4oC. Matched isotypes were used as negative controls and prepared at the 
same concentrations as their matched primary Ab. Cell fluorescence was evaluated by flow 
cytometry using a FACSCalibur instrument (BD Biosciences, Oxford, UK) and data analysed using 
FlowJo software (Tree Star Inc, Ashland, USA). At least 20,000 events were collected per sample 
and percentage positive expression for each mAb was defined as the level fluorescence >99% of 
the isotype-matched control antibodies. 
Cells from cultures from all cell digestions displayed little or no reactivity (≤1%) with antibodies 
CD31 (endothelial cells), CD45 (leukocytes), and α-SMA (248) and are therefore not included in 
our analysis.  
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6.2.8 Statistics 
Analysis of colony number and size data was performed using a one-way ANOVA, with a Tukey 
post-hoc test to establish significance (p <0.05). For histological and cell morphology analysis, data 
were analysed using the non-parametric Mann-Whitney U test to examine statistical differences 
between groups.  Data were expressed as the mean ± SD and all tests were performed using SPSS 
(Chicago, IL, USA) at a significance level of 0.05.  
6.3 Results 
6.3.1 Assessment of thickness and cellularity of human periosteum  
 
 
Figure 6.2 Histological analysis of cambium and fibrous layer thicknesses in human periosteal explants.  
Explants were harvested from 7 female donors with ages ranging from 16 to 91 years.  Fibrous layer (▲) and 
cambium layer (○) data is presented from each donor to determine potential age-related changes in tissue 
thickness of the respective layers.  The letter superscripts indicate the results of non-parametric analysis of 
significance using the Mann-Whitney U test. Results that have the same letter are not significantly different 
from one another (p>0.05). 
 
Statistical analysis of full-thickness periosteal explants harvested from 7 female donors ranging 
from 16-91 yrs of age, revealed no age-related trends in the thickness or cellularity of the cambium 
or fibrous layers.  Linear regression analysis of cambium layer and fibrous layer thickness 
measurements in Figure 6.2 revealed R2-values of 0.13 and 0.35 respectively (trend line not 
shown).  As seen in Figure 6.2 and Table 6.1, the thicknesses of the total explant and each layer 
demonstrated some donor-to-donor variation.  Cambium layer thicknesses varied between 84-111 
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µm, with the mean ± SD for all donors found to be 95.5 ± 13.4 µm.  Fibrous layer thicknesses 
demonstrated larger donor-to-donor variation, with mean values ranging from 1061.7-1525.5 µm.  
Unlike the donor differences noticed in layer thickness, the cell densities measured for each layer 
was statistically comparable for each donor apart from one (Table 6.1).  Across all donors, the 
cambium layer was found to be an average of 12.0-times more cellular than the fibrous layer (Table 
6.1).  
Donor 
Age 
Total  
Thickness 
Cambium 
Thickness 
Fibrous  
Thickness 
Cambium cell 
density  
(x10-3/µm2) 
Fibrous cell 
density   
(x10-3/µm2) 
16 1315.0 ± 107.9 84.32 ± 10.33a 1230.70 ± 110.28a 2.5 ±  0.4a 0.28  ± 0.09a 
20 1525.5 ± 66.4 100.09 ± 10.09b 1425.88 ± 68.28 2.9 ± 0.5a 0.18 ± 0.03 
24 1075.8 ± 66.8a 83.68 ± 11.22a 992.45 ± 69.17b 6.0 ± 0.7 0.31 ± 0.08a 
33 1233.8 ± 117.5b 100.25 ± 10.10b 1129.02 ± 115.83c 2.7 ± 0.5a 0.29 ±  0.05a 
48 1235.8 ± 126.5b 102.59 ± 10.90b,c 1202.41 ±140.14a,c 2.9 ± 0.6a 0.30 ± 0.04a 
74 1061.7 ± 91.4a,c 110.53 ± 7.70c 951.68 ± 92.80b 2.5 ±  0.3a 0.28 ± 0.07a 
91 1117.7 ± 114.8c 90.27 ± 9.98a 1027.50 ± 111.93b 2.7 ± 0.6a 0.35 ± 0.09a 
All 1248.1 ± 183.8 95.54 ± 13.39 1164.2 ± 185.2 3.35 ± 1.37* 0.28 ± 0.09* 
Table 6.1 Histological analysis of the cambium and fibrous layer of human periosteal explants.  Data is 
presented as mean ± SD. The letter superscripts (a,b,c) indicate the results of non-parametric analysis of 
significance using the Mann-Whitney U test. Results within a column that have the same letter are not 
significantly different from one another (p> 0.05). The row “All” is the cumulative mean ± SD of data 
measured across all donors. *The large standard deviations noticed in cambium and fibrous layer cell 
densities are a result of significantly different data derived from the 24 yr old and 20 yr old donors, 
respectively.  
6.3.2 Cell isolation 
The preliminary, 7 donor pilot study of full thickness digestion times revealed that an average time 
of 7.5 ± 0.5 hours was needed to fully digest a periosteal explant in a 6 mg/ml collagenase solution. 
Given the average thickness of the periosteal explants (1248 ± 184 µm), the average digestion rate 
over the 7.5 hours was 166 ± 24 µm of tissue/hour. However, digestion times over 5.0 hours 
resulted in a 50% decrease in cell viability as determined by trypan blue dye exclusion assay (data 
not shown).  Based on the results of cell viability, average enzymatic reaction rate, and periosteum 
layer thickness, the temporal profile of the sequential digestion steps was designed to allow for the 
isolation of viable populations enriched for cambium or fibrous layer cells (Figure 6.1).  
Histological evidence of the success of this isolation strategy is shown in Figure 6.3.  After 1.5 
hours of enzymatic digestion, most of the cambium layer cells have been liberated and only the 
fibrous layer of the periosteum explant remains intact.  Most of the fibrous layer cells were 
liberated during the last 3.0 hours of digestion (Steps 3+4).  Congruent with this, the first 2 
sequential digestion steps revealed substantially higher cell yields and associated cell release rates 
compared to the last 2 steps (Figure 6.1 and Table 6.2).  The differences in cell yields between 
initial (Steps 1+2) and final (Steps 3+4) digestion steps correlates well with the differences in cell 
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density between the cambium and fibrous layer.  This shows that the initial cell isolates (Digestion 
Steps 1+2) contain more cambium layer cells whereas final cell isolates (Digestion Steps 3+4) 
consist of mostly fibrous layer cells.   
 
Figure 6.3 Histology of representative human periosteal explant during the sequential enzymatic digestion 
method.  Image on left is of explant prior to collagenase digestion (0 hours) showing the presence of 2 
distinct layers; the highly cellular cambium layer and the less cellular fibrous layer.  After 1.5 hours of 
digestion (Steps 1+2) most of the cambium layer has been digested from the explant, leaving just the fibrous 
layer to digest during steps 3+4. 
 
To further confirm the quality of this enrichment strategy we compared the phenotype and features 
of cells isolated from digestion step 1+2 (termed initial digestion cells) against those isolated from 
final digestion step 4 (termed final digestion cells).  As an additional comparison, a full thickness 
digestion (termed full digestion cells) was performed on a separate periosteal explant harvested 
from an age- and sex- matched, 74 yr old, donor.  This digestion demonstrated a cell release rate 
between what was found in initial and final sequential digestions and resulted in a completely 
mixed population of cells from the fibrous and cambium layers. 
Enzymatic Digestion Characteristics Passage 0 Characteristics 
 Time in hrs 
(total)  
Cells 
Released 
 
Release 
Rate 
(cells/hr) 
Fold Increase 
in cell 
number 
Colony 
Forming Units  
mean ± SD 
Colony Size 
(mm) 
mean ±SD 
Step 1 0.5 (0.5) 92,500 185,000 
Step 2 1.0 (1.5) 197,256 197,256 
37.5 32.0 ± 2.2 4.4 ± 1.9 
Step 3 1.5 (3.0) 153,201 102,134 ---- ---- ---- 
Step 4 1.5 (4.5) 141,351 94,234 6.1 5.1  ± 1.0* 2.2 ± 1.0* 
Full 4.5 710,000 157,778 7.2 11.6 ± 2.2*‡ 2.9 ± 0.8* 
Table 6.2 Characterisation table of the different enzymatic isolations compared in this study.  Sequential 
digestion steps 1+2 (initial digestion cells), step 3, and step 4 (final digestion cells) from one donor (71 yr old 
female) are cross-compared to each other and cultures derived from a full thickness digestion from a different 
donor (74 yr old female) according to total cells isolated and cell release rate.  The different cell isolations are 
then placed into culture and assayed for expansion rates, colony forming ability, and colony size.  * = Values 
significantly different from initial digestion values (Digestion step 1 + 2) (p<0.05). ‡= Values significantly 
different from final digestion values (Digestion step 4) (p<0.05). 
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6.3.3 Cell proliferation 
To evaluate differences in growth kinetics and total cell yields, freshly isolated (passage 0) 
periosteal cells from initial, final, and full digestions were plated at a standard density of 5000 
cells/cm2 and were cultured for 5 passages.  Passage 0 initial digestion cells expanded 
approximately 37-fold in 14 days, whereas final and full digestion cells plated at the same density 
expanded only 6.1- and 7.2-fold respectively (Figure 6.4A and C).  Over 5 passages, the total cell 
yield was highest in initial digestion cultures (2.8 x 108 cells) compared to both final and full 
digestion cultures, which yielded similar numbers of 5.8 x 107 and 3.1 x 107 cells respectively. The 
increased cell numbers seen in initial digestion cultures over 5 passages, is comprised of 2 distinct 
proliferation trends; an initial rapid proliferation rate at passage 0 (mp0=0.37, R2=1.00) and a slower 
rate from passage 1 to 5 (mp1-5=0.21, R2=0.99) (Figure 6.4B).  The latter of which is similar to the 
proliferation rates found in both final and full digestion cultures, which maintain steady growth 
rates (m=0.19-0.20, R2=0.99) over the 5 passages.  These growth trends are further highlighted by 
examining the fold increase in cell number at each passage for each digestion (Figure 6.4C).  Here 
we find that the significant difference in early growth rates between initial and final digestion 
cultures diminishes to nominal differences after passage 0 and that final and full digestion cultures 
maintain similar growth profiles over 5 passages. This indicates that the difference in cell yields 
between the cultures seen over 5 passages is due to initial rate of expansion seen in cambial cell 
culture at passage 0. 
To study the effects of plating density on cell proliferation, isolated cells from each digestion were 
plated at a low plating density of 50 cells/cm2 and grown for a period of 14 days.  As seen in 
passage 0 standard density cultures, initial digestion cells proliferated at a significantly greater rate 
than final digestion cells over the 14 day period (Figure 6.4A).  Initial digestion cells expanded 5.3-
fold over 14 days, whereas final digestion cells demonstrated negligible growth and expanded only 
1.1-fold.  At low seeding density, full digestion passage 0 cultures expanded 2.0-fold, with a 
growth profile residing between initial and final digestion profiles.   
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Figure 6.4 Population growth characteristics of periosteal cells isolated from the different digestions.  (A) 
Primary, passage 0 cells were seeded at standard (5000 cells/cm2) and low (50 cells/cm2) density on tissue 
culture plastic and cultured for a period of 14 days in standard growth medium.  Total cell yields and fold 
increase were calculated at day 7 and day 14 by harvesting and counting a total of 3 wells per digestion 
(n=3).  (B) To examine expansion potential, cells from each of the digestions were seeded at a standard 
density (5000 cells/cm2) and expanded for 5 passages (~63 days).  The cumulative population doublings 
achieved are plotted for each culture, with linear regression curves overlaid.  The slopes (growth rates) 
highlight the presence of two distinct growth trends found in initial digestion cultures during expansion.  (C)  
The fold increase (initial cell number/final cell number) is also calculated per passage to further demonstrate 
these trends. 
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6.3.4 Colony forming efficiency 
The differences seen in the proliferative potential of passage 0 cells from the different isolates was 
further demonstrated in the ability of isolated cells to form distinct cell colonies.  In preliminary 
experiments, we found that the optimal protocol for obtaining distinct and reproducible colony 
forming units (CFUs) was to culture isolated periosteal cells at a cell density of 10,000 cells/petri 
dish (78 cm2) for 12 days (Chapter 4).  Likewise, to establish significance between cell layers, 3 
petri dishes were counted for each assay.  During culture, the enzymatically liberated cells 
experienced an initial lag-phase of roughly 3 days, during which small colonies were seen to arise 
from single cells.  After 12 days in culture, initial digestion cells produced significantly more CFUs 
(32.0 ± 2.2) compared to both final digestion cells (5.1 ± 1.0) and full digestion cells (11.6 ± 2.2) 
(p<0.05) (Table 6.2). CFUs sizes were determined as an additional estimation of the proliferative 
potential of the periosteal cells. In agreement with previous work (453), average CFU sizes 
determined here, positively correlated with the true growth rates noted in each of the respective 
digestion cultures.   Initial digestion cells showed a mean CFU area of (4.4 ± 1.9 mm) which was 
significantly greater than both final digestion (2.2 ± 1.0) and full digestion (2.9 ± 0.8) cell colonies 
(Table 6.2). The areas of colonies derived from final and full digestion were found to statistically 
similar (p= 0.344). 
6.3.5 Cell morphology 
To characterise initial cell morphologies, plastic adherent cells from each periosteal digestion were 
plated at a standard density of 5000 cells/cm2 and grown in monolayer.  After 10 days - a time-
frame we chose which constituted the log phase of growth - phase-contrast images revealed 3 
morphologically distinct cell types in all cultures: small spindle shaped cells, elongated fibroblast-
like cells, and large flat cells (data shown in Chapter 5).  To quantify the differences in cell 
morphology between the cells derived from each digestion, the mean cell area and population 
distribution were calculated.  Compared to final and full digestion cells, initial digestion cells 
contained a more homogeneous population of cells with significantly smaller cell areas (p<0.05) 
(Figure 6.5A and C).  Measures of mean cell circularity revealed initial digestion cells to also be 
significantly more rounded compared to the thinner and more elongated morphology of the final 
digestion cells (Figure 6.5B).  In examining the distribution of areas in the different cultures, we 
identified a subpopulation of cells, representing 35.8% of the cells measured, to be smaller than 
2000 µm2 (Gate R1 in Figure 6.5C).  This subpopulation was unique to initial digestion cultures as 
no cells were found to be ≤ 2000 µm2 in either final or full digestion cultures. This data also 
revealed cells in final and full digestion cultures to have similar mean cell area and circularity (p> 
0.05). 
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Figure 6.5 Characterisation of cell morphologies present in passage 0 human periosteal cell cultures from 
each digestion.  After 10 days in culture, cell area (A) and circularity (B) was measured digitally using 
ImageJ software based on cell spreading.  Data is shown as the mean ± SD, with > 50 cells being measured in 
each culture (* = p <0.05).  (C) The distribution of cell areas is also shown. Gate R1 demonstrates the 
presence of a subpopulation of small, spindle-shaped, cells ≤ 2000 µm2 in area, and represents 35.8% of 
initial digestion cultures.   
 
To further assay for morphological changes and homogeneity of the respective cultures, cells from 
each isolate were placed in suspension and examined for their light scattering properties in a flow 
cytometer.  This method excludes the effects of cell spreading on cell size.  FSC is a complex 
function related to cell diameter, while orthogonal light scattering signals (SSC) reflects the 
granularity of the cells.  After 14 days in primary culture (passage 0), analysis of forward-light 
scattering intensity indicated that initial digestion cultures contained a higher frequency of smaller 
cells compared to both final and full digestion cultures (Figure 6.6). Gating on the distribution 
histogram (Gate R2, Figure 6.6) revealed that this distinct population of small cells (55-300 FSC-
H) comprised 35.8% of the total initial digestion culture.  An observation consistent with 
evaluation of cell areas gated in R1 (Figure. 6.5C).  Upon passaging, however, this unique 
subpopulation of smaller diameter cells quickly disappeared and the differences seen in the original 
passage 0 cell size frequencies between the different digestions became negligible.  Differences in 
side-light scatter (cell granularity) were also apparent, and revealed that at passage 0, initial 
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digestion cultures contained less granular cells compared final digestion and full digestion cultures 
(Figure 6.6).  However, during subculture, a progressive shift to more granular populations was 
noted in initial and full digestion cultures.  Whereas, the opposite trend to less granular populations 
was found in final digestion cultures.   
 
Figure 6.6 Flow cytometry analysis of the cell size (FSC) and granularity (SSC) of cultured human periosteal 
cells isolated from the different cell digestions.  Distribution histograms of initial (black line), final (grey 
line), and full (dotted line) digestion cells at passage 0, 1, and 5 demonstrate the morphological differences 
between the different cultures and the changes that occur during subculture.  Gate R2 highlights a 
subpopulation of small, agranular cells unique to initial digestion cultures and represents 35.6% of the total 
cell population analysed.  
 
6.3.6 Immunophenotype 
To identify specific cell phenotypes, surface epitopes were examined in initial, final, and full 
digestion cultures over 5 passages using commercially available antibodies.  Cultures derived from 
all the digestions contained a heterogeneous population of cell phenotypes, with varying levels of 
expression of each of the 6 antibodies examined (ALP, Stro-1, CD34, CD45, CD31, and α-SMA) 
(data not shown, see Chapter 5).  In passage 0 initial digestion cultures, CD34+ (20.9%) and 
ALP+/Stro-1- (17.7%) cells represented the largest populations of stained cells, whereas Stro-
Chapter 6: Sequential Digestion of Human Periosteum 
 
137 
1+/ALP- (4.2%) and Stro-1+/ALP+ (2.3%) were expressed on a considerably smaller percentage of 
cells (Figure 6.7A).  In contrast, passage 0 final digestion cultures contained much larger 
populations of ALP+/Stro-1- (47.9%) Stro-1+/ALP+ (6.9%) and smaller populations of CD34+ 
(3.9%) and Stro-1+/ALP- (1.5%) cells (Figure 6.7A).  Full digestion cultures, as one might expect, 
contained expression levels between what we found in passage 0 initial and final digestion cultures, 
for all populations except the Stro-1+/ALP+ subpopulation (9.9%). 
 
Figure 6.7 Expression of cell specific mAbs Stro-1, ALP, and CD34 on passage 0 (A) and subcultured (B) 
periosteal cells isolated from initial, final, and full digestions.  Line graphs are displayed to highlight the 
changes in phenotype that occur during monolayer culture on tissue culture plastic. Expression levels were 
determined by recording at least 20,000 events using flow cytometry and gating using appropriately match 
isotype controls.  Results are expressed as percentages of the total cell population measured.  
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When placed in secondary culture and examined over 5 passages, the number of initially examined 
phenotypic populations changed substantially (Figure 6.7B). In final digestion cultures, both Stro-
1+ populations (Stro-1+/ALP+ and Stro-1+/ALP-) were found to rise slightly at passage 1 and 
decrease thereafter to very low levels (≤ 2%) at passage 5.  ALP+/Stro-1-, on the otherhand, 
maintained relatively consistent levels during the measured culture period , showing slightly less 
expression at passage 5 (32.4%) compared to passage 0 percentages (47.8%).  Examining the 
lineage development in initial digestion cultures, we notice different trends.  We found a drastic 
increase in both ALP+ subpopulations (ALP+/Stro-1- and Stro-1+/ALP+) over 5 passages, with the 
largest rise occurring at 1 passage.  The Stro-1+/ALP- subpopulation was found to maintain 
expression levels between 2-5% over the 5 passages.  In full digestion cultures we noticed 
consistent expression levels over the 5 passages, with subpopulations neither greatly increasing nor 
decreasing during subculture (Figure 6.7B).  The increase from 27% at passage 0 to 43% at passage 
5 of ALP+/Stro-1- expression represents the largest change seen in full digestion cultures.  Similar 
to initial digestion cells, the Stro-1+/ALP- population was maintained at levels between 2-5% over 5 
passages, and the CD34+ population was found to decrease with time in culture.  In final digestion 
cultures, the decrease in Stro-1+ subpopulations occurs in concert with an increase in CD34+ 
percentages, accounting for a majority of cells examined at passage 5.  CD34 expression in initial 
digestion cultures, in contrast, found at higher levels initially, was shown to decrease to roughly 7% 
of the total cell population at passage 5.   
6.4 Discussion 
The continued development and success of periosteum-based therapeutic strategies will be 
contingent upon the ability of researchers to safely and effectively harness the full regenerative 
potential of the periosteum.  Further, this ability necessitates that researchers establish a simple and 
reproducible method for identifying and enriching target cells with the best reparative 
characteristics for the given clinical application.  From previous studies conducted by us and 
others, it is known that a great biological variation exists between different periosteal cell 
populations.  Therefore, in considering the rich heterogeneity of the periosteum both in terms of 
cellular and extracellular composition, this capacity to identify and enrich specific cell populations 
becomes even more important.  It is well documented that cells derived from human periosteal 
tissue comprise a heterogeneous population that includes cells with the capacity to extensively self-
renew, form colonies and differentiate into multiple lineages; indicative of the presence of stem 
cells (160;422).  However, prior to this study, less focus had been given to targeting stem cell types 
or understanding the underlying differences in periosteal cell biology (398).  In this study we 
devised an enrichment strategy based on a series of enzymatic digestions to [1] optimise selection 
protocols for the isolation of precursor stem cells from human periosteum and [2] to characterise 
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the differences in cellular phenotypes and in-vitro behaviour between populations isolated from the 
distinct tissue layers of the periosteum. 
To develop an accurate and reproducible isolation method, the thickness and cellularity of the 
individual periosteal layers was measured and compared across a number of donor explants. In-
vivo, the distinct cellular and structural differences in the cambium and fibrous layers have been 
detailed previously and are found to significantly vary with species, donor site, and age 
(359;384;387;446;454-457).  Here, the metaphyseal portion of the medial proximal tibia was 
selected as the optimal donor site for periosteal explant extraction due to its easy accessibility 
during elective knee surgeries and characterised therapeutic potential.  When examining both donor 
and regional donor site variations in the periosteum, explants from the proximal tibia have been 
shown experimentally to have a greater osteogenic and chondrogenic potential than periosteum 
harvested from the middle and lower tibia, calvarium, or skull (359;367).  The regional differences 
in potential have been positively associated with the cellularity of the cambium layer, and have 
recently been shown to vary with age (394).  During aging, the size and number of cells in the 
periosteum has been found to decrease along with the absolute and relative thicknesses of each 
layer (39;456;458;459). This reduction in cell number is thought to contribute to the apparent 
atrophy and thinning of the cambium layer that occurs with age (387).  However, in our analysis of 
7 sex-matched human donors we found that age had no apparent influence over the thickness or 
cellularity of either the cambium or fibrous layer.  In fact, the cellularity of each layer was 
statistically similar across 6 of the donors tested and the thicknesses measured showed marked 
donor-to-donor variation with no direct correlation with age. The discrepancies noted between our 
histological analysis and previous studies may reflect the biological differences in human 
periosteum, used here, and animal periosteum investigated in the earlier studies.  As the 
regenerative potential of the periosteum has been linked to the cellularity of the cambium layer, our 
histological analysis of cell density may further help to explain why the capacity for 
chondrogenesis is not lost upon aging (201). 
The capacity to reproducibly harvest human periosteal explants of consistent size, structure, and 
cellularity, was important for the design of an effective sequential digestion strategy to isolate 
periosteal layer specific cells.  The time scale for each digestion was based on the average 
thickness of the cambium and fibrous layers and rate of enzymatic tissue dissociation. This design 
allowed for the isolation of cell populations consisting of mostly cambium or fibrous layer cells.  
Although this cell separation was shown histologically (Figure 6.3), further characterisation of the 
individual digestions was necessary to confirm the success of this enrichment technique.  
Therefore, the morphology, phenotype, colony forming efficiency and growth profiles of initial 
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(Digestion Step 1+2) and final (Digestion Step 4) cell digestions were characterised and cross-
compared.  
Periosteal populations isolated from both initial and final digestions contained a multitude of cell 
types at varying numbers, including progenitor cells, osteoblasts, smooth muscle cells, 
lymphocytes, red blood cells, and adipocytes (all phenotypes shown previously in chapter 5).  For 
this study, however, we focused on cells from osteogenic and hematopoeitic lineages as they were 
the most prominent cell types present in the cultures. When grown in monolayer, initial digestion 
cells exhibited the rapid proliferation and subsequent sequential expression of phenotypic markers 
associated with the early stages of osteogenesis that has been characterised in previous calvarial 
and periosteal cell cultures (296;460). Our group (Chapter 5) and others (242;244) have shown 
independently that by employing dual staining techniques with developmental markers Stro-1 and 
ALP it is possible to identify subpopulations, that based on functional and phenotypic criteria, 
appear to represent cells at different stages of osteogenic differentiation; namely early progenitors 
(Stro-1+/ALP-), preosteoblasts (Stro-1+/ALP+), and maturing osteoblasts (ALP+/Stro-1-).  Based on 
this assessment, cells of the final digestion initially contain more developmentally mature 
osteogenic cell populations than initial digestion cells. However, passage 0 initial digestion cultures 
demonstrated greater osteogenic potential, with larger populations of Stro-1+/ALP- osteoprogenitor 
cells.  The major and rapid increase in ALP expression in initial digestion cultures over time 
indicate that some of the cells, which initially did not express the ALP protein, have the ability to 
rapidly mature and differentiate, as would be expected for osteoprogenitor cells. Perhaps equally as 
interesting, however, final digestion cultures were also found to contain a small, yet consistent, 
population of Stro-1+ osteoprogenitor cells.  An observation that is consistent with previous 
immunohistological studies, where Stro-1+ cells are found to be broadly expressed in the fibrous 
layer (394), particularly at the cambium/fibrous layer interface (461).  
Upon plating, passage 0 initial digestion cells proliferated more quickly and reached a higher cell 
density (total cell number) than final digestion cells when cultured for 14 days.  In addition, two 
cell densities were investigated to examine the impact of microcellular environment on the short-
term self-renewal capabilities of the different cell isolates.  In both low density (50 cells/cm2) and 
standard density (5000 cells/cm2) cultures, initial digestion cells displayed growth rates that were 
~5x faster than final digestion cells over a period of 14 days.  This trend is opposite to what was 
found in cultures of rabbit periosteal cells, where fibrous layer cells were shown to proliferate 
faster than cambium layer cells (398).  This further highlights the cellular differences between 
human and rabbit periosteal cells, and suggests that rabbit models may not accurately reflect the 
true behaviour of human periosteal cells in-vitro (384). However, all isolated populations cultured 
at standard density exhibited elevated growth rates and population expansion compared to low 
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density cultures.  These results are in direct opposition to features found in human bone marrow 
stromal cells in which the rate of expansion and yields of progenitor cells are shown to be inversely 
related to plating density (225).  This discrepancy may be reflective of the cellular differences 
found between progenitor cell populations derived from the bone marrow and periosteum, and may 
emphasize the role that community effects or cell-cell interactions/secreted factors have on the 
maintenance and control of periosteal  progenitor cell populations [(178;429)and Chapter 5]. 
Interestingly, this is only the second study to quantify the morphological heterogeneities present in 
human periosteal cultures, and the first attempt to define these differences in terms of periosteal 
layer. We have shown that initial digestion cultures contained, on average, significantly smaller and 
rounder cell populations compared to final digestion cell populations.  These significant differences 
found are due to the presence of a morphologically distinct population of small, round, agranular 
cells that comprises roughly 35% of initial digestion cultures as confirmed by gating on flow 
cytometry histograms (R2=35.8%) and area distribution profiles (R1=35.6%).  The size of this 
population is in contrast to a previous study detailing the physical attributes of passage 0 human 
periosteal cells, in which they found only 6% of the cells to be <2000 µm2 in area, i.e. in gate R1 
(Fig. 4C) (384). This stark contrast is most likely related to the fact that the previous cultures were 
derived from complete digestions of full thickness explants.  This is supported in our analysis of 
full digestion cultures, in which no cells are found to be <2000 µm2 in area.   
Cell morphology has been strongly related to proliferative activity, with small round cells being 
associated with highly-proliferative, progenitor cells within bone marrow and periosteal tissues 
(225;384;462).  Therefore, the increased growth rates, number of colonies, and colony sizes found 
in passage 0 initial digestion cultures are directly related to the presence of this unique cell 
population.  To establish the phenotype of this distinct population we employed backgating 
techniques on flow cytometry histograms to reveal 78.8% of the Stro-1+/ALP- population to be 
present within the population of small cells (gate R2, Figure 6.5).  However, this population of 
Stro-1+/ALP- cells represents only a small percentage (7.0%) of this unique population, and argues 
for the presence of a separate, Stro-1-, stem cell like subpopulation.  Although this Stro-1- 
population has not been fully characterised here, two different hypotheses can be proposed to 
explain its existence. The first, and most orthodox hypothesis, is that the separate Stro-1- and Stro-
1+ populations represent the hierarchical organisation of stem cells, where the Stro-1+ population 
represents the progenitor cell with restricted plasticity and capacity for self-renewal (227;463).  
This argument is congruent with the presence of functionally distinct osteoprogenitor and 
chondroprogenitor populations and even more primitive multipotent stem cells found previously in 
clonal studies of cultured periosteal cells (160;184). In her eloquent limiting dilution studies of rat 
bone marrow stromal cultures, Jane Aubin postulates a second hypothesis (178).  The presence of 
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two different pools of progenitor cells: ones that differentiate in the absence of exogenously applied 
stimulus and ones that do so only in its presence and represent the majority of immature 
progenitors.  Within the context of this study, the presence of more primitive stem cells or different 
populations of committed progenitors within this unique initial digestion population has not be 
fully elucidated and warrants further analysis.  Unfortunately, the use of human monoclonal 
antibodies are restricted in their ability to delineate between these uncommitted cell pools, and 
currently enable the identification and enrichment of progenitors but not, more primitive  stem cells 
(464).  Yet in this study, which utilises standard media void of differentiation supplements, the 
combination of a consistent Stro-1+/ALP- population, rapid loss a of large population of small, 
highly-proliferative Stro-1- cells, and equally rapid increase in expression of developmentally 
mature ALP+ cells suggests that we too have isolated two unique periosteal progenitor cell 
populations from our initial sequential digestion.  However under our culture conditions, we 
indirectly selected for the expansion of only the Stro-1+ progenitor population in initial digestion 
cultures. This secondary, culture-based, enrichment step identified here could potentially be 
limiting the differentiation and proliferative capacity of human periosteal cultures.  The 
identification of a microcellular environment that maintains both, Stro-1- and Stro-1+, progenitor 
cell populations may work to enhance the therapeutic potential of periosteal cell cultures. 
During monolayer expansion, the population of small, agranular, highly proliferative cells present 
in initial cell cultures is quickly lost and replaced by larger more granular cell populations 
comparable to populations found in final digestion cultures.  Linear regression analysis of cell 
population doublings over 5 passages, clearly demonstrates the change in the initial digestion 
culture after passage 1 and the similarities in expansion potential with final digestion cells 
thereafter. The strong correlation found between growth rates and morphology in initial digestion 
cultures seems likely to be related to the rapid shift in population phenotype, from small, rapidly-
proliferating developmentally primitive cells to large, slowly cycling, and more mature ALP+ cells.  
Equally, the consistent slower expansion rates seen in cultures derived from final and full periosteal 
digestions also demonstrated a large initial and consistent ALP+ population thoughout the 5 
passages.  The relationship between cell size and growth capacity has been seen previously in full 
thickness periosteal cell isolates (Chapter 5) and cambium layer cells (398) and can be explained 
by the fact that a cell loses its proliferative potential during the differentiation and enlargement 
stage (465).   
In comparing the sequential digestion cultures to cultures derived from fully digested periosteum, 
we found freshly isolated full digestion cultures to be more similar to final digestion cultures in 
terms of growth capacity, morphology, and phenotype.  Upon subculture, however, we observed a 
mixture of trends and behaviours found in both sequential cultures and therefore can not make clear 
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comparisons to either. Importantly, however, full digestion cultures did not contain the 
morphologically distinct subpopulation composed of small, agranular, highly-proliferative cells 
with high osteogenic potential. In support of this, previous work performed is this thesis (Chapter 
5) and by others (295;384;390;398) characterising human periosteal cells derived from fully 
digested periosteal explants also failed to observe this distinct population of cells.  The absence of 
this population in full digestion cultures suggests that, as yet unidentified, cells and/or biological 
molecules intrinsic to the fibrous layer of the periosteum may act to suppress or change the 
characteristics and propagation of this unique cell population of the cambium.  The existence of 
specific cells and biological factors resident to each tissue layer may also help to explain the time 
dependent increase in CD34+ cells in final digestion cells.  Since the periosteum fibrous layer 
contains an extensive vascular network, it is likely that it would contain intrinsic environmental 
factors to support the propagation of numerous haematopoietic cell types in culture. Equally, the 
loss of the unique highly-proliferative population in initial digestion cultures suggests that this 
population requires a particular microcellular environment, not provided in this study, to maintain 
its ability to self-renew.   
The differential cell characteristics and population behaviours noted between each digestion further 
demonstrates the capacity of our sequential digestion method to enrich cells according to periosteal 
tissue layer.  In initial digestion cultures, composed mostly of cambium cells, we observed 
characteristics consistent with the enrichment of precursor cells, including significantly more and 
larger CFUs, increased proliferation rates and cell yields, and a rapid increase in osteoblastic 
phenotypes.  These characteristics are directly related to the presence of a subpopulation of small, 
agranular cells, containing both Stro-1+ and Stro-1- phenotypes, unique to initial digestion cultures.  
Conversely, the lack of this unique subpopulation from final and full digestion cultures indicates 
that enzymatically digesting full periosteal explants may prove unsuitable for the isolation of all 
developmentally immature stem/progenitor cell populations known to reside in the cambium layer. 
6.5 Conclusions 
In conclusion, we have devised a simple enrichment method utilising sequential digestions to 
isolate distinct populations of human periosteal cells from the cambium and fibrous layer. To our 
knowledge, this is first study to detail the distinct morphological, phenotypic, and growth 
characteristics of cells from the individual tissue layers of human periosteum in a monolayer 
culture environment.  Similarly, this is also the first study to isolate a morphologically unique 
subpopulation of small, rounded, agranular, highly-proliferative cells with an increased capacity for 
osteogenesis from human periosteum tissue.  The fact that this subpopulation was absent from final 
digestion and full digestion cultures demonstrates the underlying differences in the microcellular 
environment present in each of the cultures and highlights the influence that accessory cells and 
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associated biomolecules have on stem and progenitor cell populations.  Further analysis of this 
unique cell population and its surrounding microenvironment may lead to the development of 
improved periosteal-cell based treatment for orthopaedic injuries.  Lastly, the ability to further 
dissect the differential characteristics and cellular behaviours in the periosteal layers may also help 
us to develop a deeper understanding of the fracture healing process and the regulation of bone 
growth and resorption during developmental, homeostatic, and diseased states.  
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Chapter 7  
Identification of Rare Progenitor Cells from 
Human Periosteal Tissue using Droplet 
Microfluidics 
 
7.1 Introduction 
The ability to identify and isolate single cells from heterogeneous populations is an important 
procedure in a variety of experimental and clinical applications.  Segregated cells, representing 
subpopulations, can provide important information about a wide range of cell and population 
parameters and thus extend the understanding and control of biological processes.  In particular, the 
development of single-cell tools would allow the detection of rare tumour cells in blood for disease 
prognosis (235), provide an assessment of disease progression rates in human immunodeficiency 
virus (HIV) infection (466), and allow selective targeting of malignant cells (467). Moreover, 
enrichment steps will be necessary when creating novel stem cell and gene therapies, which rely 
upon the selection and characterisation of rare stem cell populations identified in numerous adult 
tissues (227-232).  In the context of this thesis, enrichment steps are also needed to simultaneous 
identify and isolate reparative periosteal progenitor cell types for further characterisation and 
therapy development. 
To date, a variety of isolation strategies have been employed for this task, including fluorescent 
activated cell sorting (FACS), limiting dilution, density centrifugation, magnetic sorting, and 
adherence to glass and plastic surfaces (233;234). Most popular amongst these techniques is FACS, 
which is a specific type of flow cytometry that allows each cell to be characterised and sorted 
according to a range of distinct biochemical and biophysical characteristics. Exploiting this 
strategy, rare cell types such as stem cells, antigen-specific B and T cells and circulating tumour 
cells have been identified and isolated (235-239). These successes are, in part, due to developments 
in fluorophore and antibody production and availability, which have led many researchers to focus 
their purification efforts on immunophenotypic assays utilizing cocktails of monoclonal antibodies 
(240-247). In this way, rare stem/progenitor cell populations are targeted based on the expression 
of intra-/extra- cellular molecules.  
Although these popular techniques have enjoyed widespread use over recent years and have been 
employed in this thesis, new analytical technologies offer the promise of improved analytical 
performance, enhanced functionality and robust versatility in a variety of cell-based assays (250-
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255). Amongst these technologies, droplet microfluidic systems offer the possibility of rapid, 
specific and detailed analysis of cell populations. In these systems, picolitre-sized droplets 
generated from immiscible phases can be produced at high frequencies (in excess of 1 KHz) and 
can act as discrete and isolated reaction compartments to study a number of biological and 
chemical processes (256). In this context, droplet microfluidic systems have been used as an 
analytical tool to examine enzyme kinetics(257), libraries(258), and assays(259), protein 
crystallisation(260;261) and biological assays(262;263). More recently, droplet microfluidic 
systems have been successfully demonstrated to effect single cell encapsulation and manipulation 
(255;262;264). Accordingly, such droplet systems have the potential to define a new high-
throughput screening platform that can sample, encapsulate, manipulate, process and detect single 
cells and more importantly the presence of rare cell phenotypes. For cell biologists and tissue 
engineers alike, the compartmentalization provided by the droplets is particularly valuable for 
precisely analyzing multiple cellular characteristics simultaneously. An initial demonstration of this 
biological potential was recently provided by Huebner et al (262) and Koster et al (265), where 
droplet-based microfluidic systems were able to quantify protein expression and cell viability and 
metabolism.  
The studies presented in this chapter significantly extend these proof-of-principle experiments and 
describe the use of droplet microfluidics to identify and quantify the presence of rare mammalian 
cell phenotypes within heterogeneous populations of human periosteal cells. Using fluorescent-
conjugated antibodies against distinct cell-surface proteins, alkaline phosphatase and Stro-1, we 
were able to able to target cells at different stages of differentiation and lineage commitment. Based 
on the time-integrated fluorescence signal of these markers, the identification and enumeration of 
three developmentally distinct cell phenotypes was demonstrated. Additionally, to test the accuracy 
and diagnostic capability of the microfluidic approach, results were compared to expression levels 
obtained using traditional flow cytometry techniques. For this study, adult human periosteal tissue 
represents an ideal cell source due to its rich cellular heterogeneity and its potential for therapeutic 
applications in the repair and regeneration of musculoskeletal tissues (30;31;159;361;362;401). As 
demonstrated previously, periosteal cells can be easily derived from small periosteum tissue 
explants harvested from adult donors and extensively expanded ex-vivo. Phenotypically, periosteal 
cells are composed of a heterogeneous population of mesenchymal and hematopoeitic cell types at 
different stages of maturation and lineage commitment, including a small subset of stem cell like 
cells (160;186;295).   Secondarily, droplet microfluidics can be used to validate the precision and 
accuracy of flow cytometry-based human periosteal cell immunophenotype studies performed in 
Chapter 5 and 6. 
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7.2 Materials and Methods  
7.2.1 Harvest of periosteal tissue and isolation of cells 
Periosteal tissue specimens were obtained from patients (providing informed consent and between 
the ages of 31-73 years) undergoing elective knee surgery at Chelsea and Westminster Hospital, 
London. Explants were harvested from the proximal tibia using a periosteal elevator, and 
transported in Earl’s Balanced Salt Solution at 37oC. Explants were weighed, finely minced, and 
enzymatically digested with 3 mg ml-1 collagenase D (Roche Applied Science, West Sussex, UK), 
3 mg ml-1 collagenase type II (Sigma-Aldrich, Poole, UK) and 5 mM CaCl2 in growth medium 
(high glucose Dulbecco’s Modified Eagle Medium containing 10% v/v foetal bovine serum, 1% 
v/v L-glutamine, 100 units ml-1 penicillin, 100 µg ml-1 streptomycin) (all from Invitrogen, Paisley, 
UK). After incubation at 37 °C for 4.5 hours, the cell suspension was washed, passed through a 70 
µm cell strainer (Falcon, Becton Dickinson, Oxford UK), and counted. Cells were then placed into 
monolayer culture and allowed to attach to tissue culture plastic for a period of four days. The 
media was changed to remove non-adherent cells and the attached cells were further cultured as 
passage 0 until confluence. All characterisation experiments were carried out using serially 
expanded periosteal cells between passage 0 and 10. 
7.2.2 Antibody staining 
Antibodies raised against Stro-1 and human bone/liver/kidney alkaline phosphatase (ALP) were 
tested for their specificity, titrated, and used at concentrations varying from 1-2.5 µg/106 cells. 
Stro-1 is a yet unidentified antigen present on the surface of developmentally primitive cell types 
with osteogenic potential. Under certain culture conditions Stro-1+ cells are able to give rise to an 
array of stromal cell types, including smooth muscle cells, adipocytes, chondrocytes, and 
osteoblasts (240;248;249). The bone/liver/kidney isoform of ALP, although not specific to the 
osteogenic lineage, is a well-documented marker of committed osteoblasts (468). Together, these 
two independent antibodies were used to dissect human periosteal cell populations according to 
surface protein expression. 
Approximately 1-3×105 periosteal cells of passages 0-10 were incubated in 1 ml of blocking buffer 
(phosphate buffered saline pH 7.4 0.01M (PBS) containing 2% (w/v) bovine serum albumin (BSA), 
0.1% (v/v) foetal bovine serum, and 0.1% (v/v) normal mouse serum) (all from Sigma-Aldrich) for 
30 minutes at room temperature to limit non-specific binding. For direct staining, cells were then 
incubated with APC (define)-conjugated ALP for 45 minutes at 4oC, washed in PBS containing 2% 
BSA (w/v) + 0.1% (w/v) sodium azide (flow buffer), centrifuged, and resuspended in 300 µl of 
flow buffer prior to analysis. For indirect staining using primary mAb Stro-1, the cells were first 
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incubated with the primary mAb (45 min at 4oC), washed, and incubated with a fluorescein 
isothiocyanate (FITC)-conjugated fragment F(ab’)2 goat anti-mouse secondary Ab (Jackson 
ImmunoResearch, Suffolk, UK) for 45 minutes at 4oC. Matched isotypes were used as negative 
controls and prepared at the same concentrations as their matched primary Ab. To facilitate an even 
supply of cells to the microdevice, 25% Percoll (Sigma-Aldrich), filtered using a 5 μm syringe 
filter, was added into the final cell suspension. Percoll is a suspension of colloidal silica particles 
(15-30 nm diameter) coated with polyvinylpyrrolidone (PVP) that alleviates cell sedimentation 
during the transferral of cells into the microfluidic device (262). 
7.2.3 Flow cytometry 
Cell fluorescence was evaluated by flow cytometry using a FACSCalibur instrument (BD 
Biosciences, Oxford, UK) with data analysis performed using FlowJo software (Tree Star Inc, 
Ashland, USA). At least 20,000 discrete events were collected per sample and the percentage 
positive expression for each mAb was defined using unstained and isotype-matched controls. 
Based on the light scattering characteristics of each sample population, dead cells, cell debris, and 
aggregates were eliminated from further phenotypic analysis. For dual-color phenotypic analysis 
and enumeration, the gating combinations were defined as Stro-1+/ALP-, Stro-1+/ALP+, and 
ALP+/Stro-1-. 
7.2.4 Microfluidic device fabrication 
Microfluidic devices were fabricated by standard soft lithographic processing of 
poly(dimethylsiloxane) (PDMS). SU-8 masters on 4 inch diameter silicon wafers (IDB 
Technologies, UK) were lithographically patterned to serve as PDMS moulds (469). A 10:1 (w/w) 
mixture of base (tetra(trimethylsiloxy)silane) and curing agent (tetramethyltetravinyl 
cyclotetrasiloxane) from a SYLGARD 184 Silicone Elastomer Kit (Dow Corning Limited, UK) 
was degassed and poured onto a master and then cured at 65°C for between 4-5 hours, after which 
PDMS replica was peeled off. For cell delivery, large access holes (~1 mm in diameter) were 
punched into PDMS channel ends using a syringe needle. To complete, the structured PDMS 
substrate was contacted with a 1 mm-thick microscope slide that acted as a support structure. 
Access holes in the microscope slide were drilled using a 1-mm-diameter diamond dental drill bit 
(Diama International, Inc., London UK). These holes coincided with inlet and outlet reservoirs in 
the PDMS layer. Fused-silica capillaries (375 μm o.d., 150 μm i.d., Composite Metal Services 
LTD, Hallow, UK) were then inserted through the holes of the microscope slide and glued using a 
two-part epoxy (Araldite 2014, RS Components, Corby, UK). These capillaries served as a fluidic 
interface between the microfluidic device and macroscale reservoir. The microscope slide with 
capillary connection was then bonded to the PDMS replica using an oxygen plasma treatment. To 
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allow efficient optical interrogation using high numerical aperture objectives, PDMS 
microchannels were enclosed permanently with a 160 μm microscope cover slip by oxygen plasma 
bonding. The completed PDMS device consisted of two inlets and an outlet, having a 50 μm deep, 
50 μm wide and 4 cm long channel. 
7.2.5 Droplet formation 
Droplets were generated using a T-junction microfluidic flow geometry incorporating 1 aqueous 
inlet as shown in Figure 7.1A. The cell suspension with 25% Percoll loaded into a 250 µl gas tight 
syringe (SGE Europe Ltd, UK) was motivated into the perpendicular inlet at a flow rate of 1.0 µl 
min-1, while an oil solution, a 1:2 v/v mixture of an electronic coating liquid (EGC-1700, 3M) and 
3M fluorinated fluid FC-3283 (3M) with a 1:10 v/v dilution of 1H,1H,2H,2H-perfluorooctanol, was 
delivered at a flow rate of 1.5 µl min-1 using a 1.0 ml gas tight syringe (SGE Europe Ltd, UK). The 
syringes were connected to the microfluidic device (via the capillaries) using Teflon tubing (0.356 
mm i.d., 1.55 mm o.d., Upchurch Scientific) and PEEK fingertights and unions (1/16", 10/32 
threads, VICI AG International, Schenkon, Switzerland). All solutions were pumped into 
microfluidic channels using precision syringe pumps (PHD 2000, Harvard Apparatus, UK).  
 
Figure 7.1 (A) A schematic of the microfluidic device having a 50 µm deep, 50 µm wide and 4 cm long 
channel. The experiment was carried out by pumping the oil and cell suspension at 1.5 µl min-1 and 1.0 µl 
min-1, respectively. The inset depicts an image of a cell which is encapsulated within a droplet moving along 
the microchannel. (B) A schematic diagram of a confocal fluorescence setup used for droplet detection. This 
setup consists of a two colour excitation system using 488 nm diode and 633 nm He/Ne lasers. APD – 
avalanche photodiode detector, DC – dichroic mirror, EM – emission filter, PH – pinhole and L – lens. 
7.2.6 Optical detection system 
A custom built confocal spectrometer in a combination with an Olympus IX71 microscope was 
used for droplet detection. This confocal spectroscopic setup, schematically shown in Figure 7.1B, 
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consists of a two colour excitation system using 488 nm diode (Coherent UK Ltd., UK) and 633 
nm He/Ne (Spectra Physics) lasers. Beam steering optics are used to align the laser beams within 
the microscope. A dual-band dichroic mirror (z488/633rdc, Chroma Technology Corporation, 
USA) is installed to allow reflection of 488 and 633 nm laser beams into a 60x water immersion 
objective lens (Olympus). This objective lens focuses the excitation radiation into the microfluidic 
channel, with the entire device being placed on a controllable stage (ProScan IITM, Prior Scientific) 
of the microscope. The two laser beams are aligned to generate completely overlapped spots that 
ensure coincident excitation of droplets. This is achieved by aligning two laser spots using an 
image from a CCD camera (Cascade II, Photometrics). 
Fluorescence emission is collected by the same objective, passed through the dichroic mirror and 
then filtered by a dual-band emission filter (z488/635, Chroma Technology Corporation, USA) to 
remove residual excitation light. After that, the fluorescence signal is focused onto a 75 μm pinhole 
(Melles Griot, UK) using a plano-convex lens (+50.2F, Newport Ltd.). Another dichroic mirror 
(630dcxr, Chroma Technology Corporation, USA) splits the fluorescence emission into two paths 
to be simultaneously detected by two avalanche photodiode detectors (APDs) (AQR-141, EG&G, 
Perkin-Elmer). The reflected fluorescence signal is filtered by an emission filter (hq540/80m, 
Chroma Technology Corporation, USA), and then focused onto the first detector (green channel) 
using a plano-convex lens (f = 30.0, i.d. 25.4 mm, Thorlabs, UK). The transmitted fluorescence 
emission is filtered by another emission filter (hq640lp, Chroma Technology Corporation, USA) 
and then focused by another plano-convex lens onto the second detector (red channel). The output 
of the detectors is concurrently sent to a multifunction DAQ device for data logging (PCI 6602, 
National Instruments). This enables both detectors to have sub-microsecond time resolution per 
channel.  
7.3 Results and Discussion 
7.3.1 Cells trajectories within droplets 
A suspension of human periosteal cells in PBS containing 1% BSA and 25% Percoll (~500000-
1000000 cells ml-1) was immunostained using FITC and APC conjugated mAbs and loaded into the 
microfluidic device to generate droplets. Importantly, the encapsulation and confinement of cells in 
droplets removes the possibility of cell-surface interaction. Moreover, the inclusion of a coating 
liquid (EGC-1700) in the oil solution renders a clear and thin uniform film (~0.1 μm thick). The 
thin film coating the microchannel walls prevents any adsorption phenomena that will bias the 
analysis. This on-line coating serves as an alternative to silane pre-treatment (470). On-line droplet 
detection was performed at 4.0 mm from the droplet forming region. As droplets (containing single 
cells) travel past the detection region (4 mm from the droplet forming region), the contained cells 
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are coincidently excited by the two laser probe volumes at the centre of the channel. Based on the 
fluorescence emission spectra and intensity of each cell-droplet, we are able to confirm the 
expression levels of cell-surface antigens Stro-1 and ALP. The fact that these antigens are present 
on distinct cell types allowed us to target three different developmental phenotypes of the 
osteoblast lineage. Two previous studies and previous results shown in the thesis [(242;244) and 
Chapter 5 & 6] have independently shown that by employing dual staining techniques with 
developmental markers Stro-1 and ALP, it is possible to identify sub-populations, that based on 
functional and phenotypic criteria, appear to represent cells at different stages of osteogenic 
differentiation; namely early progenitors (Stro-1+/ALP-), preosteoblasts (Stro-1+/ALP+), and 
maturing osteoblasts (ALP+/Stro-1-). Progenitor cells stained with Stro-1-FITC were only excited 
by the 488 nm excitation radiation and emit ‘green’ fluorescence, while ALP-APC stained pre- and 
mature- osteoblast cells were only excited by the 633 nm excitation radiation and emit ‘red’ 
fluorescence. Due to dual labelling, pre-osteoblast cells are excited simultaneously by both lasers 
and thus emit both ‘green’ and ‘red’ fluorescence. Fluorescence bursts corresponding the transit of 
single cells through the detection volume were recorded at 50 μs resolution for a 60 s acquisition 
time. It was noticed that single cells inside the droplets were preferentially located in the middle of 
the channel width, as seen in Figure 7.1A, ensuring that every cell passage was detected.  
An example of a fluorescence burst scan recorded over time period of 5 seconds for both green and 
red detection channels is shown in Figure 7.2. Droplet signatures from the green and red channels 
were coincident and approximately constant in height. It should also be noted that the fluorescence 
background present in all experiments is due to cell autofluorescence and the presence of unbound 
antibody left in solutions after staining. Attempts to reduce this non-specific fluorescent 
background resulted in an inability to clearly define positive and negative staining in droplets. In 
fact, the background fluorescence proved advantageous in some respects and was utilised to define 
droplet location. The transient ‘spiked’ peaks located on top of the background droplet signal 
correspond to the transit of a cell through the detection volume. Variation in the fluorescence 
intensity of such peaks was observed in both the green and red channels. This disparity is likely to 
be a consequence of a variable number of fluorophores being excited, which in turn is defined by a 
distribution of residence times of cells within the optical detection volume. 
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Figure 7.2 An example of fluorescence burst scan of 5 s traces recorded. Droplet signatures obtained from 
green and red channels are coincident and have almost the same height. Spiked peaks on top of the droplet 
signals signify the presence of cells. The inset illustrates an expanded 300-ms part of the main trace. The 
spiked peaks in the green and red channels represent stem cells and osteoblast cells, respectively. Co-incident 
events from both channels correspond to pre-osteoblast cells. 
7.3.2 Cell analysis 
All data originating from the droplet system were analysed using MatLab version R2007a 
(Mathworks, Cambridge, UK). The number of specific cells from each channel was counted to 
quantify each cell subpopulation of interest. MatLab algorithms, adapted from our previous work in 
single molecule and particle detection(262), were used to differentiate between background counts 
and droplet signatures to define droplet localisation. To determine single cell events, a threshold 
(Thr) was set using 2 standard deviations of the droplet mean height. This threshold is characterised 
as rectangular-shaped signal, as shown in Figure 7.3A. Accordingly, every peak above this 
threshold value was considered to originate from a single cell event. Due to the existence of 
autofluorescent proteins and molecules on and/or within cell membranes, the cell peaks observed 
were not solely representative of stained cells. Accordingly, appropriately matched-isotype control 
antibodies were used in parallel with positively stained cell samples to determine the level of 
background fluorescence and the number of unstained cells. The number of events calculated from 
the control samples was subtracted from the number of events originating from the stained samples 
to quantify the absolute numbers of stained cells in each subpopulation. Surprisingly, many ‘small’ 
peaks, having intensities just above the threshold, were observed in the positively stained samples 
and not in isotype control samples. These peaks will cause an error in the number of positive cells 
calculated in each subpopulation after subtraction. These small peaks are most likely due to 
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unbound antibodies left in solution and not a result of cell autofluorescence, since they were only 
found in stained samples. In addition, the stained cell peaks should be significantly higher than the 
threshold intensity. Consequently, a secondary threshold, namely ‘search above’ (SA), was 
established to allow discrimination of these small peaks. The SA value is defined according to, 
SA = Thr + 3/2Thr                         (7.1) 
By using this additional threshold parameter, only peaks above the SA value are called and defined 
as cell peaks. A probability distribution of cell occupancy (per droplet) is illustrated in Figure 7.3B. 
Under the flow rates operated and sample cell density, single cell occupancy per droplet was 
achieved. Specifically the instantaneous occupation probabilities are 75% (for an empty droplet), 
20% (for single occupancy) and 5% (for double occupancy). It should be noted that the cell 
occupancy in each droplet can be easily controlled by changing flow rates and cell loading. Data 
obtained from the current experiments were recorded over approximately 1000 droplets, which is 
enough for ensemble cell quantification. Additionally, average cell location within droplets was 
extracted from the temporal variation in fluorescence intensity. Inspection of Figure 7.3C illustrates 
that most cells are localised towards the front of a droplet (in the direction of flow). 
 
 
 
 
 
 
 
 
 
 
Figure 7.3 Cell characterisation. (a) An example of threshold setting in the green channel. A threshold was 
established above the droplet height to define cell peaks. The threshold was represented as rectangular-
shaped signal. (b, c) Probability distributions of cell occupancy per droplet and cell localisation within 
droplets, respectively. 
 
(a) 
(b) 
(c) 
Chapter 7: Identification of rare progenitor cells from human periosteal tissue using droplet microfluidics 
 
154 
7.3.3 Analysis of co-incident events 
To quantify each cell population (in terms of the relative proportion of progenitor cells, pre-
osteoblasts and osteoblasts), co-incident events between the green and red channels were evaluated. 
Co-incident peaks are defined by an exact temporal match between peaks in both green and red 
channels. If peaks are offset by more than 1 ms, they are not considered to be co-incident. An 
example of such co-incident data is shown in Figure 7.4. In this sample, 70 co-incident events were 
identified, indicating the number of preosteoblast cells possessing both ALP and Stro-1 markers 
(Stro-1+/ALP+) present. Subtraction of these co-incident events from the total number of cells 
called in the green and red channels provides the true number of only green and red cells, i.e. 
progenitor cells and osteoblasts, respectively. 
 
 
 
 
 
 
  
Figure 7.4 Co-incident events between green and red channels. The number of co-incident peaks denotes 
pre-osteoblast cell populations. 
 
7.3.4 Flow cytometry analysis 
When detecting rare cells within heterogeneous populations, it is crucial that one be able to 
objectively discriminate between true staining of cells by immunofluorescence methods and 
experimental staining artefacts, which includes dead cells, aggregates, non-specific staining, and 
autofluorescence. This is particularly important for flow cytometry-based methods where accuracy 
and interpretation of the results are defined in large part by the expertise of the user. Accordingly, 
numerous steps were taken to improve the accuracy and reproducibility of the analytical data 
relating to the cell populations under study. First, mouse serum was used to block non-specific Fc 
receptor binding sites present on the surfaces of cells, thereby reducing the number of false 
positives present in each analysis. Second, cell debris and staining aggregates were eliminated from 
further analysis based on their distinct light scattering characteristics (Figure 7.5A). Third, to 
Co-incident 
events 
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reduce high levels of autofluorescence exhibited by periosteal cells, the APD operating voltages 
were decreased so that >85% of the signals from the unstained cells appeared in the first decade of 
each fluorescence channel (Figure 7.5B).  Attempts to further decrease the voltage resulted in a 
significant reduction in instrument sensitivity and an inability to discern positive staining. Lastly, 
isotype controls matched to each primary mAb were used to set the gates used in determining the 
true proportions of cells positively expressing each antigen (Figure 7.5C). For each antibody or 
antibody combination, positive expression was defined as the percentage of stained cells with 
fluorescence levels ≥ 99% of the corresponding isotype-matched control antibody stained cells. 
 
Figure 7.5  Representative dot-plot histograms demonstrating the light scattering characteristics (A), 
autofluorecence (B), and immunoreactivity of isotype controls (C) and mAbs ALP and Stro-1 (D) with 
human periosteal cells derived from a 73 yr old female. Dual color flow cytometric analysis identified the 
presence of three distinct phenotypes (D), namely Stro-1+/ALP- (lower right gate), ALP+/Stro-1- (upper left 
gate), and Stro-1+/ALP+ (upper right gate). To determine the relative population size of each phenotype, 
>20,000 events were collected per sample and positive expression was set as the level fluorescence ≥99% of 
the isotype control (D).  
 
Flow cytometric analysis of periosteal cell light scattering characteristics revealed the presence of a 
heterogeneous mixture of cells with varying sizes (FSC) and granularity (SSC) (Figure 7.5A). This 
observation confirms previous cell characterisation studies in this thesis which detailed the 
presence of morphologically and phenotypically heterogeneous cell populations. The 
immunophenotypic analysis, presented here, revealed three distinct cell phenotypes based on the 
differential expression of antigens Stro-1 and ALP. A representative example of the gating schemes 
and resulting expression levels of each target phenotype present in periosteal cells derived from one 
donor is shown in Figure 7.5. Across all donors, periosteal cells demonstrated a heterogeneous 
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pattern of expression for both the Stro-1 and ALP antigens. The majority (>70%) of periosteal cells 
demonstrated no detectable levels of Stro-1 or ALP at the surface (Stro-1-/ALP-). A high proportion 
of the remaining periosteal cell populations expressed the osteoblastic maker ALP exclusively 
(14.1 ± 11.2%, mean ± SD), while only minor populations were found to express the Stro-1 antigen 
(3.4 ± 3.6%). While inter-donor variations in phenotype were found, this experimental set-up and 
gating system enabled us to objectively and reproducibly identify and enumerate distinct cell 
phenotypes in heterogeneous populations. This proves that flow cytometry provides an analytical 
platform to compare droplet microfluidics against.   
7.3.5 Droplet-based microfluidics versus flow cytometry 
To prove the accuracy and biological capability of the droplet-based microfluidic system, cell 
characterisation results from the microfluidic system were correlated with flow cytometry data. 
Phenotypic results were compared in periosteal cell cultures derived from 4 different donors aged 
31-73 yrs. For both analytical techniques the same sample population was used, so as to allow for 
direct comparison and reduce the likelihood of population differences. Comparative results are 
presented in Table 7.1, in which Stro-1+/ALP-, ALP+/Stro-1- and Stro-1+/ALP+ symbolise 
progenitor cells, osteoblasts and pre-osteoblasts respectively.  
Stro-1+/ALP-  
(% total)  
ALP+/Stro-1-  
(% total)  
Stro-1+/ALP+  
(% total) Donor 
FC Droplet  FC Droplet  FC Droplet 
31 yrs male 4.31 4.08  3.78 3.20  0.41 0.32 
73 yrs male 10.12 8.23  9.35 9.15  2.36 2.86 
32 yr male 0.70 0.75  13.71 13.80  0.50 0.57 
43 yrs female 0.29 0.38  29.64 30.43  n/a n/a 
Table 7.1 Identification of stage-specific cell phenotypes using flow cytometry and droplet microfluidics. 
Data are displatyed as percentages of total cell populations examined.  N/a = no measurements due to lack of 
cells. 
 
When comparing the results generated using flow cytometry (FC) with droplet-based microfluidics, 
we found that both systems detected almost identical expression levels of each phenotype in each 
donor. Similarly, these population percentages, particularly Stro-1+ cells, are consistent with 
expression levels measured in other stem cell sources; such as the trabecular bone explants, bone 
marrow, synovium, adipose tissue, and muscle (242;422;471). The small differences (± 1.9 %) 
noted in the expression levels between the two analytical techniques were most likely due to 
discrepancies between the user-defined gates and thresholds. Furthermore, the droplet-based 
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microfluidics approach was able to detect both minute and substantial donor dependent differences 
in each target phenotype; particularly the ALP+/Stro-1- population, which was expressed in <3% to 
>29% of the total population. This wide range in sensitivity is important to many biological based 
assays, which are reliant on the ability to detect both small- and large- scale changes in cell 
characteristics and functions. These include the identification of phenotypic changes in cells due to 
donor age, sex, and health, and cell culture microenvironment (226;359;368;376;386-388;472). 
7.4 Conclusion 
This study demonstrates that droplet-based microfluidics is an accurate and reproducible strategy to 
simultaneously isolate and detect typical (ALP+) and atypical (Stro-1+) cell types present in 
heterogeneous cell cultures. By controlling fluid streams in microchannels, we were able to 
compartmentalise single cells and direct droplet-laser interactions to measure cell surface 
properties. These data (measured for each individual cell) when correlated with other cell 
characteristics, allowed us to easily obtain information on how a targeted parameter is distributed 
in a cell population. Moreover, single-cell measurements performed using the droplet-based 
microfluidics platform were found to be in excellent agreement to results generated using 
conventional flow cytometry. This confirms the biological capacity of droplet-based microfluidics 
and further verifies this technology as an accurate and reliable alternative to flow cytometry-based 
assays for cell characterisation.  
For therapy development, droplet microfluidics represents a potentially fast and efficient clinical 
platform technology for purifying and further characterising heterogeneous populations. The ability 
to target cell surface markers expressed selectively by distinct cell types is particularly useful for 
the enrichment of stem cells, which are found to reside in a variety of tissues at extremely low copy 
numbers (e.g. about 0.01-0.001% of total bone marrow cells(163)). The isolation of rare cells is, of 
course, entirely dependent on their identification. Accordingly, this study is the very first step 
towards the development of a novel microfluidics-based cell-sorting platform. As shown here, 
droplet microfluidics provides a simple route to physically encapsulating and simultaneously 
characterising single-cells. Future experiments will now focus on the use of droplet-based 
microfluidic systems combined with external electric fields to safely and effectively separate viable 
cells from heterogeneous populations. This will define the next generation of high throughput 
single cell assays using droplet-based microfluidics. 
Ultimately, droplet microfluidics is a robust tool that has the potential to simplify complex 
biological processes so that we may better comprehend their interactions, functions, and role in 
biology.  Apart from stem cell research, this technology would be hugely useful in numerous 
application fields, including immunology, microbiology, parasitology, and oncology. 
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Chapter 8  
 
Dynamic Compressive Strain Influences 
Chondrogenic Gene Expression in Human 
Periosteal Cells 
 
8.1 Introduction 
Various tissue engineering and regenerative medicine strategies, have exploited the therapeutic 
potential of periosteal cells through use of tissue grafts (147;189), explants (190;362), or isolated 
cells with or without an associated 3D scaffold (30;186;201;473).  As shown in this thesis and 
previous studies, periosteal cells hold promise in osteochondral repair applications due to their ease 
of isolation, expansion potential in-vitro, and ability to differentiate into multiple mesenchymal 
lineages (160;295).  All these approaches would benefit from a thorough exploration and 
optimisation of the governing factors controlling periosteal cell osteogenesis and chondrogenesis. 
Periosteal cells play a role in the development and maintenance of the musculoskeletal system 
(47;395;474), including long-bone growth, bone fracture repair, and bone remodelling.  In 
embryonic and postnatal bone development, radial growth of long bones involves the direct 
conversion of mesenchymal precursor cells in the periosteum to osteoblasts (433;475;476).  In 
fracture healing, the periosteum is responsible for bridging the callus formation and participating in 
endochondral and intramembranous ossification (477;478). The migration, proliferation, and 
differentiation of periosteal precursor cells during these processes are coordinated by a variety of 
systemic, local, and mechanical factors.  The effects of systemic hormones (404;405;479;480) (e.g. 
growth hormone, parathyroid hormone, bisphosphonates, sex steroids) and local growth factors and 
cytokines (395;406;407;481;482) (e.g. FGF, TGF, BMP, IGF, VEGF, interleukins, tumour necrosis 
factor) on periosteal cell proliferation and differentiation have been well-studied and characterised 
both in-vivo and in-vitro. Mechanical control mechanisms over periosteum function, however, have 
received considerably less attention.   
In-vivo, it has been suggested that mechanical loading environment is a primary modulator of bone 
apposition rate (409;454;483) and secondary chondrogenesis (484) on periosteal surfaces during 
joint formation and post-natal growth.  Attempts to characterise the biological responses of the 
periosteum to mechanical loading have led researchers to develop small-animal models using 
externally applied loading devices (408;485-489).  By applying mechanical forces in-vivo, the 
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expression of a variety of osteogenic and chondrogenic genes in the periosteum can be induced 
(408;490) and rapidly transforms quiescent periosteal surfaces to those on which bone formation 
occurs (491).  Based on this link between local physical milieu and periosteum function in-vivo, it 
is speculated that mechanical forces could be used as a means to induce and control periosteal cell 
differentiation.  Based on experimental studies and corresponding finite element models of the 
bone repair process and articular cartilage development, Carter et al  proposed a mechanobiological 
theory that states low stresses and strains cause bone formation, hydrostatic compressive stresses 
stimulate chondrogenesis, and high tensile strains produce fibrous tissue in developing/regenerating 
skeletal tissues (279;409;492).  Indeed, previous studies have suggested that compressive loading 
regimes can stimulate chondrogenic differentiation of MSCs (297;493;494) and enhance cartilage-
specific matrix formation of differentiated chondrocytes (495-497). To date, however, there are no 
comparable studies published on the effects of mechanical stimulation on human periosteal cells in-
vitro. 
This study aims to determine whether compressive mechanical strains provide early chondro-
inductive effects in isolated human periosteal cells.  This required the development of a 3D culture 
system and determination of appropriate conditions for applying controlled external loading 
regimes.  Accordingly, expression patterns of early response genes will be examined in periosteal 
cells cultured in 3D agarose constructs under dynamic compression strain in the presence or 
absence of TGF-β.   
8.2 Materials and Methods 
8.2.1 Human periosteal cell culture 
For all optimisation and mechanical stimulation experiments, human periosteal cells were 
enzymatically isolated from periosteum explants and cultured in monolayer as described in detail in 
Chapter 5.  Briefly, explants were harvested from the proximal tibia of donors using a periosteal 
elevator, and transported in Earl’s Balanced Salt Solution (EBBS, Invitrogen, Paisley, UK) at 37 
°C. Explants were weighed, finely minced, and enzymatically digested in a collagenase solution 
consisting of 3 mg/ml collagenase D (Roche Applied Scienc, West Sussex, UK), 3 mg/ml 
collagenase type II (Sigma-Aldrich, Poole, UK), and 5 mM CaCl2 in growth medium (high glucose 
Dulbecco’s Modified Eagle Medium containing 10% v/v foetal bovine serum, 1% v/v L-glutamine, 
100 units/ml penicillin, 100 µg/ml streptomycin [all from Invitrogen, Paisley, UK]). After 
incubation at 37 °C for 4.5 hours, the cell suspension was washed, passed through a 70µm cell 
strainer (Falcon, Becton Dickinson, Oxford UK), and counted.  The cells were expanded in 
monolayer at the seeding density of 5000 cells/cm2 for up to 10 passages in growth medium.  Upon 
confluence periosteal cells were recovered from monolayer culture by enzymatic treatment with 
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0.25% (v/v) trypsin and 1mM EDTA and replated at the optimised density of 5000 cells/cm2 in a 
T75 flask containing 15 mls of growth medium.  Viable cell number was determined using trypan 
blue dye exclusion and a haemocytometer.  To examine the phenotypes present in each culture 
during expansion, periosteal cells were stained with monoclonal antibodies against Stro-1 and ALP 
and analysed using flow cytometry (for methodology see Chapter 5). All experiments were carried 
out using isolated periosteal cells serially expanded from passage 1-6 from 2 different donors. 
8.2.2 Preparation of periosteal cell-agarose constructs 
A 6% (w/v) low gelling temperature agarose (type VII; Sigma) solution was prepared in EBSS and 
sterilised by autoclaving. The agarose was then cooled to 37°C and an equal volume of a periosteal 
cell suspension was added to the agarose, to yield a final concentration of 3% (w/v) agarose.  To 
prepare 3-dimensional constructs, the cell/agarose suspension was added by Pasteur pipette to 
cylindrical wells of a stainless steel casting mould of 6 mm diameter and 4 mm depth.  This casting 
mould was bound at the top and bottom surfaces by glass slides and allowed to gel for 10 minutes 
at 4°C. 
8.2.3 Effect of seeding density on cell viability  
The effect of nutrient diffusivity on cellular viability was examined in order to mitigate the 
challenges associated with the preparation and culture of 3-dimensional cell-seeded constructs.  
This was done by comparing the effects of cell-seeding density on cellular viability.  Cellular 
constructs were produced as described above with final cell densities of 0.5, 2.0, and 8.0 x 106 
cells/ml in 3% (w/v) agarose.  The resultant constructs were washed 2X in EBSS and cultured flat 
in individual wells of a 24-well plate (Nunc; Fisher Scientific, Loughborough, UK) and supplied 
with 1 ml of growth medium.  The constructs were incubated in a humidified environment at 37°C 
and 5% CO2 for 10 days with media replacement every 2 days.  At days 2, 4, and 10, three 
constructs per density were removed from culture, sectioned vertically, and incubated for 1 hr at 
37°C with 5 µM calcein-AM and 5 µM ethidium homodimer-1 (Molecular Probes; Paisley, UK) in 
2 mls of complete media. The constructs were laid cut-side down on a cover slip and placed on a 
stage of an inverted fluorescent microscope (TE2000-S; Nikon Instruments, Surrey, UK.).  
Fluorescently stained cells were visualised using filter attachments allowing for the separation of 
green (live) and red (dead) cells.  A systematic sampling procedure, as described in a previous 
study (498), was adapted and applied to this microscope set-up.  Briefly, images were taken 
(Olympus DP70 Camera; Olympus Ltd, Middlesex, UK) in a continuous series running from the 
top to the base of the construct and the number of live and dead cells and a threshold was applied  
using Image J software to count cells.  The 0.875 x 0.660 mm sampling area was calibrated by a 1 
mm stage graticule as viewed under the 10x objective.  A minimum of 4 replicate sampling series 
were performed per specimen, with an n=3 per density per time-point.  The live-dead cell counts 
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were subsequently converted to percentage viability and the average viable percentages (mean ± 
SD) were determined for each density throughout the whole construct and peripheral and core 
regions.  To determine the influence of cell proliferation on viability and other results exploring the 
functionality of periosteal cells in agarose, total cell numbers were calculated per image across the 
depth of each construct.  These total cell numbers were used to assess cell proliferation and cell-
agarose homogeneity as a function of initial cell density, time in culture, and distance from the 
construct surface. 
8.2.4 Determination of optimum strain level 
To determine the optimal conditions for effective strain translation from mechanical apparatus to 
cells, cell constructs were subjected to a range of physiologic strains and the cell displacements 
measured.  Periosteal cell agarose constructs were produced with a final density of 2.0 x 106 
cells/ml in 3% (w/v) agarose.  Cell constructs were selected based on their integrity and were 
immediately incubated in a solution of Calcein-AM (5µM; Molecular Probes, Paisley,UK) and 
Hoechst 33258 (5 µM; Sigma, Poole, UK) prepared in PBS for 30 min at 37° C.  The constructs 
were then rinsed twice and left in PBS at 37° C until loading into the mechanical straining 
apparatus.  The test rig used in this study was previously designed at Queen Mary University 
London (QMUL) to facilitate the compression of individual cell-agarose specimens and to allow 
for the simultaneous visualisation of cells using an inverted microscope.  A schematic cross-section 
of the test rig is shown in Figure 8.1.  A cell-agarose construct was placed on a coverslip within the 
test rig and was kept hydrated in PBS throughout the experiment.  The rig was then mounted on the 
stage of an inverted fluorescent microscope and subjected to gross compressive loads. Compression 
was applied to the construct via a sliding platen attached to and controlled by a micrometer.  
Uniaxial, unconfined compressive strains of 1.0, 5.0, 10, 15, and 20% were applied statically and 
analysed using microscopy techniques. 
 
 
Figure 8.1 Schematic cross-section of the mechanical straining apparatus used to measure the translation 
applied to local strains in human periosteal cell-seeded agarose constructs. 
 
Cell nuclei within the cell-agarose specimen were visualised using fluorescence microscopy with a 
10x objective lens coupled to a lens extender (Nikon, UK). High-contrast images were recorded via 
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an Olympus DP070 digital camera and analysed using Olympus DP Controller software (Olympus 
Imaging, London, UK).  Prior to the application of compression, an image was captured of an 
easily distinguished cluster of cells in the construct.  Static compression was then applied 
sequentially from 0 to 20% strain by twisting the micrometer nob.  Two images were taken at each 
applied strain; one directly after the application of strain and one after the rough centring of the 
image.  This centring was done by sequentially moving the microscope stage to allow for the 
following and focusing of the same cell populations in the construct.  The subsequent images were 
manipulated and analysed using ImageJ software (NIH, Bethesda, MD).  Briefly, a threshold was 
applied to the image which allowed the cells to be outlined and assigned Cartesian coordinates 
(Appendix F).  After assigning coordinates, we were able to quantify cell displacements and stage 
translations to determine the local strains in the construct.    
8.2.5 Chondrogenic culture of cell-agarose constructs in static conditions 
Periosteal cell agarose constructs were produced as described above with a final density of 2.0 x 
106 cells/ml in 3% (w/v) agarose.  The periosteal cells used for this study were harvested from a 43 
year old female (donor 2) and cultured for two passages prior to gel encapsulation.  The cell-
agarose constructs were distributed, one per well, into a 24-well plate and bathed overnight in 1 ml 
of chondrogenic media, consisting of high glucose DMEM, 1µM dexamethasone, 1mM sodium 
pyruvate, 0.17 mM ascorbic acid-2-phosphate, 0.35 mM praline and ITS + premix (defined 
chondrogenic media without TGF-β3, Lonza, Slough, UK).  The following day, designated time 0, 
the constructs were bathed in 1 ml of chondrogenic media with or without 10 ng/ml TGF-β3 and 
incubated for periods of up to 16 days in static conditions.  Media replacement and TGF-β3 
supplementation were performed every other day.  Samples were taken at 0.5, 1, 2, 4, 8, and 16 
days for analysis of gene expression using real-time RT-PCR (n=3 per time point per condition).   
8.2.6 Intermittent dynamic mechanical stimulation of periosteal cell-
agarose constructs 
All mechanical stimulation experiments were performed at QMUL  and were set-up using methods 
described previously (297;298). Cell-seeded agarose constructs (3% w/v) with a cell density of 2.0 
x 106 cells/ml were prepared using periosteal cells derived from two different donors (32 year old 
male-Donor 1 and 43 year old female-Donor 2).  Constructs were incubated overnight in defined 
chondrogenic media in the absence of TGF-β3.  Individual constructs were arranged in the centre of 
each 24-well plate, and positioned within the custom made cell-straining apparatus (Zwick-Roel, 
Redditch, UK) (Figure 8.2A).  This apparatus was positioned into a custom made cell-straining rig 
and individual flat-ended indenters at the base of stainless steel pins platens were lowered onto the 
top surface of the cell-seeded constructs to provide a tare load of 0.028 N (Figure 8.2B).  A syringe 
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fitted with an angled gauge 22 needle was used to deliver 1 ml of defined chondrogenic media, 
with or without 10 ng/ml TGF-β3, into each of the wells.  Each mechanical experiment 
incorporated 12 constructs (6 unloaded + 6 dynamically loaded) which were bathed in control 
chondrogenic media without TGF-β3 supplementation and a further 12 constructs bathed in 
chondrogenic media with TGF-β3 supplementation.  In this context, there were 4 separate 
conditions per plate.  Experimental time course conditions were selected as 0.5, 1, 2, and 4 days, 
with or without dynamic compressive strain.  The assembled straining apparatus with cell-seeded 
constructs was transferred to an adapted incubator at 37 °C and 5% CO2, where the loading frame 
was secured to the loading actuator.  Dynamic unconfined compression with amplitude of 15% 
strain and frequency of 1 Hz was applied to the experimental constructs with repeated cycles of 
loading and recovery of 1.5 hours and 4.5 hours, respectively.  In this way, 4 complete 
loading/unloading cycles of 6 hours per 24 hour period were performed.  The medium in each 
condition was changed every 2 days.   
 
Figure 8.2 Schematic diagrams of the apparatus used to apply compressive strain to agarose-periosteal cell 
constructs (A) and locked and floating loading pins applying strains of 0% and 15% to loaded and control 
(unloaded) constructs (B). 
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8.2.7 Real time RT-PCR 
For gene expression experiments cellular RNA was extracted from cell-agarose constructs by 
incubating constructs for 10 min at RT in a modified agarose disruption buffer, consisting of a 
chaotropic salt buffer, Buffer QG, (Qiagen, UK) supplemented with 0.1% β-Mercaptoethanol.  The 
released RNA was then isolated, purified, and reverse transcribed into cDNA as done previously in 
monolayer cultures (Chapter 5).  Single-plex real-time RT-PCR reactions were carried out in 20 µl 
volumes containing 10 µl Taqman® universal mastermix (Applied Biosystems, CA, US), 7μl 0.1% 
v/v diethylpyrocarbonate (DEPC) water (Invitrogen Ltd, Paisley, UK), 2μl extracted cDNA and 1μl 
Taqman® probe (Applied Biosystems, CA, USA).  TaqMan® probes used to target genes are 
detailed in Table 8.1, and include Runx-2, Sox-9, bone-specific ALP, and collagen I, II, and X. 18S 
ribosomal RNA was used as a housekeeping gene. Each reaction was carried out in triplicate. The 
PCR reaction was initiated by a 2 minute 50˚C and a 10 minute 95˚C step to optimise thermal 
cycling conditions for the ABI Prism 7700 sequence detection system (Applied Biosystems, CA, 
USA) used to detect relative quantification of gene expression. This was followed by PCR 
amplifications performed for 40 cycles in a Corbett Rotor-Gene 6000 (Corbett Life Science, 
Sydney, Australia) at 95˚C for 15 seconds and 60˚C for 1 minute. A measurement of quantitative 
expression of target sequences, normalised to the abundance of the endogenous reference gene 
(18s) and expressed relative to day 0 control constructs was carried out using the –ΔΔCT  method, 
as previously described (414).  The target signal was plotted against the number of cycles and the 
threshold level was set at 0.05. Comparison of all data was taken at the intercept, where sample 
reactions crossed this phase of amplification.  No template and no-amplification controls were run 
to check for evidence of contaminating external and internal sources, respectively. Fold changes in 
gene expression are presented as mean ± SD change relative to day 0 control constructs.  
8.2.8 ICP analysis of metal dissolution ions 
The presence of metallic ions within cultures subjected to mechanical loading regimes was 
measured using inductively coupled plasma atomic emission spectroscopy (ICP-AES) (Varian 
Vista-Pro; Varian Scientific Instruments,Yarnton, UK).  After 1 and 4 days under intermittent 
mechanical loading, culture media was aspirated from the periosteal cell-agarose constructs and 
analysed for the presence of metallic ions Al, Fe, Cr, and Ni.  For analysis, 3 different media 
samples from each time point were diluted 1/10 with 2% nitric acid and the apparatus was 
calibrated with synthetic standards at concentrations 0-200 ppm. 
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Taqman™ gene probes (Applied Biosystems) 
Gene name Symbol Catalogue 
number 
Accession 
number 
Chromosome 
location 
Alkaline phosphatase ALP Hs00758162  NM000478 Chr. 1  
21,769,385 - 
21,772,879 
Collagen Type 1, alpha 1 COL1A1 Hs00164004 NM000088 Chr. 17 
45,632,113 - 
45,633,974 
Runt-related transcription 
factor 2 
Runx-2 Hs00298328 NM001015051 Chr. 6  
45,622,542 - 
45,626,797 
SRY (sex determining region-
y)-box 9 
Sox-9 Hs00165814 NM000346 Chr. 17 
67,630,455 -
67,634,156 
Collagen Type II, alpha 1 COL2A1 Hs00156568 NM001844 Chr. 12 
46,679,969- 
46,684,528 
Collagen Type X COL10A1 Hs00166657 NM000493 Chr. 6 
116,546,814- 
116,553,363 
Eukaryotic 18S rRNA 18s Hs99999901 X03205 
 
N/A 
Table 8.1 Taqman™ gene probes used in this study, with details of their sources and specificities. 
8.2.9 Statistics 
For cell viability and cell density measurements a Mann-Whitney U test was used to assess 
significance between data from the construct periphery and core across time.  Mann-Whitney U 
tests were also used to examine the differences in loaded and unloaded constructs in the absence or 
presence of TGF-β3.  In all cases, a level of 5% was considered statistically significant (*p ≤ 0.05).  
8.3 Results 
8.3.1 Encapsulation and culture of periosteal cells in agarose 
The encapsulation of periosteal cells in 3% (w/v) agarose resulted in a significant change in cell 
morphology.  Periosteal cells in monolayer exhibited spindle-shaped, and elongated fibroblastic 
phenotypes with long membrane extensions, whereas corresponding encapsulated cells were 
smaller and more rounded (Figure 8.3). 
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Figure 8.3 Phase contrast (A) and fluorescent imaging (B) of human periosteal cells (43 yr old female) in 
monolayer culture (A) and 3D agarose culture (B).  To visualise cells within the agarose gels, periosteal cells 
were stained with 5 µm Calcein-AM.  The images were taken prior to gel encapsulation (A) and 24 hours 
post encapsulation (B).  Scale bars = 200 µm 
 
At 24 hours post-cell encapsulation, periosteal cells in agarose exhibited significant increases in 
Runx-2, Sox-9, collagen I, and collagen X mRNA (Figure 8.4).  In particular, hypertrophic 
chondrocyte marker collagen X, increased 19.6-fold, osteogenic transcription factor Runx-2 
increased 9.5-fold, and chondrogenic transcription factor Sox-9 increased 4.6-fold.    
 
Figure 8.4 Real time RT-PCR quantification of Sox-9, Runx-2, ALP, Collagen X, and Collagen I gene 
expression for periosteal cells encapsulated in 3% (w/v) agarose and incubated for 24 hours in standard 
growth medium.  Fold changes in mRNA expression are expressed relative to patient matched monolayer 
cultured cells.  A Mann-Whitney U test was used to assess significant differences between gene expression 
levels in periosteal cells in monolayer and agarose gels (* p< 0.05). 
 
In 3D culture, encapsulated periosteal cells were well dispersed throughout the construct.  The cell 
encapsulation method used in this study resulted in a homogenous distribution of cells throughout 
the construct, independent of initial cell-seeding density.  During culture, no significant differences 
in absolute cell number or density were found between the core and periphery of the constructs of 
each seeding density (Figure 8.5).   
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Figure 8.5 Differences in cell density between the core and periphery of periosteal cell-constructs seeded at 
different densities and cultured over a period of 10 days.  The peripheral region represents the initial and final 
1/3 of the construct and the core region represents the central 1/3 of the construct.  Each value represents the 
mean ± standard deviation of 20 replicate samplings in each region for 3 constructs per seeding density.  No 
statistically significant differences in cell number were noted between the two construct regions for all 
seeding densities (Mann-Whitney U test, *p<0.05). 
 
 
Additionally, there were no significant changes in overall construct cell density over 10 days in 
culture at initial seeding densities of 0.5 and 2.0 x 106 cells/ml (Figure 8.6).  Constructs seeded at 
8.0 x 106 cells/ml experienced a significant decrease in cell density over 10 days in culture.  Under 
these static culture conditions, in the absence of local growth factors and mechanical stimuli, 
agarose embedded periosteal cells were found not to proliferate.  
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Figure 8.6 Average cell density in full-thickness constructs seeded at 0.5, 2.0, and 8.0 x 106 cells/ml and 
cultured for a period of 10 days.   Values are recorded as the mean viability ± standard deviation of 2D cross-
sectional scans across the whole of the construct (n=3).  Statistical differences in construct density over time 
are assessed at each seeding density using a Mann-Whitney U test was used (*p<0.05). 
 
8.3.2 Cell viability in 3% (w/v) agarose culture 
Periosteal cell viability profiles were analysed to determine the optimal seeding density for the 
established model parameters of 3% (w/v) agarose and 1 ml media changes.  Prior to seeding the 
constructs, post-trypsinisation viability exceeded 97%, as assessed by trypan blue dye exclusion 
assay, and was maintained at 1 day post-construct production.  During culture, however, there was 
a reduction in cell viability, particularly in the construct core, for all seeding densities.  A 
representative sequence of live-dead staining images are shown to highlight the spatial profile of 
viability across the thickness of cell constructs (Figure 8.7).  To statistically assess the spatial 
reduction in viability, construct data was dissected into peripheral and core regions based on 
distance from the construct surface (Figure 8.8).  The spatial decrease in viability from the 
periphery to the core of the constructs was found to be statistically significant within constructs 
seeded at low-density (500,000 cells/ml) at all time points (p<0.05).  However, these differences 
between construct regions were found to become less significant with increased cell-density.  
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Figure 8.7 Representative overlay of micrographs indicating fluorescently labelled viable cells (green) and 
nonviable cells (red) across a cell-seeded agarose construct (2.0 x 106 cells/ml) at day 10.  The corresponding 
graph indicates percentage viability versus position in the same construct. 
 
The average viability across the whole cell-construct was also calculated to determine the density-
dependent effects on viability during extended 3D culture (Figure 8.9).  After 4 days in culture, 
construct viability as a whole significantly decreased for each cell density examined.  In the case of 
constructs seeded at 500,000 cells/ml, the percentage of viable cells was found to further decrease 
from 4 (87.6 ± 5.5%) to 10 (82.4 ± 9.2%) days in culture.  Constructs seeded at 2 x 106 cells/ml 
maintained the greatest level of cell viability over the 10 day period (86.3 ± 5.5%), and were found 
to have statistically similar full-thickness viabilities at day 1 and day 10 in culture.   The temporal 
profiles for viability revealed greater rates of viability loss in constructs seeded at high (8.0 x 106 
cells/ml) and low (0.5 x 106 cells/ml) densities, as compared to the middle seeding density of  2 x 
106 cells/ml.   
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Figure 8.8 Spatial and temporal profiles throughout 3% (w/v) agarose constructs seeded with 0.5, 2.0, and 
8.0 x 106 periosteal cells/ml.  Profiles were determined on day 1 (open circles), day 4 (closed squares), and 
day 10 (open squares).  Individual data points represent the mean viability ± standard deviation of 3 
constructs with 2-4 replicates per construct. The depth of construct has been normalised such that 0 is the 
upper surface of the construct and 1 is the lower surface.  The bar graphs display the change in viability 
profiles in peripheral and core regions of constructs over time.  The peripheral region represents the initial 
and final 1/3 of the construct and the core region represents the central 1/3 of the construct.  Each value 
represents the mean ± standard deviation of 20 replicate samplings in each region.  Statistical significance 
was assessed between the two construct regions using a Mann-Whitney U test. (*p<0.05). 
 
For our model parameters, this data revealed that seeding density had a profound effect on the rate 
of full-thickness and core viability loss in periosteal cell-seeded agarose constructs.  Further, 
consistent cell density measurements of seeded-constructs over the 10 day culture period ruled out 
the influences of seeding density dependent cell distribution and cell division heterogeneities on 
spatial and temporal viability profiles. Thus, the mid-level seeding density of 2x106 cells/ml 
represented the critical seeding density necessary for maintaining the largest percentage of viable 
periosteal cells in the core and peripheral regions of cell-seeded 3% (w/v) agarose constructs whilst 
in culture.    
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Figure 8.9 Cell viability over 10 days within 3% (w/v) agarose constructs seeded with 0.5, 2.0, 8.0 x 106 
periosteal cells/ml.  Values are recorded as the mean viability ± standard deviation of the construct as a 
whole (n=3).  To statistically assess significant differences in construct viability within each seeding density 
over time, a Mann-Whitney U test was used.  (*p<0.05) 
8.3.3 Temporal profiles of gene expression in free-swelling agarose 
constructs 
The temporal profiles for osteogenic (Runx-2, ALP, and Col Ia1) and chondrogenic (Sox-9, Col 
IIa1, Col X) gene expression by periosteal cells in 3D agarose static culture are illustrated in 
Figures 8.10. For this study, periosteal cells were encapsulated in 3% (w/v) agarose at a density of 
2.0 x 106 cells/ml and were cultured in defined chondrogenic media in the absence or presence of 
TGF-β3 for a period of 16 days. In general, the addition of 10 ng/ml of TGF-β3 during culture was 
found to increase mRNA levels of each gene examined, as compared to untreated constructs (-
TGF-β3).  Peak expression levels of Sox-9, Col X, and Runx-2 were found at 16 days in the 
presence of TGF-β3. In the absence of TGF-β3, Runx-2, Col I, and Col X mRNA levels were 
upregulated after 12 hours in culture and subsequently decreased to levels similar to or below 
baseline day 0 control expression levels at 48 hours.  
Expression of osteoblast marker ALP progressively declined during culture in both TGF-β3 treated 
and untreated constructs (Figure 8.10).  Conversely, periosteal cells in agarose exhibited a 
progressive increase in hypertrophic chondrocyte marker, Col X, expression from 0.5 to 16 days in 
the presence of TGF-β3 (Figure 8.10). Periosteal cells exhibited transient up-regulation of 
transcription factors Runx-2 and Sox-9 and type I collagen during culture.  Peak collagen I mRNA 
levels were found at day 8, whereas Runx-2 and Sox-9 peaked at day 16, with fold increases of 3.5- 
and 26.5-fold respectively.  Importantly, Col II mRNA expression only became detectable in 
cultured constructs at day 16 in the presence of TGF-β3.  Collagen II data was not shown on graphs 
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due to an inability to express Day 16 mRNA levels relative to day 0 control samples, which 
expressed negligible levels of  mRNA. 
 
Figure 8.10 The relative gene expression of Sox-9 (A), Collagen Type X (B), Runx-2 (C), ALP (D), and 
Collagen Type I (E) in periosteal cell-agarose constructs cultured for a 16 day culture period in chondrogenic 
media with or without 10 ng/ml TGF-β3.  Expression levels are normalised to internal housekeeping gene 18s 
and data are presented relative to day 0 expression levels (>1 = increase and <1 = decrease in expression). 
Each value represents the mean ± SD of 3 constructs.   
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8.3.4 Validation for cell-construct straining 
Prior to studying the effects of mechanical stimulation on periosteal cell differentiation, the 
effective translation of external applied strains into the local cellular environment needed to be 
validated in this agarose culture system.  For this, a previously designed mechanical testing system 
(QMUL) was adapted to microscopically visualise cell displacements within cell seeded-agarose 
constructs subjected series of compressive strains.  Figure 8.11 displays the results of overall cell 
displacement from a common origin versus the distance away from the moving platen at five 
different physiologically relevant applied strain levels.  
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Figure 8.11 Cell displacement versus distance from moving platen for periosteal cells in agarose constructs 
at 5 different applied compressive strains (1.0%, 5.0%, 10.0%, 15.0%, and 20.0%).  Linear fits were used to 
find the slopes at each applied strain rate. The slope of the line indicates the average local strain that the 
periosteal cells experienced inside the agarose construct.  
 
This graph shows a trend of higher displacements near the moving interface with the platen, 
decreasing as we move towards the centre of the specimen, as evidenced by the negative slopes.  
These localised strain concentrations are suggestive of physically and mechanically heterogeneous 
constructs exhibiting properties of a viscoelastic material.  This result is in support of the fact that 
tissue strain in response to an applied load is greatest in the superficial regions (499). Based on the 
slopes of the cell displacement data (Figure 8.11), corresponding local cellular strain for each 
applied external strain were plotted (Figure 8.12).  Figure 8.12, revealed that increases in applied 
strain resulted in increases in local cell strain in the construct after a strain level of ~5.0%.  Thus 
5.0% strain represented a threshold value, exceeding which, allowed for a near linear translation of 
strain until the construct’s physical integrity began to be compromised (≥ 19.0%).  At strain levels 
Chapter 8: Dynamic compressive strain influences chondrogenic gene expression in human periosteal cells 
 
174 
of 10.0 and 15.0% the ratio of local strain to gross applied strain were found to be 0.9 and 1.01, 
respectively, resulting in near-perfect translation of mechanical strains to the cellular environment.  
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Figure 8.12 Local strain versus applied strain for a randomly selected area in periosteal explant-agarose 
constructs.  This graph shows an initial non-linear toe region, followed by a near-linear increase as gross 
strain is increased.  At ~19% the physical integrity of the construct becomes compromised and results in local 
strain levels exceeding applied levels. In this graph 15.0% applied strain is seen as the ideal strain level in 
this culture model. 
 
 
This non-linearity noticed in the strain translation, resembles strain profiles of other viscoelastic 
biological materials such as ligaments, arterial walls, and skin (35). In this culture system, agarose 
chain entanglements result in a linear elastic effect, and fluid streams from the media absorbed in 
and surrounding the construct result in a non-linear viscous effect.  Additionally, linear deviations 
could arise from the fact that we are trying to analyse cell displacements in one-direction, using 2-
dimensional images, of a 3-dimensional environment. Since we are working with a 3-dimensional 
construct, with viscoelastic properties, the cells can not be expected to serially move in one 
direction.   
Importantly, the 3% (w/v) agarose gel allowed for direct translation of gross, applied, strains into 
the cellular construct at a strain level of 15%.  The optimisation and validation of this periosteal 
cell-agarose culture model in a mechanical environment was a critical step for the investigation of 
mechanical stimulation on periosteal cell differentiation.  
8.3.5 Influence of dynamic stimulation on periosteal gene expression in 
agarose constructs 
Periosteal cells harvested from two different donors (32 year old male and 43 year old female) were 
encapsulated in 3% (w/v) agarose at densities of 2.0 x 106 cells/ml and subjected to intermittent 
dynamic compressive strains of 15.0% for periods of up to 4 days.  All constructs remained intact 
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throughout the in-vitro dynamic mechanical stimulation procedure.  Total RNA was successfully 
isolated from cells embedded in agarose constructs, quantified (ng/µl), and analysed for purity by 
ratio measurement of absorbances for nucleic acid (A260) against protein (A280).  The average 
absorbance ratio (A260/ A280) of isolated RNA from periosteal cell-constructs was 2.08 ± 0.11.  This 
average absorbance ratio falls within the range of values for pure RNA (A260/ A280 = 1.9-2.1) and 
demonstrated that RNA preparations were free of contaminating proteins, DNA, and other cellular 
material. 
To determine the effects of mechanical stimulation on periosteal cells, constructs were exposed to 
intermittent stimulation blocks of 1.5 hrs loading followed by 4.5 hrs unloading for initial durations 
of 12, 24, and 48 hours in chondrogenic media with or without TGF-β3. At a loading frequency of 1 
Hz, this translated to construct loading cycles of 10800, 21600, and 43200 at 12, 24, and 48 hours 
respectively. Quantitative, real-time RT-PCR analysed the expression of early transcription factors 
Sox-9 and Runx-2 for each experimental condition (loaded + TGF-β3, unloaded +TGF-β3, loaded -
TGF-β3, loaded -TGF-β3) at each time point in each donor. In each case (n=6 per condition per time 
point), mRNA expression levels were normalized to individual sample 18s ribosomal RNA and 
displayed relative to day 0 control periosteal cell constructs.   
The effects of dynamic compression varied greatly between medium conditions, genes, and donor. 
Overall, Runx2 and Sox9 gene expressions were highest in constructs treated with TGF-β3 and 
subjected to intermittent compressive strains over a period of 24 hours (Figure 8.13).  RT-PCR 
analysis performed on loaded and unloaded cell constructs from both patients demonstrated 
significant increases in Sox-9 and Runx-2 expression with the addition of TGF-β3 at all time points 
as compared to untreated (-TGF-β3) constructs (Table 8.2).  In both donors, the largest TGF-β3 
induced increases in gene expression were found to occur at 24 hours of culture.  The effects of 
mechanical loading on periosteal cell gene expression levels, however, were found to be much 
more donor dependent.  
In periosteal cell-constructs derived from donor 1 (32 year old male), loading did not have a 
positive effect on Sox-9 or Runx-2 mRNA levels compared to unloaded constructs at all time 
points.  In the absence of TGF-β3, periosteal cells responded to mechanical compression by 
significantly down-regulating Sox-9 expression at 12 (1.6-fold ↓) and 48 (1.7-fold ↓) hours.  A 
similar decrease (1.6-fold) was found in Runx-2 expression after 48 hours of loading in constructs 
treated with TGF-β3. 
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Figure 8.13 The relative gene expression of Sox-9 (A and C) and Runx-2 (B and D) by human periosteal 
cells encapsulated in 3% (w/v) agarose subjected to 15% intermittent dynamic compression at 1Hz for 12, 24, 
and 48 hours, in chondrogenic medium with or without 10 ng/ml of TGF-β3.  Expression levels are presented 
from periosteal cells derived from 2 different donors; 32 year old male (A and B) and 43 year old female (C 
and D).  For each condition mRNA levels have been normalized to endogenous 18s rRNA levels and are 
expressed as the mean ± SD relative to day 0 control constructs.  Non-parametric Mann-Whitney U tests 
were used to assess significant differences between loaded and unloaded constructs (*p≤ 0.05). 
 
Conversely, periosteal cells from donor 2 (43 year old female), were much more responsive to 
compressive loading cycles (Figure 8.13).  In general, constructs responded to mechanical loading 
by up-regulating Sox-9 expression. In cultures without TGF-β3, loading regimes of 12 and 24 hours 
significantly up-regulated the expression of Sox-9 compared to unloaded constructs.  Oppositely, 
Runx2 mRNA levels in loaded and unloaded constructs cultured without TGF-β3 were found to be 
statistically similar at all time points.  Importantly, in this donor the addition of TGF-β3 
significantly changed the mechanoresponsive behavior of the cells (Table 8.2).  The combined 
effects of loading and TGF-β3 on gene expression levels are demonstrated at all time points for 
both genes of interest. In particular, Sox-9 mRNA levels in periosteal cells were increased by 4.0-, 
59.0-, and 4.0-fold, respectively, following loading for 12, 24, and 48 hours in the presence of 
TGF-β3.  These levels were significantly higher than levels found in unloaded constructs (p< 0.05).  
A synergistic effect was also seen in Runx-2 expression levels in constructs subjected to loading in 
the presence of TGF-β3. 
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Presence of TGF-β3 Donor Gene of 
interest Unloaded Loaded (1 Hz) 
1 (32-m)  12 hrs 24 hrs 48 hrs 96 hrs 12 hrs 24 hrs 48 hrs 96 hrs 
 Sox-9 1.7↑ 4.7↑* 1.7↑*  2.4↑* 5.0↑* 2.4↑*  
 Runx-2 3.7↑* 6.6↑* 6.3↑*  3.3↑* 9.8↑* 5.3↑*  
2 (43-f)          
 Sox-9 1.3↑ 7.0↑* 1.3↓ 1.1↓ 2.2↑* 22.1↑* 6.0↑* 1.5↑ 
 Runx-2 2.6↑* 3.8↑* 1.1↓ 3.1↑* 4.2↑* 11.9↑* 4.7↑* 3.9↑* 
Table 8.2 Trends in gene regulation with the addition of TGF-β3 in the presence or absence of intermittent 
dynamic compression at 12, 24, 48, and 96 hours in periosteal cells derived from two different patients.  
Numbers represent fold increase or decrease in gene expression as compared to corresponding constructs 
without TGF-β3 under similar loading conditions.  *Indicates statistical significance (p ≤ 0.05). 
 
To determine the effects of more prolonged exposure to mechanical compression, periosteal cells 
from donor 2, were dynamically loaded for a period of 4 days (86,400 loading cycles) under 
identical conditions to the previous studies.  RT-PCR analysis revealed no additional increase in 
mRNA levels in constructs mechanically stimulated over a period of 4 days (Figure 7.14).  Loaded 
constructs with and without TGF-β3 demonstrated no significant differences in Sox-9 or Runx-2 
mRNA expression compared to corresponding unloaded constructs.  In the absence of TGF-β3, the 
mRNA levels of both genes were found to be similar to day 0 expression levels.  Supplementation 
with TGF-β3 increased Runx-2 expression 5.3- and 4.7-fold in unloaded and loaded constructs 
respectively (Figure 8.14).  Comparatively, TGF-β3 had no effect on Sox-9 mRNA levels at day 4 
(Table 8.2). 
 
Figure 8.14 The relative gene expression of Sox-9 (A) and Runx-2 (B) by donor 2 human periosteal cells 
encapsulated in 3% (w/v) agarose subjected to 15% intermittent dynamic compression at 1Hz for 4 days, in 
chondrogenic medium with or without 10 ng/ml of TGF-β3.  For each condition mRNA levels have been 
normalized to endogenous 18s rRNA levels and are expressed as the mean ± SD relative to day 0 control 
constructs.  Non-parametric Mann-Whitney U tests were used to assess significant differences between 
loaded and unloaded constructs (*p≤ 0.05) 
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8.3.6 Metallic ion dissolution 
The constant contact between the metal loading pins and cellular environment during construct 
loading led us to look at the presence of metallic ions within the culture media.  It is well known 
that metallic dissolution ions will influence the behaviour of bone cells, by significantly altering 
cellular metabolism and differentiation (500;501).  The presence of metal analytes Cr, Fe, Ni, and 
Al were therefore examined in the culture media to identify their presence and elucidate their 
potential influence on periosteal cell gene expression patterns.  ICP-AES analysis revealed no 
detectable levels of Cr, Fe, Ni, or Al ions in any of the culture samples examined at both 1 and 4 
days under loading (data not shown).  This result eliminates the potential role that stainless steel or 
aluminium corrosion elements or dissolution ions may have on the results obtained from 
mechanical loading studies performed in this chapter. 
8.4 Discussion 
In this study, a model system in which human periosteal cells were embedded in agarose was 
developed and optimised to assess whether periosteal cell gene expression profiles are influenced 
by the application of mechanical strains.  Although in-vitro culture systems are inherently non-
physiological, the agarose-cell culture model is ideally suited for this study.  This system allows for 
the simple and reproducible capacity to apply physiological levels of strain to cells whilst 
maintaining cell viability and phenotypic stability.  Intermittent dynamic strains were applied to 
periosteal cell-agarose constructs using a specially designed loading apparatus.  However, due to 
design constraints associated with the straining apparatus, a number of design parameters had to 
first be optimised for this culture model, including construct seeding density, applied strain level, 
loading duration, and frequency.  
The clinical and experimental success of any 3D cellular construct is dependent on the maintenance 
of cell viability throughout its entirety. Furthermore, to study the influence of mechanical 
stimulation on periosteal cell behaviour the cells must continue to be metabolically active and 
retain the ability to respond to the external environment. The restriction of cell viability and ECM 
formation to the periphery of 3D tissue-engineered constructs is frequently observed.  This 
phenomenon can be attributed to a number of factors including a non-homogenous cell distribution 
and/or insufficient transfer of nutrients to the centre of the construct (498;502).  The latter of which 
is directly influenced by initial cell seeding density, hydrogel density, and medium volume (498).  
An agarose density of 3% (w/v) was selected based on its capacity to permit optimal strain 
translation whilst allowing for efficient nutrient diffusion to cells.  Medium volume, however, was 
limited to 1 ml based on the design of the mechanical straining apparatus.  Therefore, to establish 
the optimal culture parameters for sustained cell viability throughout the full construct, 3 different 
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cell-seeding densities (low, medium, and high) were examined.  In agreement with reports of other 
authors (297;498), loss of periosteal cell viability was observed at the centre of 3D constructs 
(Figure 8.8).    The decrease in core viability was inversely related to initial seeding density, with 
constructs seeded at 500,000 cells/ml demonstrating significant reductions in core viability during 
culture.  This loss of viable cells across the agarose constructs can be attributed in part to 
inadequate mass transfer of key nutrients to the cells at the center of the construct. Similarly, cell 
density had an effect on cell viability during the 10 day culture period.  However, periosteal cell 
viability reductions (2-15% during 10 day culture period) were not as profound as decreases seen in 
mesenchymal stem cell- (~10-30%) and chondrocyte- (~2-70%) seeded hydrogels (297;498). 
Indeed, average periosteal cell viability levels remained >75% during culture for all densities 
examined.  However, for our model parameters 2 x 106 cells/ml represented the optimal seeding 
density for sustained periosteal cell viability during in-vitro culture.   
Critically, cell density calculations performed on periosteal cell constructs during culture revealed; 
(1) a homogenous distribution of cells throughout the construct thickness regardless of cell seeding 
density and (2) agarose encapsulated periosteal cells did not actively proliferate during 10 days in 
culture.  In the context of this study, these two observations are significant, as heterogenous cell 
distributions due to seeding method and/or cell proliferation can lead to considerable construct-
construct variations which can ultimately affect experimental outcomes.  
The level of gross strain used (15%) resulted in local cell strain values of approximately 15%, 
which lies in the 0-30% physiological range of cell strains found in intact cartilage subjected to 
physiologic loads (499;503).  This is in support of previous studies which found that compression 
of cell/agarose constructs caused cell strains of approximately the same magnitude as that applied 
to the agarose (504;505).  Further, Lee and Guilak found that local cell strains of 15% resulted in 
changes to cell area and nuclear deformation, prior to increases in proteoglycan and collagen 
production in chondrocyte constructs (504;506).  Deformations at the cellular and subcellular level 
lead to intracellular signalling events that finally lead to altered effector-cell response.  It is through 
these mechanotransduction pathways that we aimed to induce and study periosteal cell 
chondrogenesis at the molecular level.  Previous in-vitro loading studies using cell and explant 
culture models have demonstrated that the method of application, as well as the duration, 
frequency, and duty cycle of loading can influence genetic and biosynthetic response (496;507-
510). 
The loading frequency of 1 Hz was selected based on the viscoelastic properties of agarose and 
results of previous chondrocyte loading studies, where frequency-dependent matrix metabolism 
was noted (496;511).  Due to the viscoelastic nature of agarose, dynamic loading regimes result in 
both dynamic and increasing (cumulative) compressive strain components [unpublished results of 
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QMUL researchers and (511)].  Cumulative displacement (analogous to creep strain under static 
loading conditions) is defined as the portion of starting thickness not recovered upon return to 
minimum applied stress.  Importantly, low loading frequencies (<0.33 Hz) result in significantly 
higher cumulative strain components which are known to have an inhibitory effect on chondrocyte 
differentiation and chondrogenesis (512). Conversely, reduced cumulative strains were found in 
chondrocyte constructs and explants loaded at higher physiologically relevant frequencies (0.4-1.0 
Hz) and resulted in enhanced matrix production and chondrogenic gene expression levels 
(496;513).  Lee and Bader found that 15% dynamic compression of chondrocytes embedded in 
agarose was inhibitory at 0.3 Hz, stimulatory at 1 Hz, and did not change proteoglycan synthesis at 
3 Hz (496).   
In the second phase of this work, chondrogenic differentiation was initiated in free-swelling 
agarose cultures.  Prior to chondrogenic induction, the encapsulation of periosteal cells in agarose 
gels caused a change in morphology, which coincided with a significant up-regulation in Sox-9, 
Runx-2, and Coll I and X (Figure 8.4). Previous studies have reported phenotypic modulation 
caused by an enforced spherical morphology within hydrogels.  For example, Coll II and aggrecan 
gene expression was less evident in marrow stromal cells cultured in collagen gels where cells 
could assume a more stellate morphology, as opposed to alginate and agarose hydrogels (514).  
Although the mechanism behind this change in periosteal gene expression was not explored here, 
Hardingham et al. found that cell rounding in alginate gels, causes cytoskeletal reorganisation 
which leads to induction of Sox-9 expression through the p38 MAPK stress-activated protein 
kinase signalling pathway (515). 
Chondrogenic differentiation was induced through TGF-β and dexamethasone supplementation, as 
described in previous bone marrow stromal cell cultures (241;297;516).  In periosteal cell-
constructs treated with TGF-β3 the expression of transcription factors Runx-2 and Sox-9, and Col I 
and X all increased over the 16 day culture period as compared to day 0 controls (Figure 8.10).  
Increased expression of Coll I is a feature common with the early stages of chondrogenesis, where 
mesenchymal precursor cells produce type I collagen (517). The occurrence and accumulation of 
Coll X mRNA over the 16 day period would tend to indicate differentiation toward the 
hypertrophic phenotype.  The corresponding levels of Runx-2 and ALP found during culture would 
, however, suggest that cells are present as a pre-hypertrophic phenotype at day 16.  Runx-2 serves 
as a positive regulatory factor in chondrocyte maturation to hypertrophic phenotype and is 
expressed mainly in pre-hypertrophic and less in late hypertrophic phenotypes (518).  Similarly, 
increased ALP expression, not seen in this study, usually accompanies Coll X up-regulation during 
the late phases of chondrocyte hypertrophy (518). This pre-hypertrophic expression pattern 
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analysed here correlates with previous human mesenchymal stem cell studies that report the up-
regulation of collagens type I and X during the early stages of chondrogenesis (519-521). 
Additionally, the presence of pre-hypertrophic phenotypes in periosteal cell-constructs during free-
swelling culture was further substantiated by the heightened expression levels of both Runx-2 and 
Sox-9 at day 16.  Both transcription factors are highly expressed in osteochondroprogenitor cells 
and pre-hypertrophic chondrocytes.  Sox-9, however, is dominant over Runx-2 function, acting as a 
transcriptional repressor for osteoblast differentiation (522).  In this context, the 3-fold increase in 
Sox-9 expression compared to Runx-2 levels at day 16 suggests that cultures are progressing down 
the chondrogenic lineage.  In agreement with this, Hardingham et al demonstrated, in retroviral 
transduction studies, the importance of Sox-9 expression for maintaining a chondrogenic phenotype 
and promoting cartilage matrix production (520;523).  Indeed, a change is noticed in collagen 
expression at day 16. Coll I expression levels which peaked at day 8 were found to decline at day 
16.  Accordingly, Coll II mRNA became detectable at day 16.   This apparent switch in collagen 
expression suggests that day 16 represents the beginning of the next phase of chondrogenesis, 
namely chondrocyte differentiation (517). Longer culture studies, however, are needed to examine 
the complete temporal expression profile of periosteal cells during chondrogenesis and to compare 
this marker pattern to what is seen in-vivo (524).  Importantly, the results shown in this study, 
demonstrate the capacity of this agarose culture model to support chondrogenic phenotypes during 
periosteal cell chondrogenesis and supports similar results reported previously (525). 
The in-vitro culture and loading conditions, detailed above, permitted mechanical stimulation to be 
applied to periosteal cells with precise control and reproducibility.  Interval-based loading was 
based on the enhanced effects of intermittent compressive loading regimes on metabolic activity 
and extracellular matrix production in chondrocytes and cartilage explants compared to static 
loading (507;526-528).  Further, chondrogenic differentiation  has been demonstrated in MSC 
constructs under dynamic compressive loading conditions (297;493;494;509). 
Extending upon these studies, we aimed to impose a new level of control over the differentiation 
potential of human periosteal cells through the combined use of biomechanical and biochemical 
stimuli.  This study represents a necessary first step towards this aim, by providing an initial proof-
of-purpose detailing the effects of short-term dynamic mechanical loading regimes on periosteal 
cell phenotype. For this purpose the expression levels of two important early transcription factors, 
Runx-2 and Sox-9, were examined in periosteal cells subjected to different loading cycles and 
culture conditions for periods of up to 4 days.  The application of dynamic compressive strains at 
15%, 1.0 Hz resulted in a donor-dependent response in human periosteal cells.  In cells from donor 
1, loading had a negative effect on Runx-2 and Sox-9 expression, as demonstrated by decreased 
mRNA levels compared to unloaded constructs at nearly all time points.  Conversely, in donor 2 
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cells, loading significantly increased gene expression levels, particularly in the presence of TGF-β3.  
Utilising an intermittent dynamic compression profile, of 1.5 hours loading/4.5 hours unloading, 
we were able to establish a short-term temporal response profile over a period of 4 days.  It is well 
known that the duration of loading and the number of loading cycles applied play a role in the 
downstream response of cells  (507;509;529).  In particular, periodic applications of low pressure 
dynamic fluid pressures at 4 hours/day enhanced cartilage formation in periosteal explants (510). 
Similarly, we found that periosteal cell reponse to dynamic compressive strains was dependent on 
the schedule of loading.  In responsive constructs (43-f), expression levels peaked in the presence 
of TGF-β3 at 24 hours, which consisted of 2 separate loading blocks of 1.5 hours (5400 cycles).  
This peak in expression was much more evident in the profile of Sox-9 mRNA, which 
demonstrated a 59-fold increase at 24 hours.  The profile of Runx-2 expression under each 
condition, however, remained relatively consistent over the 4 day study.  Notably, in periosteal 
cells from donor 2, significant increases in Sox-9 mRNA levels occurred in the absence of TGF-β3, 
suggesting that mechanical signals alone may be enough to begin induction of chondrogenesis.  To 
confirm this, longer loading studies (≥ 2 weeks) with more donor populations are needed to 
examine the production of Coll II and aggrecan.  Miyanishi et al (494), for example, only detected 
an increase in Coll II and aggrecan after 14 days in human MSCs undergoing loading without the 
addition of TGF-β3. 
In agreement with results from free-swelling constructs, TGF-β3 treatment alone was found to 
increase expression levels of Runx-2 and Sox-9 mRNA in periosteal cells from both donors.  In 
donor 2 cells, however, the combination of mechanical stimulation and TGF-β3 was found to 
significantly up-regulate mRNA levels at all time points compared to either factor alone. This is 
particularly evident at 24 hours, where a 59-fold increase was seen in loaded constructs treated with 
TGF-β3, compared to loading (2.7-fold ↑) and TGF-β3 treatment (7.7-fold ↑) alone.  The synergistic 
effects of mechanical stimulation and TGF-β treatment are consistent with recent studies.  In the 
presence of TGF-β and cyclic compressive strains (10%), Terraciano et al. demonstrated increased 
chondrogenic differentiation and cartilage-related matrix production in human MSCs after 14 days 
of exposure (299). Similarly, Huang et al. found an increase in TGF-β receptor gene expression of 
rabbit MSCs after 1 hour of stimulation, which contributes to a greater amount of TGF-β binding 
(529).  
The interactions between TGF-β signalling and mechanical stimulation could be due to a wide 
range of potential mechanisms.  Stimulated TGF-β signalling pathways could modulate 
mechanotransduction either directly or indirectly by increasing the sensitivity of periosteal cells to 
loading.  For example, TGF-β treatment may lead to the activation of mechanoosensitive proteins, 
such as focal adhesion kinase and paxillin, which might increase the mechanosensitivity of the cells 
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(530;531).  Alternatively, downstream targets of TGF-β signalling may be necessary components 
of mechanotransduction in periosteal cells.  TGF-β has been shown to up-regulate Sox-9 gene 
expression in differentiating periosteal cells (Figure 7.10 and 7.13) and is known to modulate 
periosteal chondrogenesis (481;532;533).  Prior to matrix deposition in the cartilage anlagen, 
nuclear transcription factor Sox-9 promotes the expression of the type II collagen and aggrecan 
mRNA by binding with the promoter of type II collagen and aggrecan genes (534;535).  Thus by 
increasing transcription of downstream targets of mechanical stimulation, TGF-β signalling may 
indirectly amplify the effects of mechanotransduction.   
Conversely, mechanical stimulation may modulate TGF-β signalling.  One mechanism may involve 
the production of TGF-β or its receptors through upregulation of mRNA expression by mechnical 
loading.  Raab-Cullen et al found that in-vivo controlled four-point bending promoted c-fos and 
TGF-β mRNA in rat periosteum within 4 hours of loading (490). In addition, Huang et al found 
that dynamic compressive loading promoted gene expression and protein production of both TGF-β 
receptors (TβR-I and II) in rabbit-MSCs in agarose (529). This is important because TGF-β 
receptor 1 can initiate intracellular TGF-β signal transduction after phosphorylation (536), which 
may mediate chondrogenic differentiation of chondroprogenitor cells and mesenchymal stem cells 
(537) 
 Although both TGF-β treatment and physical strain represent strong transcriptional stimuli for 
early chondrogenic differentiation in periosteal cells cultured in agarose, this response is markedly 
donor dependent.  Similar donor-to-donor variability was also seen in the molecular response of 
human mesenchymal stem cells subjected to dynamic strains (538).  In general, the intrinsic 
heterogeneity of periosteal cells, in terms of lineage hierarchy and differentiation potential, 
represents a major challenge towards studying their cellular responses.  As shown in this thesis  and 
previous studies, differentiation processes in human periosteal cultures are not sychronised 
throughout the cell populations (160;295).  In fact, phenotypic and genotypic analysis of periosteal 
cells and other adult stem cell cultures suggest that early differentiation may be regulated, at least 
in-vitro, by stochastic mechanisms (539;540). This is thought to represent the developmental 
flexibility found in undifferentiated stem cells, which is lost during the commitment to more 
mature phenotypic state.   
To elucidate if donor-dependent responses to loading were due to differences in population 
phenotypes, an immunophenotypic analysis was performed on cells from both donors (For 
methodology see Chapter 5).  Flow cytometry, however, did not reveal any significant differences 
in the number of progenitor cell (Stro-1+/ALP-), preosteoblast (ALP+/Stro-1+), or osteoblast 
(ALP+/Stro-1+) phenotypes present in periosteal cell cultures from both donors (Table 8.3).   
Although we were unable to establish a relationship between cell phenotype and molecular 
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response to loading, further attempts should be made to understand the effects of loading at 
different stages of periosteal progenitor differentiation.  This information, for example, could be 
used for the development of pre-treatment regimes for cultured cells prior to introduction into 
cartilage defects. 
Phenotype Profile ( mean ± SD % of total population) 
Donor Stro-1+/ALP- 
progenitor cells 
ALP+/Stro-1- 
osteoblasts 
Stro-1+/ALP+   
pre-osteoblasts 
Donor 1 (32-m) 3.3 ± 1.9 36.1 ± 14.4 4.7 ± 2.2 
Donor 2 (43-f) 2.9 ± 0.8 45.2 ± 11.5 3.6 ± 2.5 
Table 8.3 Immunophenotypic profile of human periosteal cells from the two donors used in this study.  
Monoclonal antibodies against Stro-1 and ALP and flow cytometry were used to examine the relative sizes of 
3 developmentally distinct cell populations present in human periosteal cell cultures.  A two-tailed Student t 
test was used to assess significant differences in population phenotypes between the two donors (*p ≤ 0.05). 
No significant differences were found. 
 
8.5 Conclusion 
In conclusion, a periosteal cell-agarose culture model has been successfully developed and 
optimised, allowing for the study of cell differentiation in a biomechanical environment.  This 
study demonstrated temporal expression patterns of early response genes (Sox-9 and Runx-2) in 
human periosteal cells under dynamic compressive loading. Based on the significant up-regulation 
of Sox-9, the application of 15% dynamic compressive strain was found to promote early 
chondrogenic differentiation in human periosteal cells in-vitro.  This chondrogenic effect was 
dependent upon the applied temporal loading profile, complex interaction between TGF-β3 and 
dynamic loading, and donor.  This established model can now be used to elucidate the specific 
mechanotransduction pathways involved in periosteal cell response to short-term loading and to 
determine whether chondrogenesis can be further induced with sustained loading.  Studies, similar 
to that of Chowdhury et al (507), are required to more accurately examine the optimum loading 
conditions needed to stimulate chondrogenic differentiation in human periosteal cells.  Ultimately, 
these studies will be useful in understanding the influences of loading on human periosteal cell 
differentiation and in enhancing the in-vitro development of tissue engineered constructs for 
cartilage regeneration. 
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Chapter 9  
Conclusions 
Tissue Engineering is a thriving area of multi-disciplinary research that has the potential to 
revolutionise the treatment of diseased and damaged tissue.  In orthopaedics, the ultimate challenge 
of repairing and regenerating joints compromised by injury or disease is massive and should not be 
underestimated.  Even small chondral defects may necessitate surgical intervention and would 
benefit from the development of new material- or cell- based therapies that fill the defect and 
integrate with the surrounding tissue; preventing further degeneration and consequent osteoarthritis. 
The size and complexity of the challenges faced by Tissue Engineers over the last 20 years is 
reflected by the relatively few tissue engineered products clinically available to the public.  
Although it is difficult to identify where the largest clinical hurdles are, I believe the greatest need 
for research input resides at the cellular and molecular level.  The successful design of scaffold 
materials and cellular therapies requires an intimate understanding of the complex molecular 
interactions that occur within tissues, between cells and the extracellular environment.  This level 
of understanding is particularly necessary in stem cell research, where remarkable new 
developments have shown adult stem cells to reside in numerous tissues throughout the body.  
These multipotent cell types, recently identified in human periosteal tissue, have the capacity to 
form multiple tissues in-vitro and in-vivo, and will likely fuel the next wave of tissue engineered 
therapies. 
In this thesis, broadly based research teams were brought together to form interdisciplinary 
collaborations, with input received from cell biologists, biomaterial scientists, biomedical 
engineers, and orthopaedic physicians.  Utilising these collaborations, successful in-vitro 
therapeutic models were developed and optimised to characterise, understand, and control 
orthopaedic tissue regeneration using key elements of the tissue engineering tool kit; namely 
differentiated and undifferentiated skeletal cell types with particular tissue function, and polymeric 
biomaterials to support the culture of cells in-vitro and form 3D scaffolds for tissue regeneration in-
vivo. 
In a commercial research venture with Polynovo Biomaterials Pty. Ltd., I helped to develop and 
characterise a novel two-component polyurethane platform that can be administered 
arthroscopically, polymerise at biological temperatures in-situ, and provide appropriate bonding 
strength and mechanical support for orthopaedic applications. These novel polymers provided a 
favourable in-vitro environment for initial cell adhesion, maintained cell viability, and normal rates 
of proliferation of human osteoblasts.  Physicochemical characterisation techniques revealed that 
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heterogeneous topographies and chemical moieties present on the polymer surfaces created 
favourable hydrophilic environments to support human osteoblast attachment and growth. Based on 
the encouraging structural, mechanical, and biological properties, I was able to identify suitable 
orthopaedic applications for this platform technology, particularly as bone glues/cements.   
For cell-based tissue engineering strategies, human periosteum was selected as the therapeutic cell 
source due to its intimate involvement in bone and cartilage formation during embryogenesis, 
fracture healing, and bone remodelling in-vivo and proven osteochondral potential in-vitro.   The 
feasibility in therapeutic applications for isolated periosteal cells and explants has been 
demonstrated previously in small animal models, where certain cells are capable of multilineage 
differentiation, forming bone and cartilage tissue as well as participating in skeletal myogenesis 
(160).  Moreover, the clinical feasibility and safety of the periosteum for cartilage repair has been 
shown in numerous clinical models using periosteal tissue grafts alone or in combination with 
autologous chondrocytes (17;358).  However, a major concern for periosteum-based therapies has 
been the large functional variability in experimental and clinical outcomes. This variability is at 
least partly due to donor-related and harvest site-specific factors, and inconsistencies in cell/explant 
preparation protocols. Previously, surgical skill (386), explant size (368), donor site (359) and 
donor age (387) have been found to significantly influence the quality and regenerative potential of 
periosteal grafts.   
In building on the seminal periosteum studies of Stevens et al.(361;362;401), O’Driscoll et 
al.(31;189-191), and De Bari et al.(160;201), the research presented herein has successfully bridged 
the knowledge gap between periosteal cell phenotype and functionality.  Through the development 
of in-vitro culture models I have successfully investigated the underlying heterogeneities present in 
donor derived human periosteal cell populations. High-quality, viable, human periosteal explants 
composed of both tissue layers were reproducibly harvested from donors during both arthroscopic 
and invasive knee surgeries.  Different enzymatic digestion protocols were designed and optimized 
to preferentially isolate heterogeneous periosteal cell populations from full tissue explants or 
distinct periosteal tissue layers.  Initial cell isolates were found to be morphologically and 
phenotypically heterogeneous, consisting of distinct cell types at different stages on lineage 
commitment and developmental maturation.  A monolayer culture system, without differentiation 
supplements, was designed to allow for the extensive expansion (>20 population doublings) of all 
adherent periosteal cell populations and simultaneous examination of population properties, such as 
growth, morphology, differentiation, phenotype, and genotype.  Robust cell and molecular biology 
assays such as flow cytometry, real time RT-PCR, and immunocytochemistry, were combined with 
standard microscopy techniques to probe distinct cellular changes during culture and examine 
differences between donor-derived populations.  Interestingly, the behavior and phenotype of 
human periosteal cells, particularly progenitor cell types, was heavily influenced by a combination 
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of environmental and cellular factors, including cell-seeding density, culture media, cell-cell 
interactions, and cell-secreted autocrine/paracrine factors.  During culture, significant changes in 
population proliferation rates, growth potential, and colony forming efficiency were correlated with 
changes in cell morphology and linked to progressive changes in overall population phenotype.  
Although significant donor-dependent differences were initially identified in culture, the time-
dependent trends in growth kinetics, morphology, and gene/protein expression were consistent 
across all donors.   
Apart from the biological exploration of general periosteal population characteristics, considerable 
research efforts were made to identify, characterise, and discuss periosteal progenitor cell 
populations.  The ability to continuously examine periosteal cell populations for 15 passages and 
preferentially enrich for cambium layer cells has enabled the identification of two distinct precursor 
populations based on the expression of Stro-1.  In all donors, colony forming, Stro-1+, 
osteoprogenitor cell populations were consistently isolated from tissue explants, regardless of 
donor age.  A separate Stro-1-, more primitive precursor cell subpopulation was only isolated and 
identified in cambium enriched cell cultures.  This morphologically distinct subpopulation was 
found to consist of small, rounded, agranular, highly-proliferative cells with an increased capacity 
to form large cell colonies and differentiate into osteogenic cell types.  This more primitive Stro-1-, 
subpopulation, however, was rapidly lost in culture, whereas Stro-1+ osteoprogenitor cells were 
cultured for up to 15 passages without a loss in population numbers or ability to form mineralized 
tissue.  Gene expression analysis confirmed that in the absence of differentiation stimuli, 
monolayer cultured human periosteal cells were found to adopt a more osteogenic phenotype.   
To induce periosteal cell chondrogenesis, a 3-dimensional culture environment combined with 
chondroinductive stimuli, in the form of chemical and physical factors, was required.  For this, a 
periosteal-agarose cell culture model was created to control and monitor lineage specific 
differentiation in biomechanical and biochemical environments.  As an initial proof-of-concept 
demonstration, dynamic mechanical loading of periosteal cell constructs was found to successfully 
promote early chondrogenic differentiation.  This chondrogenic effect was dependent upon the 
applied loading profile, complex interaction between TGF-β3 and dynamic loading, and donor.  
Although more studies with more donor populations are needed, initial results demonstrate the 
usefulness of this model system for studying the complex cellular and molecular responses to 
biophysical and biochemical loading environments.   
For the development of periosteal cell-based therapies, there is a considerable need to target and 
isolate specific cell types to allow for further analysis and amplification ex-vivo.  In this thesis 
numerous cell enrichment techniques were performed to isolate rare progenitor cell phenotypes 
present in heterogeneous human periosteal cell cultures.  These techniques included selective 
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adherence to tissue culture plastic, FACS, MACS, sequential tissue digestion, and droplet 
microfluidics.  The selective adherence of periosteal cells to tissue culture plastic resulted in the 
propagation of numerous mesenchymal cell types and was unable to selectively enrich progenitor 
cell types.  The physically demanding sorting processes of FACS and MACS were continuously 
plagued by viability loss and compromised sterility and were also unable to accurately isolate pure 
Stro-1+ progenitor cell populations.  Due to these challenges, alternative strategies were explored.   
The design of a sequential digestion protocol allowed for the preferential isolation, expansion, and 
characterisation of periosteal cell populations consisting mostly of cambium or fibrous layer cells.  
Although this technique was found to be successful in its ability to identify and enrich for highly 
proliferative Stro-1+ and Stro-1- precursor cell types, these liberated periosteal cell populations 
were phenotypically heterogeneous.  In moving forward to more complex strategies, droplet 
microfluidics was identified as a promising alternative technology for the rapid, specific and 
detailed analysis of periosteal cell populations due to its robust functionality and versatility.  By 
controlling fluid streams in microchannels, we were able to compartmentalise single cells and 
direct droplet-laser interactions to measure cell surface properties.  Single-cell immunodetection 
measurements were correlated with other phenotypic characteristics, allowing information to be 
easily gathered on how progenitor cells were distributed in heterogeneous periosteal cell 
populations.  Based on these results, droplet-based microfluidics was found to be an accurate and 
reproducible strategy to simultaneously isolate and detect typical (ALP+) and atypical (Stro-1+) cell 
types present in human periosteal cell cultures. Moreover, the biological utility and reliability of 
this system for cell characterisation was further confirmed by comparing results with conventional 
flow cytometry.  In the context of this thesis, droplet microfluidics was found to be a robust tool, 
with the potential to simplify complex biological processes present in human periosteal cell 
cultures so that we may better comprehend their interactions, functions, and role in biology.  Apart 
from stem cell research, this technology would be hugely useful in numerous application fields, 
including immunology, microbiology, parasitology, and oncology.  Utilising this exciting platform 
technology, future work should focus on sorting potentially therapeutic periosteal cell types 
identified in this thesis (Stro-1+ and Stro-1- precursor cells) so that they may be further 
characterised and exploited in tissue engineering applications.   
It is hoped that the promising results and well-defined and optimised cell isolation and culture 
models presented in this thesis will encourage researchers to further explore the behaviour and 
characteristics of human periosteal cells.  In building off of the protocols developed here, more 
robust analytical technologies such as microarrays (145) and mass-spectroscopy proteomics (541), 
may provide a definitive picture of the complex biological signals and cues that trigger natural 
development and repair processes in joints.  In progressing into clinic, it is this knowledge that will 
be exploited in tissue engineering and regenerative medicine applications. 
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Appendices 
 
Appendix A: Osteoblast phenotyping 
 
An all important aspect for the study performed in Chapter 3 was the confirmation of the osteoblast 
phenotype of the primary human cells isolated from femoral heads.  This was achieved by positive 
immunostaining of 2 bone specific proteins, alkaline phosphatase (ALP) and collagen type I (Col. 
Type I) after 7 days in culture (Figure A.1.).  These two markers have been used extensively to 
identify differentiated osteoblastic phenotypes.  ALP is a plasma membrane bound enzyme found 
in differentiated osteoblasts and has been implicated in the initiation of mineralization.  Col type I 
is a protein synthesised and secreted by osteoblasts and is therefore one of the major proteins found 
in bone ECM. The images positive for Collagen Type I (figure 12b) and ALP (figure 12a) show 
strong positive cell cytoplasm staining, indicating that the cell population used in this study is 
composed of differentiated osteoblasts.  This study was performed at 7 days to show that the 
osteoblasts used throughout this study maintain a stable phenotype in all the assays run.  Thus, this 
quality control experiment confirms that we are in fact performing this study with differentiated 
human osteoblasts. 
 
Figure A.1 Detection of ALP (A) and Col Type I (B) expression in adult human osteoblasts by 
immunofluorescent staining.  Primary osteoblasts were grown on chamber slides for 7 days and stained with 
conjugated antibodies specific for bone ALP (Green) and Col Type I (Red).  Cells were counter-stained with 
dapi (blue) to display cell nuclei.  Images show a significant amount of positively staining, indicative of 
mature osteoblasts. 
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Appendix B: Cell-cycle analysis of periosteal cells 
 
 
 
Figure B.1 Representative results of the step-wise gating method used to analyse the percentages of 
quiescent and proliferating cell populations in human periosteal cell cultures.  Cellular debris and clumped 
cell clusters were excluded from the analysis by progressively gating on nucleated and single cells (Gates R1 
and R2).  From this filtered population a gate (R3) was set, based on the isotype control histogram, to identify 
the total population of cells expressing the proliferation marker, Ki-67.  Additionally, the percentages of cells 
in G0/G1, S, or G2/M phase were determined in each sample based on the DNA histogram.  Further, a gate 
(R4) was set for cells in G0/G1 phase based on DNA content.  Double staining with Ki-67 was used to 
discriminate between cells in resting G0 and cells in activated G1 phase. Cells in the active, proliferating 
phase were defined as cells expressing Ki-67 (R5), whereas cells in G0 showed no expression of Ki-67.   
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Appendix C: Shape factor coefficient analysis of human 
periosteal cells 
 
 
 
Figure C.1 Characterisation of cell shape in human periosteal cell cultures from 6 donors between passages 
0-20.  At each passage, area and perimeter of 50-100 cells were measured and used to calculate shape factor 
coefficient.  By definition, a Sfc value of 1 corresponds to a perfect circle, whereas a straight line has a value 
of 0: hence the more elongated the cell shape is, the lower the Sfc value.  Scatter plots display the changes in 
Sfc values (mean ± SD) during culture.  Linear regression analysis of this data reveals no significant 
correlation (two-tailed t-test, p > 0.05) between Sfc and time in culture in 5 of the 6 donors examined, with 
Pearson’s product-moment correlation coefficients ranging from -0.33 to 0.98.   
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Appendix D: Antibody binding, titration, and specificity 
 
To reduce the amount of cross-reactivity and non-specific mAb-protein binding, animal serums 
were tested for their ability to block non-specific binding sites (Figure D.1). Normal mouse serum 
was chosen as the optimal blocking agent for its ability to reduce non-specific background noise 
without significantly affecting positive staining.  This allows for improved separation between 
negatives (isotype control stained cells) and positives (antigen specific staining).   
 
 
Figure D.1 Bivariate dot-plots of flow cytometric analysis of serum blocking experiments. Human periosteal 
cells were blocked with 0.1% (v/v) normal animal serum from a mouse or goat and further stained with APC-
conjugated alkaline phosphatase and appropriately matched isotype-matched control antibodies.  Gates were 
set on each sample to determine the effectiveness of the blocking agent to reduce background staining 
(isotype controls) without causing a decrease in positive staining.  Control samples of unblocked cells were 
used to establish the baseline level of non-specific binding in periosteal cell cultures.  Normal mouse serum 
was chosen as the optimal blocking agent for its ability to reduce non-specific background noise without 
significantly affecting positive staining. 
 
Second, mAbs Stro-1, D7-fib, ALP, and CD34 were titrated with periosteal cells at concentrations 
between 0.25-3.0 3.0 µg/106 cells using appropriately matched isotype controls.  Based on the 
signal to noise ratio or %Fsp (specific fluoresecence/total fluorescence x 100) the saturation point 
of each mAb was defined and further used to test to their specificity in various cell types (Figure 
D.2).     
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Figure D.2 Titration of antibody cell reactions by flow cytometry.  Graphs A and E, B and F, C and G, and D 
and H represent four different antibodies with different affinities: ALP (A and D), D7-fib (B and F), Stro-1 
(C and G), CD34 (D and H). Graphs A, B, C, D show mean fluorescence intensity of positively stained 
periosteal cells (Ftot, ■) with mAb concentrations between 0.25 – 3.0 µg/106 cells.  The mean fluorescence 
of appropriately match Isotype controls (Fbkgd, ○) were used at the same concentrations as positive samples.  
These values were then used to find the staining sensitivity, or % Fsp, that is defined by the equation %Fsp = 
(Ftot – Fbkgrd)/Ftot x 100.  Graphs E, F, G, and H show % Fsp for each antibody.  The peak value of % Fsp 
determines the optimal staining concentrations used in this thesis. At these concentrations the greatest 
distances between positive and negative fluorescent distributions are achieved.   
 
Third, flow cytometry was used to define the level of mAb staining in human osteoblasts, fetal 
osteoblasts, human forskin fibroblasts, and osteosarcoma cell lines Saos-2 and MG63 (Figure D.3).  
Results revealed that fibroblast marker, D7-fib, was broadly expressed on all cell types tested 
(>95% of cells) and was therefore not specific to fibroblasts.  This level of non-specific binding 
was deemed unsatisfactory and the antibody was therefore not used for subsequent periosteal 
characterisation studies.  Conversely, the cell specificity of mAb ALP was predictable, with a high 
level of expression in osteoblasts (>72%) and osteosarcoma cell lines (>90%) and low  expression 
levels in fibroblasts (~2%). Stro-1, a progenitor cell marker, showed a high level of reactivity in 
MG63 cells (>98%) and low to undetectable levels of expression in Saos-2 cells and primary 
osteoblasts and fibroblasts (<2%).    
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Figure D.3  Bivariate dot plots of the tissue specificity of mAbs D7-fib (fibroblasts), ALP (osteoblasts), and 
Stro-1 (progenitor cells).  Flow cytometry was used to assess the level of positive staining in human 
osteoblasts (hOBs), fetal osteoblasts (fOBs), foreskin fibroblasts (HFFs) and osteosarcoma cell lines SaoS-2 
and MG63. In all cases, aggregates and dead cells were filtered from the analysis by examining plots of 
population light-scatter characteristics.  Additionally, in each analysis quandrant gates were set using 
appropriately matched isotype controls.  The numbers shown in each gate represent the number of positively 
stained cells as a percentage of total cells examined.  More than 20,000 cells were stained and examined in 
each plot.  
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Appendix E: Human periosteal cell phenotype 
 
 
 
Figure E.1  Expression of SSEA-1 and α-smooth muscle actin in embryonic stem cells and periosteal cells 
cultured on 4-well chamber slides for a period of 4 days. Images show (A) Positive staining for SSEA-1 (red) 
in differentiating embryoid bodies present in passage 15 mouse embryonic stem cells. (B) SSEA-1 staining in 
passage 0 human periosteal cells, showing no expression of the antigen.  (C and D) Positively stained cells 
within passage 0 human periosteal cell cultures isolated from a 32 yr old male, expressing α-smooth muscle 
actin (green) within the cell cytoplasm. (E and F) Positively stained cells identified within passage 13 
periosteal cell cultures isolated a 32 yr old male. (In all images blue stain = cell nuclei).  
 
 
FigureE.2  Oil-Red O staining of lipid droplets (dark red) within A549 and periosteal cells cultured for 4 
days on 4-well chamber slides.  (A) Positive control A549 cells showing a majority of cells expressing large 
deposits of lipids within their cytoplasm. (B & C) Passage 0 periosteal cells isolated from a 74 yr old female 
highlighting cells positive (B) and negative (C) for lipid droplets. (D) Positive staining of passage 5 
periosteal cells isolated from a 74 yr old female.  (E and F) Passage 12 periosteal cells isolated from a 74 yr 
old female (E) and 32 yr old male showing populations of cells void of cytoplasmic lipid accumulation. In all 
images a filter was applied to equalise shadows, midtones, and highlights by automatically redistributing the 
significant pixel values throughout the tonal range (Corel Photo-Paint; Corel Corporation, Berks, UK). 
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Figure E.3  Dual-color flow cytometric analysis depicting the cell surface expression of the Stro-1 and ALP 
antigens (A) and CD34 and CD45 antigens (B) on single-cell suspensions of periosteal cells.  The gates were 
set to  >98% of reactivity levels obtained with the isotype matched control antibodies for Stro-1 (IgM: FITC) 
and ALP (IgG1:APC) and CD34 (IgG1: PE) and CD45 (IgG1: APC), shown in histograms (C) and (D) 
respectively. In each instance, more than 20,000 events were collected to determine the percentage positive 
expression. 
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Appendix F: Strain translation methodology 
 
 
 
Figure F.1 ImageJ software manipulation of a representative fluorescent image of cell-agarose constructs in 
compression. a) The original digital image taken after compression. b) Threshold applied to distinguish cell 
nuclei. c) Cells outlined and assigned numbers and (X, Y) coordinates, which are then used to determine 
displacements. 
a) b) 
c) 
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